
<html lang="en"     class="pb-page"  data-request-id="936aae96-1eb1-432f-86a3-bd08e126dbae"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b00797;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-15;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor" /></meta><meta name="dc.Creator" content="Jayaraman  Chandrasekhar" /></meta><meta name="dc.Creator" content="Ryan  Dick" /></meta><meta name="dc.Creator" content="Joshua  Van Veldhuizen" /></meta><meta name="dc.Creator" content="David  Koditek" /></meta><meta name="dc.Creator" content="Eve-Irene  Lepist" /></meta><meta name="dc.Creator" content="Mary E.  McGrath" /></meta><meta name="dc.Creator" content="Leena  Patel" /></meta><meta name="dc.Creator" content="Gary  Phillips" /></meta><meta name="dc.Creator" content="Kassandra  Sedillo" /></meta><meta name="dc.Creator" content="John R.  Somoza" /></meta><meta name="dc.Creator" content="Joseph  Therrien" /></meta><meta name="dc.Creator" content="Nicholas A.  Till" /></meta><meta name="dc.Creator" content="Jennifer  Treiberg" /></meta><meta name="dc.Creator" content="Armando G.  Villaseñor" /></meta><meta name="dc.Creator" content="Yelena  Zherebina" /></meta><meta name="dc.Creator" content="Stephane  Perreault" /></meta><meta name="dc.Description" content="Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis. In this manuscript, we report a case in which torsional scan ..." /></meta><meta name="Description" content="Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis. In this manuscript, we report a case in which torsional scan ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 17, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00797" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00797" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00797" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00797" /></link>
        
    
    

<title>Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00797" /></meta><meta property="og:title" content="Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0011.jpeg" /></meta><meta property="og:description" content="Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis. In this manuscript, we report a case in which torsional scan studies guided the thoughtful creation of a restricted axis of rotation between two heteroaromatic systems of a phosphoinositide 3-kinase (PI3K) β inhibitor, generating a pair of atropisomeric compounds with significantly different pharmacological and pharmacokinetic profiles. Emblematic of these differences, the metabolism of inactive (M)-28 is primarily due to the cytosolic enzyme aldehyde oxidase, while active (P)-28 has lower affinity for aldehyde oxidase, resulting in substantially better metabolic stability. Additionally, we report torsional scan and experimental studies used to determine the barriers of rotation of this novel PI3Kβ inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00797"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00797">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00797&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00797&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00797&amp;href=/doi/10.1021/acs.jmedchem.8b00797" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6858-6868</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00737" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00808" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jayaraman Chandrasekhar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jayaraman Chandrasekhar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jayaraman++Chandrasekhar">Jayaraman Chandrasekhar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ryan Dick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryan Dick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryan++Dick">Ryan Dick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joshua Van Veldhuizen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joshua Van Veldhuizen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joshua++Van+Veldhuizen">Joshua Van Veldhuizen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Koditek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Koditek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Koditek">David Koditek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eve-Irene Lepist</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eve-Irene Lepist</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eve-Irene++Lepist">Eve-Irene Lepist</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mary E. McGrath</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mary E. McGrath</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mary+E.++McGrath">Mary E. McGrath</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leena Patel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leena Patel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leena++Patel">Leena Patel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary Phillips</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary Phillips</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Phillips">Gary Phillips</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kassandra Sedillo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kassandra Sedillo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kassandra++Sedillo">Kassandra Sedillo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John R. Somoza</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John R. Somoza</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+R.++Somoza">John R. Somoza</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph Therrien</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph Therrien</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Therrien">Joseph Therrien</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicholas A. Till</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicholas A. Till</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+A.++Till">Nicholas A. Till</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer Treiberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer Treiberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Treiberg">Jennifer Treiberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Armando G. Villaseñor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Armando G. Villaseñor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Armando+G.++Villase%C3%B1or">Armando G. Villaseñor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yelena Zherebina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yelena Zherebina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yelena++Zherebina">Yelena Zherebina</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Stephane Perreault</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephane Perreault</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (206) 832-2029. E-mail: <a href="/cdn-cgi/l/email-protection#d0a3a4b5a0b8b1beb5fea0b5a2a2b5b1a5bca490b7b9bcb5b1b4feb3bfbd"><span class="__cf_email__" data-cfemail="4e3d3a2b3e262f202b603e2b3c3c2b2f3b223a0e2927222b2f2a602d2123">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephane++Perreault">Stephane Perreault</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8732-5243" title="Orcid link">http://orcid.org/0000-0001-8732-5243</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00797&amp;href=/doi/10.1021%2Facs.jmedchem.8b00797" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6858–6868</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 17, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 May 2018</li><li><span class="item_label"><b>Published</b> online</span>17 July 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 August 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00797" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00797</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6858%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJayaraman%2BChandrasekhar%252C%2BRyan%2BDick%252C%2BJoshua%2BVan%2BVeldhuizen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D15%26contentID%3Dacs.jmedchem.8b00797%26title%3DAtropisomerism%2Bby%2BDesign%253A%2BDiscovery%2Bof%2Ba%2BSelective%2Band%2BStable%2BPhosphoinositide%2B3-Kinase%2B%2528PI3K%2529%2B%25CE%25B2%2BInhibitor%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6868%26publicationDate%3DAugust%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00797"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2256</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00797" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jayaraman&quot;,&quot;last_name&quot;:&quot;Chandrasekhar&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;Dick&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;Van Veldhuizen&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Koditek&quot;},{&quot;first_name&quot;:&quot;Eve-Irene&quot;,&quot;last_name&quot;:&quot;Lepist&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;E. McGrath&quot;},{&quot;first_name&quot;:&quot;Leena&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Phillips&quot;},{&quot;first_name&quot;:&quot;Kassandra&quot;,&quot;last_name&quot;:&quot;Sedillo&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;R. Somoza&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Therrien&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;A. Till&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Treiberg&quot;},{&quot;first_name&quot;:&quot;Armando&quot;,&quot;last_name&quot;:&quot;G. Villaseñor&quot;},{&quot;first_name&quot;:&quot;Yelena&quot;,&quot;last_name&quot;:&quot;Zherebina&quot;},{&quot;first_name&quot;:&quot;Stephane&quot;,&quot;last_name&quot;:&quot;Perreault&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6858-6868&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00797&quot;},&quot;abstract&quot;:&quot;Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis. In this manuscript, we report a case in which torsional scan studies guided the thoughtful creation of a restricted axis of rotation between two heteroaromatic systems of a phosphoinositide 3-kinase (PI3K) β inhibitor, generating a pair of atropisomeric compounds with significantly different pharmacological and pharmacokinetic profiles. Emblematic of these differences, the metabolism of inactive (M)-28 is primarily due to the cytosolic enzyme aldehyde oxidase, while active (P)-28 has lower affinity for aldehyde oxidase, resulting in substantially better metabolic stability. Additionally, we report torsional scan and experimental studies used to determine the barriers of rotation of this novel PI3Kβ inhibitor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00797&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00797" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00797&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00797" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00797&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00797" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00797&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00797&amp;href=/doi/10.1021/acs.jmedchem.8b00797" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00797" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00797" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00797%26sid%3Dliteratum%253Aachs%26pmid%3D30015489%26genre%3Darticle%26aulast%3DChandrasekhar%26date%3D2018%26atitle%3DAtropisomerism%2Bby%2BDesign%253A%2BDiscovery%2Bof%2Ba%2BSelective%2Band%2BStable%2BPhosphoinositide%2B3-Kinase%2B%2528PI3K%2529%2B%25CE%25B2%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D15%26spage%3D6858%26epage%3D6868%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=290795" title="Quinolines">Quinolines</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/jmcmar.2018.61.issue-15/20180809/jmcmar.2018.61.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to hindered rotation around a bond axis. In this manuscript, we report a case in which torsional scan studies guided the thoughtful creation of a restricted axis of rotation between two heteroaromatic systems of a phosphoinositide 3-kinase (PI3K) β inhibitor, generating a pair of atropisomeric compounds with significantly different pharmacological and pharmacokinetic profiles. Emblematic of these differences, the metabolism of inactive (<i>M</i>)-<b>28</b> is primarily due to the cytosolic enzyme aldehyde oxidase, while active (<i>P</i>)-<b>28</b> has lower affinity for aldehyde oxidase, resulting in substantially better metabolic stability. Additionally, we report torsional scan and experimental studies used to determine the barriers of rotation of this novel PI3Kβ inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chirality exists in different forms. Although central or point chirality (a central atom bearing different substituents) is by far the most commonly encountered, other forms of chirality, such as axial chirality, helical chirality, and planar chirality, have been investigated over the years.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Atropisomerism is a type of axial chirality in which enantiomers or diastereoisomers arise due to restricted or hindered rotation around a bond axis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Atropisomer interconversion occurs via an intramolecular dynamic process that only involves bond rotation. This time-dependent event is primarily affected by steric hindrance, stereoelectronic effects, solvent, and temperature.</div><div class="NLM_p">Similar to central stereoisomers, atropisomeric drug molecules have been shown to exhibit distinct biological activity on- and off-target.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Differences in toxicological and pharmacokinetic properties are also encountered. The presence of an axis of atropisomerism can complicate several aspects of drug discovery, including synthesis, analytical characterization, drug metabolism, and pharmacokinetics. Strategically, these potential issues can be alleviated by introducing symmetry to remove the axis of chirality or reducing steric hindrance to allow free rotation. Alternatively, purposely increasing steric hindrance around atropisomeric axes to prevent interconversion can potentially result in improved potency, selectivity, safety, and chemical stability.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The rate of interconversion of an atropisomeric drug molecule is an important parameter to consider.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Many compounds with atropisomeric centers advance into development, but the majority of them have low rotational barriers (Δ<i>E</i><sub>rot</sub>) and are classified as class 1 atropisomers, meaning they are rapidly equilibrating mixtures with all Δ<i>E</i><sub>rot</sub> < 20 kcal/mol.<a onclick="showRef(event, 'cit6a'); return false;" href="javascript:void(0);" class="ref cit6a">(6a)</a> It has been recommended that an atropisomeric compound containing one or more atropisomeric axes with Δ<i>E</i><sub>rot</sub> > 30 kcal/mol (class 3) should be developed as a single atropisomer. Compounds in class 2 (20 kcal/mol < Δ<i>E</i><sub>rot</sub> < 30 kcal/mol) can be challenging to develop given that stereochemical integrity can be compromised over the time course of drug production and administration to patients.</div><div class="NLM_p">We are interested in the development of selective inhibitors of the Class I PI3Kβ lipid kinase for the treatment of various malignancies.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Class I PI3Ks comprise four different isoforms (PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ) and catalyze the phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) to produce the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), which propagates intracellular signaling.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The most common genetic alteration of the PI3Kβ signaling pathway found in human cancer is the inactivation of the phosphatase and tensin homologue (PTEN) tumor suppressor gene. Inactivation of PTEN leads to loss of its lipid phosphatase activity, causing accumulation of PIP3 and aberrant downstream signaling.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Preclinical studies have shown that down-regulation of PI3Kβ in PTEN-deficient cancer cells results in pathway inactivation and subsequent inhibition of growth in both cell-based and in vivo settings.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">In this manuscript, we describe the utility of atropisomerism in the discovery of a potent, selective, and metabolically stable PI3Kβ inhibitor. Torsional scan studies guided the strategic design of a restricted axis of rotation around a carbon–nitrogen bond between two heteroaromatic systems, generating a pair of atropisomeric compounds with differential pharmacological and pharmacokinetic profiles. Additionally, we report torsional scan and experimental studies used to determine the rotational barriers of this novel PI3Kβ inhibitor.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A compound arising from our PI3K program is the ATP competitive PI3Kβ inhibitor <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The binding mode of <b>1</b> has not been characterized crystallographically in PI3Kβ. However, it can be modeled in a published cocrystal structure of mouse p110β (catalytic subunit of PI3Kβ, residues 114–1064, pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BFR">4BFR</a>).<a onclick="showRef(event, 'cit7c'); return false;" href="javascript:void(0);" class="ref cit7c">(7c)</a> Compound <b>1</b> is likely to bind to the ATP binding site of the kinase domain of p110β with the 2-aminopyridine moiety acting as a two-point hinge binder with Val848. The quinoline adopts an orthogonal conformation relative to the benzimidazole to partially fill the specificity pocket between Met773 and Trp781. The triazole is oriented toward the affinity pocket, and Lys799 potentially interacts with both the triazole and the benzimidazole nitrogen atoms.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Docked pose of <b>1</b> in the cocrystal structure of mouse p110β (catalytic subunit of PI3Kβ, residues 114–1064, pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BFR">4BFR</a>, coordinates included in the <a class="ref internalNav" href="#notes1" aria-label="SI">SI</a>). The quinoline adopts an orthogonal conformation relative to the benzimidazole. For clarity, some residues have been removed. Blue dashed lines show hydrogen bond contacts between the inhibitor and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of this modeled orthogonal binding mode of compound <b>1</b> in PI3Kβ, we envisioned restricting the free rotation around the C–N bond connecting the two bicyclic systems by generating an axis of atropisomerism. The general idea behind this strategy was to minimize the loss in entropy to reach the preferred binding conformation, ultimately resulting in a gain in binding free energy. Additionally, in the context of kinase inhibitor research, this approach can possibly lead to improved kinome selectivity resulting from a limitation of accessible conformations.<a onclick="showRef(event, 'cit5d'); return false;" href="javascript:void(0);" class="ref cit5d">(5d)</a></div><div class="NLM_p">Consequently, we computationally explored the rotational barriers (Δ<i>E</i><sub>rot</sub>) of a large set of 4-(1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)quinolines with different substitution patterns that could impact the rate of interconversion between atropisomers (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In the torsional scan studies using molecular mechanics (MMFFs force field), the rotation around the C–N bond connecting the quinoline and the benzimidazole was driven in both directions (clockwise and counterclockwise) for both possible transition states (TS<sub>in</sub> and TS<sub>out</sub>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> As the bond torsion approaches coplanarity, the strain energy increases. The best estimates for the barriers via TS<sub>in</sub> and TS<sub>out</sub> were obtained from the lowest energy pathway in either direction. For compounds with extremely hindered rotation, the truly coplanar states could never be achieved, revealing significant hysteresis due to high energy penalties.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The rotational barriers of those compounds are reported as >40 kcal/mol.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Rotational Barriers of Related 4-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)quinolines<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0008.gif" alt="" id="GRAPHIC-d7e441-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0009.gif" alt="" id="GRAPHIC-d7e442-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Using MMFFs force field, the best estimates for the rotational barriers Δ<i>E</i><sub>rot</sub> via TS<sub>in</sub> and TS<sub>out</sub> were obtained from the lowest energy pathway in either direction (clockwise or counterclockwise). The lowest energy pathway is highlighted in blue. Because of significant distortion, all values above 40 kcal/mol are reported as >40 kcal/mol.</p></div></div><div></div></div><div class="NLM_p">For all monosubstituted compounds (<b>2</b>–<b>9</b>), bond rotation via TS<sub>out</sub> is consistently predicted to have the lowest energy pathway. The analogs are all indicated to be class 1 or 2 in terms of the magnitude of the barrier for atropisomer interconversion according to Laplante et al.<a onclick="showRef(event, 'cit6a'); return false;" href="javascript:void(0);" class="ref cit6a">(6a)</a> The 2-methyl substituent on the benzimidazole (<b>9</b>) leads to the highest TS<sub>out</sub> rotational barrier of this group with a Δ<i>E</i><sub>rot</sub> = 28.3 kcal/mol. Disubstitution appears to be needed to shift the analogs to class 3 category. With a few exceptions, the lowest energy pathway for the disubstituted compounds <b>10</b>–<b>27</b> is also TS<sub>out</sub>. Among those compounds, ten have Δ<i>E</i><sub>rot</sub> > 30 kcal/mol, putting them in the class 3 atropisomer category. The combination of a 2-substituted benzimidazole with a 3- or 5-substituted quinoline appears to be a consistently reliable way to create noninterconverting, class 3 atropisomerism.</div><div class="NLM_p">According to the previous estimated rotational barriers, compound <b>1</b>, which is closely related to compound <b>3</b>, is predicted to have a low rotational barrier (Δ<i>E</i><sub>rot</sub> < 20 kcal/mol). Applying the findings of compound <b>10</b>, we envisaged restricting free rotation around the C–N bond of <b>1</b> by introducing a methyl group at the C2-position of the benzimidazole in combination with the 5,8-difluoroquinoline ((<i>rac</i>)-<b>28</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This modification results in enhanced PI3Kβ biochemical potency, presumably by minimizing entropic loss to reach the preferred binding conformation; it also affords improved selectivity over the other three Class I PI3K isoforms.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency Profiles against Class I PI3Ks<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0010.gif" alt="" id="GRAPHIC-d7e538-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center">(<i>rac</i>)-<b>28</b></th><th class="colsep0 rowsep0" align="center">(<i>M</i>)-<b>28</b></th><th class="colsep0 rowsep0" align="center">(<i>P</i>)-<b>28</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kα IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">233</td><td class="colsep0 rowsep0" align="left">264</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">188</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kβ IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1423</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kδ IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kγ IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">440</td><td class="colsep0 rowsep0" align="left">4156</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">4269</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The activity against each Class I PI3K was evaluated in in vitro kinase assays containing 2*K<sub>m</sub> steady state concentrations of ATP (average of ≥2 determinations; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for more details).</p></div></div></div><div class="NLM_p">Chiral supercritical fluid chromatography (SFC) analysis of (<i>rac</i>)-<b>28</b> revealed the presence of atropisomers, which were not observed for compound <b>1</b>. The C2-methyl group likely hinders rotation around the C–N bond due to a larger steric clash with the C5-fluorine of the quinoline moiety. This observation encouraged us to separate both atropisomers by chiral preparative SFC to provide enantiopure (<i>M</i>)-<b>28</b> and (<i>P</i>)-<b>28</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Upon evaluation in our Class I PI3K biochemical assays, the single atropisomers (<i>M</i>)-<b>28</b> and (<i>P</i>)-<b>28</b> exhibit substantially different potency profiles in all four isoforms. (<i>P</i>)-<b>28</b> displays an IC<sub>50</sub> of 2 nM against PI3Kβ with good selectivity over the other three isoforms, while (<i>M</i>)-<b>28</b> is significantly less active.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">The absolute configurations of the single atropisomers were unambiguously determined by X-ray crystallography of (<i>P</i>)-<b>28</b> bound in the PI3Kδ ATP binding site (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DGT">6DGT</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The axial configurations were determined by analysis of Newman projections and assignment of atom priority according to the CIP-system.<a onclick="showRef(event, 'cit2b ref16'); return false;" href="javascript:void(0);" class="ref cit2b ref16">(2b,16)</a> As predicted, the 2-aminopyridine moiety acts as a two-point hinge binder, making two hydrogen-bond interactions with Val828. The quinoline occupies the specificity pocket between Met752 and Trp760, a closed pocket in the apo structure of the enzyme.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> The dihedral angle of the quinoline and benzimidazole C–N bond is 85°. The triazole is directed toward the affinity pocket, making hydrogen bond contacts with Lys779, Asp787, and Tyr813.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. 2.60 Å X-ray crystal structure of (<i>P</i>)-<b>28</b> bound in the PI3Kδ ATP binding site (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DGT">6DGT</a>). For clarity, some residues have been removed. Blue dashed lines show hydrogen bond contacts between the inhibitor and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The limited number of accessible conformations of (<i>P</i>)-<b>28</b> may impart improved selectivity over other protein and lipid kinases that show reduced conformational flexibility of their ATP pocket. Profiling of the freely rotating compound <b>1</b> and the locked single atropisomer (<i>P</i>)-<b>28</b> against more than 400 human kinases using the DiscoveRx KINOMEscan platform at a compound concentration of 10 μM revealed superior selectivity of the atropisomeric compound (<i>P</i>)-<b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a for <b>1</b> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b for (<i>P</i>)-<b>28</b>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In this active site-directed competition assay, (<i>P</i>)-<b>28</b> has higher affinity binding for PI3Kβ (lager blue circle) and still shows considerably less off-kinase activity (fewer and smaller red circles).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Protein and lipid kinase selectivity profiles of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a) and (<i>P</i>)-<b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b) using the DiscoveRx KINOMEscan platform at a compound concentration of 10 μM (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for data report). PI3Kβ highlighted with a blue circle. Image generated using TREEspot Software Tool and reprinted with permission from KINOMEscan, a division of DiscoveRx Corporation, DiscoveRx Corp., 2010.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further characterization of the single atropisomers revealed very low intrinsic clearance in human hepatocytes (hHep) for the potent atropisomer (<i>P</i>)-<b>28</b> (0.08 L/h/kg), contrasted with much a higher value for (<i>M</i>)-<b>28</b> (1.97 L/h/kg) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The large difference in intrinsic hepatic clearances prompted us to determine their respective metabolic profiles in cryopreserved human hepatocytes (see <a class="ref internalNav" href="#notes1" aria-label="Supporting Information">Supporting Information</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a>) for complete analyses of the metabolic profiles of (<i>M</i>)-<b>28</b> and (<i>P</i>)-<b>28</b>)). In the case of metabolically less stable (<i>M</i>)-<b>28</b>, the major metabolites result from the oxidation of the quinoline moiety to the corresponding quinolinone <b>M1</b><named-content content-type="anchor" rid="fig4" type="simple"></named-content>(mainly observed as glucuronide adduct) and the formation of three unique metabolites stemming from triazole oxidation (<b>M2</b>-<b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Interestingly, the analogous oxidation of the quinoline could not be identified and the oxidative turnover of the triazole seems to be much slower for (<i>P</i>)-<b>28</b> in the same experiment. The latter observations are consistent with the lower intrinsic hepatic clearance value of the single atropisomer (<i>P</i>)-<b>28</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Intrinsic Clearances and Fraction Metabolized by AO</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(<i>M</i>)-<b>28</b></th><th class="colsep0 rowsep0" align="center">(<i>P</i>)-<b>28</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hHep CL<sub>int</sub> (L/h/kg)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1.97</td><td class="colsep0 rowsep0" align="left">0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM CL<sub>int</sub> (L/h/kg)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left"><0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">f<sub>m,AO</sub> (%)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">BLQ</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Intrinsic clearance determined from cryopreserved human hepatocytes.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Intrinsic clearance determined from human liver microsomes fortified with NADPH and UDGPA.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Fraction metabolized by AO determined from the ratio of human hepatocyte <i>t</i><sub>1/2</sub> with and without hydralazine (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for more details). NADPH = nicotinamide adenine dinucleotide phosphate; UDGPA = uridine diphosphate glucuronic acid; BLQ = below level of quantification.</p></div></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Major metabolites of (<i>M</i>)-<b>28</b> after 4 h incubation in cryopreserved human hepatocytes. The analogous oxidation of the quinoline to <b>M1</b> for (<i>P</i>)-<b>28</b> could not be identified in the same experiment (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for complete analyses of the metabolic profiles of (<i>M</i>)-<b>28</b> and (<i>P</i>)-<b>28</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Comparison of the intrinsic clearance values obtained in human hepatocytes with those generated in human liver microsomes exposed a significant discrepancy for (<i>M</i>)-<b>28</b> (hHep CL<sub>int</sub> = 1.97 L/h/kg and HLM CL<sub>int</sub> = 0.15 L/h/kg) but not in the case of (<i>P</i>)-<b>28</b>. Human liver microsomes predominantly contain membrane-bound drug-metabolizing enzymes (e.g., cytochromes P450) and lack appreciable cytosolic enzyme activity. The difference in stability suggests that metabolic enzymes other than CYPs and UGTs are most likely responsible for the majority of the metabolism of (<i>M</i>)-<b>28</b>. Individual metabolic profiles in human liver cytosol revealed significant conversion of (<i>M</i>)-<b>28</b> to <b>M1</b>, while no metabolism of (<i>P</i>)-<b>28</b> was observed (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. UV chromatograms of (<i>M</i>)-<b>28</b> and (<i>P</i>)-<b>28</b> following 2 h incubation with human liver cytosol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Aldehyde oxidase (AO) is one of the few cytosolic oxidative enzymes expressed in the human liver and plays a key role in the metabolism of drugs containing aza-heterocycles, such as purines and quinolines.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To test whether AO is involved in the metabolism of (<i>M</i>)-<b>28</b>, the effect of a specific AO inhibitor, hydralazine at 50 μM, on human hepatocyte stability was determined for both isomers.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The metabolism of (<i>M</i>)-<b>28</b> was inhibited by 69% (equivalent to f<sub>m,AO</sub>) with the inclusion of hydralazine, while no change was observed for (<i>P</i>)-<b>28</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). These data demonstrate clear stereospecific substrate specificity for AO for this atropisomeric pair of compounds.</div><div class="NLM_p">Advanced characterization of (<i>P</i>)-<b>28</b> revealed that it does not inhibit CYPs or hERG at a concentration of 25 μM. Moreover, no substantial activity was noted for (<i>P</i>)-<b>28</b> when tested for off-target activity in a CEREP panel screen at 10 μM. A summary of the pharmacokinetic parameters in preclinical species after intravenous and oral administration of (<i>P</i>)-<b>28</b> is presented in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. The in vivo data indicate that (<i>P</i>)-<b>28</b> has low to intermediate total clearance (CL) with respect to hepatic blood flow in all species evaluated. Volumes of distribution (<i>V</i><sub>ss</sub>) are close to or lower than total body water in all species with the exception of rat, in which lower plasma protein binding (PPB) is observed. The high oral bioavailability (<i>F</i>) in rat and cynomolgus monkey are consistent with low observed clearance, high permeability (Caco-2 (AB) = 17 × 10<sup>–6</sup> cm/s), and low efflux (Caco-2 (BA/AB) < 1.5).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of Pharmacokinetic Parameters for (<i>P</i>)-28 in Preclinical Species</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">Sprague–Dawley rat</th><th class="colsep0 rowsep0" align="center">Beagle dog</th><th class="colsep0 rowsep0" align="center">Cynomolgus monkey</th><th class="colsep0 rowsep0" align="center">Rhesus monkey</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB (% free)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>3</sup>H CL<sub>pr</sub> (L/h/kg)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (L/h/kg)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.68 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.22 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.10 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2.68 ± 1.10</td><td class="colsep0 rowsep0" align="left">0.89 ± 0.16</td><td class="colsep0 rowsep0" align="left">0.45 ± 0.18</td><td class="colsep0 rowsep0" align="left">0.63 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Terminal t <sub>1/2</sub> (h)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">9.55 ± 2.92</td><td class="colsep0 rowsep0" align="left">3.61 ± 0.16</td><td class="colsep0 rowsep0" align="left">5.17 ± 0.65</td><td class="colsep0 rowsep0" align="left">6.04 ± 0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">3.87 ± 1.14</td><td class="colsep0 rowsep0" align="left">4.04 ± 0.49</td><td class="colsep0 rowsep0" align="left">4.30 ± 0.65</td><td class="colsep0 rowsep0" align="left">6.20 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">60.4 ± 30.1</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">64.2 ± 12.2</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Plasma protein binding.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Predicted clearance in hepatocytes using <sup>3</sup>H compound.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Intravenous doses of (<i>P</i>)-<b>28</b> (1 mg/kg) formulated at in 40% PEG 300 and 60% water.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Half-life intravenous.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Mean residence time intravenous.</p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last">Bioavailability calculated after oral doses of (<i>P</i>)-<b>28</b> (5 mg/kg) formulated in 40% PEG 300 and 60% water. ND = value not determined. (Mean ± SD, <i>n</i> = 3)</p></div></div></div><div class="NLM_p">As discussed earlier, the rate of interconversion of an atropisomeric compound is an important parameter to consider for its development as a clinical candidate. Accordingly, we determined the rotational barriers of compounds <b>1</b> and <b>28</b> using molecular mechanics (MMFFs force field) and ab initio quantum mechanics theory (B3LYP/6-31G**) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In the calculated minimum energy conformations of compound <b>1</b> ((<i>P</i>)-<b>1</b> and (<i>M</i>)-<b>1</b>), the quinoline is twisted with respect to the plane of the benzimidazole by approximatively 45°. In the case of atropisomers (<i>P</i>)-<b>28</b> and (<i>M</i>)-<b>28</b>, the presence of the 2-methyl group on the benzimidazole forces the quinoline to adopt a ground state conformation with a dihedral angle near 60°. The torsional scan studies were again carried out by driving the rotation around the C–N bond connecting the quinoline and the benzimidazole in both directions. For both <b>1</b> and <b>28</b>, the pathway involving TS<sub>in</sub> is calculated to have a higher rotational barrier (35.5 and 39.4 kcal/mol, respectively, using MMFFs).</div><div class="NLM_p">Interconversion of atropisomeric minima is expected to occur exclusively via TS<sub>out</sub> where the corresponding barriers are calculated to be substantially different for compounds <b>1</b> and <b>28</b>. Consistent with the absence of atropisomers for <b>1</b>, the computed rotational barrier via TS<sub>out</sub> is only 16.7 kcal/mol (17.6 kcal/mol with ab initio), suggesting rapid interconversion under ambient conditions (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). At the transition point TS<sub>out</sub> for <b>28</b>, the larger C2-methyl group must overcome steric repulsion with the 5-fluorine of the quinoline, resulting in a higher barrier of rotation of 34.6 kcal/mol (32.6 kcal/mol with ab initio). Compounds (<i>P</i>)-<b>28</b> and (<i>M</i>)-<b>28</b> are predicted to be class 3 atropisomers.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Rotational Barriers of Compounds <b>1</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>The best estimates for the rotational barriers Δ<i>E</i><sub>rot</sub> via TS<sub>in</sub> and TS<sub>out</sub> were obtained from the lowest energy pathway in either direction (clockwise or counterclockwise).</p><p class="last"><span class="fn-label"><sup>b</sup></span>Determined using equilibrium kinetics and the Eyring–Polanyi equation (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for details).</p></p></figure><div class="NLM_p last">We confirmed the conformational stability experimentally by heating to 120 °C an <i>N</i>-methylpyrrolidine solution of atropisomerically pure (<i>M</i>)-<b>28</b>. Chiral SFC analysis after 240 and 432 h revealed partial conversion to (<i>P</i>)-<b>28</b> (22% and 27%, respectively). The interconversion is a reversible process following first order kinetics in both directions in which the rotational barriers are the same for both atropisomers. Applying the principles of equilibrium kinetics, the rate constant <i>k</i> at 120 °C was determined to be 2.64 × 10<sup>–7</sup> s<sup>–1</sup> (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for details).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> On the basis of the Eyring-Polanyi equation Δ<i>E</i><sub>rot</sub> = −<i>RT</i> × ln(<i>kh</i>/<i>k</i><sub>B</sub><i>T</i>), the corresponding rotational barrier is 35.0 kcal/mol, which is near the range of MMFFs and ab initio values for TS<sub>out</sub> (34.6 and 32.6 kcal/mol, respectively).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> According to the experimental value, the time required to reach a 95:5 atropisomeric ratio (<i>t</i><sub>95</sub>) from enantiopure (<i>M</i>)-<b>28</b> (or (<i>P</i>)-<b>28</b>) is estimated to be more than 750 years at 40 °C (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for details).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The previously discussed compounds were synthesized following the sequences depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. An S<sub>N</sub>Ar of 4-chloro-5,8-difluoroquinoline (<b>29</b>) with ethyl 3-amino-2-nitrobenzoate (<b>30</b>) affords <b>31</b>. Reduction of the nitro group of <b>31</b> followed by <i>para</i>-bromination yields the common intermediate <b>32</b>. In the case of compound <b>1</b>, the benzimidazole ring is formed in refluxing trimethyl orthoformate to give <b>33</b>. Saponification of the ester of <b>33</b> followed by coupling with ammonium chloride leads to the primary amide <b>34</b>. A Miyaura borylation to give <b>35</b> and a subsequent Suzuki reaction with 2,3-difluoro-4-iodopyridine install the precursor of the hinge binding motif. The amide of <b>36</b> is then converted to the corresponding triazole using a one-pot, two-step procedure with DMF-DMA and hydrazine sequentially. Finally, S<sub>N</sub>Ar with ammonia completes the synthesis of compound <b>1</b>. (<i>rac</i>)-<b>28</b> is synthesized in an analogous manner, with the benzimidazole ring being formed from intermediate <b>32</b> in the presence of acetic anhydride in refluxing acetic acid. The single atropisomers (<i>P</i>)-<b>28</b> and (<i>M</i>)-<b>28</b> are obtained via chiral preparative SFC separation.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>1</b>, (<i>rac</i>)-<b>28</b>, (<i>P</i>)-<b>28</b>, and (<i>M</i>)-<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C (49%); (b) Zn dust, AcOH, MeOH, rt (93%); (c) bromine, DCM, 0 °C (62%); (d) trimethyl orthoformate, reflux (61%); (e) 1 M LiOH, THF, rt; (f) NH<sub>4</sub>Cl, EDC, HOBt, DIEA, 50 °C (82% over 2 steps); (g) bis(neopentyl glycolato)diboron, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, dioxane, reflux (96%); (h) 2,3-difluoro-4-iodopyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 100 °C (54%); (i) DMF-DMA, 100 °C, then hydrazine, AcOH, 45 °C; (j) NH<sub>4</sub>OH (28–30% in water), DMSO, 85 °C (16% over 2 steps); (k) Ac<sub>2</sub>O, AcOH, reflux (62%); (l) bis(neopentyl glycolato)diboron, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, dioxane, reflux (91%); (m) 2,3-difluoro-4-iodopyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C (72%); (n) 1 M LiOH, THF, rt; (o) NH<sub>4</sub>Cl, EDC, HOBt, DIEA, 50 °C (80% over 2 steps); (p) DMF-DMA, 100 °C, then hydrazine, AcOH, 45) NH<sub>4</sub>OH (28–30% in water), DMSO, 85 °C (55% over 2 steps); and (r) chiral separation (CHIRALPAK OD-H SFC 5 μM 21 × 250 mm column in 30% MeOH/CO<sub>2</sub> at 60 mL/min).</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have discovered a potent, selective, and orally bioavailable PI3Kβ inhibitor. The thoughtful creation of a restricted axis of rotation around a carbon–nitrogen bond of compound <b>1</b> generated a pair of atropisomeric compounds, (<i>P</i>)-<b>28</b> and (<i>M</i>)-<b>28</b>, with significantly different pharmacological profiles. The locked conformation of (<i>P</i>)-<b>28</b> leads to improved kinome selectivity relative to the freely rotating compound <b>1</b>, presumably the result of a limited number of accessible conformations. Among the differences between (<i>P</i>)-<b>28</b> and (<i>M</i>)-<b>28</b>, we found that the majority of the metabolism of the inactive atropisomer (<i>M</i>)-<b>28</b> is the result of the action of the cytosolic enzyme aldehyde oxidase. In contrast, the active atropisomer (<i>P</i>)-<b>28</b> has lower affinity for AO resulting in substantially better metabolic stability. We also reported torsional scan studies in support of the high barrier of rotation of this new PI3Kβ inhibitor. Additional studies will be presented in future publications.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Procedures</h3><div class="NLM_p">All commercial reagents and anhydrous solvents were used as provided without further purification. Flash chromatography was performed using an ISCO Combiflash or a Biotage Isolera purification system with Silicycle prepacked silica gel cartridges. Final compounds were purified by prep HPLC on a Gilson 271 system, with a Phenomenex Kinetex C18 Column (250 × 30 mm<sup>2</sup>, 100 A, 5 μ) and a gradient elution of acetonitrile/water with, 5–95% for 20 min at a flow rate of 35 mL/min. For all samples, 0.1% TFA was added to both eluents. All <sup>1</sup>H NMR spectra were recorded on a Varian 400-MR 400 MHz spectrometer. Proton chemical shifts are reported in parts per million from an internal standard or residual solvent. The purity of the tested compounds was assessed by an Agilent LCMS. A Silicycle Siliachrom SB C18 column (4.6 × 50 mm<sup>2</sup>, 3 μ) was used with a gradient elution of acetonitrile in water, 0–95% for 7 min at a flow rate of 0.9 mL/min with detection at 256 nm. Alternatively, a Chromolith column (50 × 2 mm<sup>2</sup>) was used with a gradient elution of acetonitrile in water, 0–95% for 3 min at a flow rate of 1.9 mL/min with detection at 256 nm wavelength. For all samples 0.1% TFA was added to both eluents. All final compounds were determined to be at least 95% pure by LC analysis.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 4-(1-(5,8-Difluoroquinolin-4-yl)-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-3-fluoropyridin-2-amine (<b>1</b>)</h4><div class="NLM_p last">Ammonium hydroxide (28–30% solution in water, 1.5 mL) was added to a solution of crude 4-(6-(2,3-difluoropyridin-4-yl)-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-5,8-difluoroquinoline (0.457 mmol) in DMSO (4.0 mL). The reaction vessel was sealed and the reaction mixture was stirred at 85 °C for 20 h. The excess ammonia was removed under reduced pressure and the resulting solution was purified by preparative HPLC eluting with 5–95% water/acetonitrile (0.1% v/v trifluoroacetic acid). The appropriate fractions were pooled and concentrated under reduced pressure. The resulting solid was dissolved in dichloromethane, washed sequentially with a saturated aqueous NaHCO<sub>3</sub> and water. The organic phase was concentrated. The residue was dissolved in a 1:1 mixture of acetonitrile/water and lyophilized to afford <b>1</b> (52 mg, 16% over 2 steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (d, <i>J</i> = 4.6 Hz, 1H), 8.91 (s, 1H), 8.21 (s, 1H), 8.06 (d, <i>J</i> = 4.6 Hz, 1H), 7.78 (ddd, <i>J</i> = 10.1, 8.8, 4.2 Hz, 1H), 7.73 (d, <i>J</i> = 5.3 Hz, 1H), 7.66 (s, 1H), 7.48 (ddd, <i>J</i> = 12.4, 8.8, 3.9 Hz, 1H), 6.68 (t, <i>J</i> = 5.2 Hz, 1H), 6.30 (s, 2H). ES/MS <i>m</i>/<i>z</i> = 459.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (<i>rac</i>)-4-(1-(5,8-Difluoroquinolin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-3-fluoropyridin-2-amine ((<i>rac</i>)-<b>28</b>)</h4><div class="NLM_p last">Ammonium hydroxide (28–30% solution in water, 5.0 mL) was added to a solution of crude 4-(6-(2,3-difluoropyridin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-5,8-difluoroquinoline (3.61 mmol) in DMSO (15 mL). The reaction vessel was sealed and the reaction mixture was stirred at 85 °C for 20 h. The excess ammonia was removed under reduced pressure and the resulting solution was purified by preparative HPLC, eluting with 5 to 95% water/acetonitrile (0.1% v/v trifluoroacetic acid). The appropriate fractions were pooled and lyophilized to afford (<i>rac</i>)-<b>28</b> as a bis-2,2,2-trifluoroacetic acid salt (1.40 g, 55%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.31 (d, <i>J</i> = 4.5 Hz, 1H), 8.41 (br s, 1H), 8.22 (s, 1H), 8.09 (d, <i>J</i> = 4.5 Hz, 1H), 7.78 (td, <i>J</i> = 9.5, 4.2 Hz, 1H), 7.74 (dd, <i>J</i> = 6.2, 0.9 Hz, 1H), 7.52 (s, 1H), 7.47 (ddd, <i>J</i> = 12.3, 8.8, 3.8 Hz, 1H), 6.84 (br s, 1H), 2.51 (s, 3H). ES/MS <i>m</i>/<i>z</i> = 473.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (<i>M</i>)-4-(1-(5,8-Difluoroquinolin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-3-fluoropyridin-2-amine ((<i>M</i>)-28) and (<i>P</i>)-4-(1-(5,8-difluoroquinolin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-3-fluoropyridin-2-amine ((<i>P</i>)-<b>28</b>)</h4><div class="NLM_p last">The atropisomers of (<i>rac</i>)-<b>28</b> were separated using SFC CHIRALPAK OD-H 5uM 21 × 250 mm<sup>2</sup> column eluting with 30% MeOH/CO<sub>2</sub> at 60 mL/min. The appropriate fractions were pooled and concentrated to afford (<i>M</i>)-<b>28</b> (first eluting peak) and (<i>P</i>)-<b>28</b> (second eluting peak) <b>28</b> as 2,2,2-trifluoroacetic acid salts. <sup>1</sup>H NMR (400 MHz, DMSO-d6) δ 9.30 (d, <i>J</i> = 4.5 Hz, 1H), 8.38 (s, 1H), 8.21 (t, <i>J</i> = 1.6 Hz, 1H), 8.08 (d, <i>J</i> = 4.5 Hz, 1H), 7.78 (ddd, <i>J</i> = 10.0, 8.8, 4.2 Hz, 1H), 7.73 (d, <i>J</i> = 5.9 Hz, 1H), 7.51–7.43 (m, 2H), 6.81 (t, <i>J</i> = 5.8 Hz, 1H), 2.49 (s, 3H). ES/MS <i>m</i>/<i>z</i> = 473.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Ethyl 3-((5,8-Difluoroquinolin-4-yl)amino)-2-nitrobenzoate (<b>31</b>)</h4><div class="NLM_p last">To a solution of 4-chloro-5,8-difluoroquinoline (<b>29</b>) (171 g, 859.3 mmol) in DMF (1.7 L) at 0 °C were added ethyl 3-amino-2-nitrobenzoate (<b>30</b>) (181.5 g, 859.3 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (614.4 g, 1890 mmol). The reaction mixture was stirred at 90 °C for 18 h. The reaction mixture was cooled down and filtered through a pad of diatomaceous earth. The filtrate was partitioned between ethyl acetate and water. The organic phase was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatograph, eluting with 30% ethyl acetate in petroleum ether to afford <b>31</b> (158 g, 49%). ES/MS <i>m</i>/<i>z</i> = 374.4 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Ethyl 2-Amino-3-((5,8-difluoroquinolin-4-yl)amino)benzoate</h4><div class="NLM_p last">To a solution of <b>31</b> (158 g, 423.5 mmol) in AcOH (1.3 L) and MeOH (320 mL) at 0 °C was slowly added Zn dust (166 g, 2541 mmol) and the mixture was stirred at ambient temperature for 1 h. The reaction mixture was filtered through a pad of diatomaceous earth and evaporated under reduced pressure. The resulting residue was suspended in DCM and washed sequentially with an aqueous saturated solution of NaHCO<sub>3</sub> and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give ethyl 2-amino-3-((5,8-difluoroquinolin-4-yl)amino)benzoate (135 g, 93%). ES/MS <i>m</i>/<i>z</i> = 344.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Ethyl 2-Amino-5-bromo-3-((5,8-difluoroquinolin-4-yl)amino)benzoate (<b>32</b>)</h4><div class="NLM_p last">To a solution of ethyl 2-amino-3-((5,8-difluoroquinolin-4-yl)amino)benzoate (135 g, 393 mmol) in DCM (2.7 L) at 0 °C was added bromine (30.4 mL, 1180 mmol) and the mixture was stirred at 0 °C for 1 h. The reaction mixture was quenched with aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, diluted with DCM and washed sequentially with an aqueous saturated solution of NaHCO<sub>3</sub> and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give <b>32</b> (103 g, 62%). ES/MS <i>m</i>/<i>z</i> = 422.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Ethyl 6-Bromo-1-(5,8-difluoroquinolin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate (<b>33</b>)</h4><div class="NLM_p last">A solution <b>32</b> (3.7 g, 8.76 mmol) in trimethyl orthoformate (50 mL) was refluxed for 30 min. Upon cooling to ambient temperature, the mixture was concentrated under reduced pressure. The resulting solid was triturated with 25 mL of diethyl ether. The solid was recovered by filtration to afford <b>33</b> (2.3 g, 61%). ES/MS <i>m</i>/<i>z</i> = 432.0 (M + H<sup>+</sup>).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Lithium 6-Bromo-1-(5,8-difluoroquinolin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate</h4><div class="NLM_p last">Aqueous 1 M lithium hydroxide (5.5 mL) was added to <b>33</b> (1.19 g, 2.75 mmol) in THF (15 mL). The reaction was stirred at ambient temperature for 1 h. The reaction mixture was concentrated under reduced pressure to afford lithium 6-bromo-1-(5,8-difluoroquinolin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate, which was used without further purification for the next step. ES/MS <i>m</i>/<i>z</i> 404.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6-Bromo-1-(5,8-difluoroquinolin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxamide (<b>34</b>)</h4><div class="NLM_p last">To a solution of lithium 6-bromo-1-(5,8-difluoroquinolin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate (2.75 mmol) in DMF (9.0 mL) were added ammonium chloride (1.03 g, 19.2 mmol), 1<i>H</i>-benzo[<i>d</i>][1,2,3]triazol-1-ol (2.10 g, 11.0 mmol), <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (2.10 g, 11.0 mmol), and diethylisopropylamine (4.8 mL, 27.5 mmol). The mixture was stirred at 50 °C for 20 h. The material was precipitated by the addition of water. The resulting solid was isolated via filtration, washed with water, and dried under vacuum to afford <b>34</b> (910 mg, 82%). ES/MS <i>m</i>/<i>z</i> 403.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(5,8-Difluoroquinolin-4-yl)-6-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxamide (<b>35</b>)</h4><div class="NLM_p last">[1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (276 mg, 0.34 mmol) was added to a solution of <b>34</b> (910 mg, 2.26 mmol), bis(neopentyl glycolato)diboron (663 mg, 2.93 mmol), and potassium acetate (554 mg, 5.64 mmol) in dioxane (20 mL). Nitrogen was bubbled through the reaction mixture for 10 min and the reaction mixture was stirred at refluxing temperature for 24 h. The reaction mixture was cooled to ambient temperature and the solid was isolated via filtration. The solid was washed with water and dried under vacuum to afford <b>35</b> (945 mg, 96%). ES/MS <i>m</i>/<i>z</i> = 369.2 (ArB(OH)<sub>2</sub>+H)<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-(2,3-Difluoropyridin-4-yl)-1-(5,8-difluoroquinolin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxamide (<b>36</b>)</h4><div class="NLM_p last">Tetrakis(triphenylphosphine)palladium(0) (146 mg, 0.13 mmol) was added to a solution of <b>35</b> (550 mg, 1.26 mmol), 2,3-difluoro-4-iodopyridine (365 mg, 1.51 mmol), and potassium phosphate tribasic (669 mg, 3.15 mmol) in dioxane (6.0 mL) and water (1.5 mL). Nitrogen was bubbled through the reaction mixture for 10 min and the reaction mixture was stirred at 100 °C for 8 h. Upon cooling to ambient temperature, the reaction mixture was partitioned between ethyl acetate and water. The organic phase was washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography, eluting with 5 to 100% of (10% methanol in ethyl acetate) in hexane to afford <b>36</b> (300 mg, 54%). ES/MS <i>m</i>/<i>z</i> = 438.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-(6-(2,3-Difluoropyridin-4-yl)-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-5,8-difluoroquinoline</h4><div class="NLM_p last"><b>36</b> (200 mg, 0.457 mmol) was suspended in 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (3.0 mL, 22.8 mmol) and stirred at 100 °C for 3 h. The solution was cooled to ambient temperature, concentrated under reduced pressure and dried under vacuum for overnight. The residue was dissolved in acetic acid (5.0 mL), and hydrazine (43 μL, 1.37 mmol) was added. The reaction mixture was stirred at 45 °C for 1 h, after which the reaction mixture was cooled to ambient temperature and concentrated under reduced pressure. The residue was taken up in ethyl acetate, washed sequentially with saturated aqueous NaHCO<sub>3</sub>, and brine, dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. Crude 4-(6-(2,3-difluoropyridin-4-yl)-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-5,8-difluoroquinoline was used without further purification in the next step. ES/MS <i>m</i>/<i>z</i> 462.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Ethyl 6-Bromo-1-(5,8-difluoroquinolin-4-yl)-2-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate (<b>37</b>)</h4><div class="NLM_p last">A solution of <b>32</b> (103 g, 244 mmol) in Ac<sub>2</sub>O (515 mL) and AcOH (1 L) was refluxed for 18 h. The reaction mixture was concentrated under reduced pressure. The residue was diluted with ethyl acetate and washed sequentially with an aqueous saturated solution of NaHCO<sub>3</sub> and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude compound was triturated with petroleum ether to give <b>37</b> (68 g, 62%). ES/MS <i>m</i>/<i>z</i> = 446.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Ethyl 1-(5,8-Difluoroquinolin-4-yl)-6-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-2-methyl-1<i>H</i>-benzo[d]imidazole-4-carboxylate (<b>38</b>)</h4><div class="NLM_p last">[1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (1.83 g, 2.24 mmol) was added to a solution of <b>37</b> (10 g, 22.4 mmol), bis(neopentyl glycolato)diboron (7.6 g, 33.6 mmol), and potassium acetate (5.5 g, 56.0 mmol) in dioxane (150 mL). Nitrogen was bubbled through the reaction mixture for 10 min, and the reaction mixture was stirred at reflux for 24 h. The reaction mixture was cooled to ambient temperature, and the solids were removed by filtration. The filtrate was dry-loaded onto silica gel and purified by silica gel column chromatography eluting with 25% to 100% ethyl acetate in hexane to afford <b>38</b> (9.8 g, 91%). ES/MS <i>m</i>/<i>z</i> = 412.3 (ArB(OH)<sub>2</sub>+H)<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Ethyl 6-(2,3-Difluoropyridin-4-yl)-1-(5,8-difluoroquinolin-4-yl)-2-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate (<b>39</b>)</h4><div class="NLM_p last">Tetrakis(triphenylphosphine)palladium(0) (723 mg, 0.626 mmol) was added to a solution of <b>38</b> (3.0 g, 6.25 mmol), 2,3-difluoro-4-iodopyridine (1.81 mg, 7.51 mmol), and potassium phosphate tribasic (3.32 g, 15.7 mmol) in dioxane (30 mL) and water (6 mL). Nitrogen was bubbled through the reaction mixture for 10 min, and the reaction mixture was stirred at 90 °C for 4 h. Upon cooling to ambient temperature, the reaction mixture was partitioned between ethyl acetate and water. The organic phase was washed with brine, dried with magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography, eluting with 5 to 100% of (10% methanol in ethyl acetate) in hexane to afford <b>39</b> (2.17 g, 72%). ES/MS <i>m</i>/<i>z</i> = 481.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Lithium 6-(2,3-Difluoropyridin-4-yl)-1-(5,8-difluoroquinolin-4-yl)-2-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate</h4><div class="NLM_p last">Aqueous 1 M lithium hydroxide (9.0 mL) was added to <b>39</b> (2.17 g, 4.52 mmol) in THF (25 mL). The reaction was stirred at ambient temperature for 1 h. The reaction mixture was concentrated under reduced pressure to afford lithium 6-(2,3-difluoropyridin-4-yl)-1-(5,8-difluoroquinolin-4-yl)-2-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate, which was used without further purification for the next step. ES/MS <i>m</i>/<i>z</i> 453.1 (M+H)<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-(2,3-Difluoropyridin-4-yl)-1-(5,8-difluoroquinolin-4-yl)-2-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxamide (<b>40</b>)</h4><div class="NLM_p last">To a solution of lithium 6-(2,3-difluoropyridin-4-yl)-1-(5,8-difluoroquinolin-4-yl)-2-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-4-carboxylate (4.52 mmol) in DMF (15.0 mL) were added ammonium chloride (1.69 g, 31.6 mmol), 1<i>H</i>-benzo[<i>d</i>][1,2,3]triazol-1-ol (3.46 g, 18.1 mmol), <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (3.46 g, 18.1 mmol) and diethylisopropylamine (7.9 mL, 45.2 mmol). The mixture was stirred at 50 °C for overnight. The material was precipitated by the addition of water. The resulting solid was isolated via filtration, washed with water, and dried under vacuum to afford <b>40</b> (1.63 mg, 80%). ES/MS <i>m</i>/<i>z</i> 552.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-(6-(2,3-Difluoropyridin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-5,8-difluoroquinoline</h4><div class="NLM_p last"><b>40</b> (1.63 g, 3.61 mmol) was suspended in 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (24.0 mL, 181 mmol) and stirred at 100 °C for 3 h. The solution was cooled to ambient temperature, concentrated under reduced pressure, and dried under vacuum overnight. The residue was dissolved in acetic acid (18 mL), and hydrazine (227 μL, 7.22 mmol) was added. The reaction mixture was stirred at 45 °C for 1 h, after which the reaction was cooled to ambient temperature and concentrated under reduced pressure. The residue was taken up in ethyl acetate, washed sequentially with saturated NaHCO<sub>3</sub>, and brine, dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. Crude 4-(6-(2,3-difluoropyridin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-5,8-difluoroquinoline was used without further purification in the next step. ES/MS <i>m</i>/<i>z</i> 476.1 (M + H)<sup>+</sup>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00797" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">. The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00797" class="ext-link">10.1021/acs.jmedchem.8b00797</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Details of all protocols for in vitro and in vivo experiments, chiral SFC and calculations leading to the experimental rotational barrier, NMR spectra (<sup>1</sup>H, <sup>19</sup>F, and <sup>13</sup>C), kinase selectivity, and molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">(<i>P</i>)-<b>28</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Compounds,	smiles	 data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf">jm8b00797_si_001.pdf (972.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_002.pdb">jm8b00797_si_002.pdb (1.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_003.csv">jm8b00797_si_003.csv (0.41 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates of compound <b>1</b> docked in the cocrystal structure of mouse p110β (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BFR">4BFR</a>, ref <a onclick="showRef(event, 'cit7c'); return false;" href="javascript:void(0);" class="ref cit7c">(7c)</a>) are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a>. PDB code for (<i>P</i>)-<b>28</b> is 6DGT. Authors will release the atomic coordinates and experimental data upon publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00797" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephane Perreault</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8732-5243" title="Orcid link">http://orcid.org/0000-0001-8732-5243</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fc8f88998c949d9299d28c998e8e999d899088bc9b9590999d98d29f9391"><span class="__cf_email__" data-cfemail="a5d6d1c0d5cdc4cbc08bd5c0d7d7c0c4d0c9d1e5c2ccc9c0c4c18bc6cac8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayaraman Chandrasekhar</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan Dick</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua Van Veldhuizen</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Koditek</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eve-Irene Lepist</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span>Present Address:
                        Pliant Therapeutics, 700 Saginaw Drive, Suite 150, Redwood City, California 94063, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary E. McGrath</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leena Patel</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Phillips</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kassandra Sedillo</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John R. Somoza</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Therrien</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas A. Till</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span>Present Address:
                        Department of Chemistry, Princeton University, Princeton, New Jersey, 08544, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Treiberg</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 East Blaine Street, Seattle, Washington 98102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armando G. Villaseñor</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yelena Zherebina</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors are employees of Gilead Sciences except for N.T. who was intern at Gilead Sciences during this research and E.-I.L. who was employed at Gilead Sciences during this research. All authors except N.T. are shareholders of Gilead Sciences.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank John Bui from Gilead Sciences for generating the HLM data and Zach E. Newby from Gilead Sciences for curating the crystal structure of (<i>P</i>)-<b>28</b> and depositing coordinates in the RCSB PDB. We also thank Jennifer Loyer-Drew from Gilead Sciences for thoughtful review of the manuscript. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abreviations Used</td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PIP2</td><td class="NLM_def"><p class="first last">phosphatidylinositol-4,5-bisphosphate</p></td></tr><tr><td class="NLM_term">PIP3</td><td class="NLM_def"><p class="first last">phosphatidylinositol-3,4,5-trisphosphate</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">hHep</td><td class="NLM_def"><p class="first last">human hepatocytes</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>pr</sub></td><td class="NLM_def"><p class="first last">predicted clearance</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">AO</td><td class="NLM_def"><p class="first last">aldehyde oxidase</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">UDGPA</td><td class="NLM_def"><p class="first last">uridine diphosphate glucuronic acid</p></td></tr><tr><td class="NLM_term">BLQ</td><td class="NLM_def"><p class="first last">below level of quantification</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochromes P450</p></td></tr><tr><td class="NLM_term">UGT</td><td class="NLM_def"><p class="first last">uridine 5′-diphospho-glucuronosyltransferase</p></td></tr><tr><td class="NLM_term">MMFF</td><td class="NLM_def"><p class="first last">molecular mechanics force field</p></td></tr><tr><td class="NLM_term">TS</td><td class="NLM_def"><p class="first last">transition state</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-pressure liquid chromatography.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Eliel, E. L.</span>; <span class="NLM_string-name">Wilen, S. H.</span></span> <i>Stereochemistry of Organic Compounds</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=E.+L.+Eliel&author=S.+H.+Wilen&title=Stereochemistry+of+Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEliel%26aufirst%3DE.%2BL.%26btitle%3DStereochemistry%2520of%2520Organic%2520Compounds%26pub%3DWiley%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasamy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaguru, J.</span></span> <span> </span><span class="NLM_article-title">Nonbiaryl and heterobiaryl atropisomers: molecular templates with promise for atroposelective chemical transformations</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">11239</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKru7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=11239-1130&author=E.+Kumarasamyauthor=R.+Raghunathanauthor=M.+P.+Sibiauthor=J.+Sivaguru&title=Nonbiaryl+and+heterobiaryl+atropisomers%3A+molecular+templates+with+promise+for+atroposelective+chemical+transformations&doi=10.1021%2Facs.chemrev.5b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Nonbiaryl and Heterobiaryl Atropisomers: Molecular Templates with Promise for Atropselective Chemical Transformations</span></div><div class="casAuthors">Kumarasamy, Elango; Raghunathan, Ramya; Sibi, Mukund P.; Sivaguru, J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11239-11300</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on synthesis, phys. characteristics, and applications of nonbiaryl atropisomers in synthetic transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLa9BsyBCVwrVg90H21EOLACvtfcHk0lh16R0JazLL3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKru7jE&md5=64f3442934834101d51dcbe7d6fd1122</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00136%26sid%3Dliteratum%253Aachs%26aulast%3DKumarasamy%26aufirst%3DE.%26aulast%3DRaghunathan%26aufirst%3DR.%26aulast%3DSibi%26aufirst%3DM.%2BP.%26aulast%3DSivaguru%26aufirst%3DJ.%26atitle%3DNonbiaryl%2520and%2520heterobiaryl%2520atropisomers%253A%2520molecular%2520templates%2520with%2520promise%2520for%2520atroposelective%2520chemical%2520transformations%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D11239%26epage%3D1130%26doi%3D10.1021%2Facs.chemrev.5b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span> <span> </span><span class="NLM_article-title">A twist of nature - the significance of atopisomers in biological systems</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1562</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1039/C4NP00121D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1039%2FC4NP00121D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=26282828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=1562-1583&author=J.+E.+Smythauthor=N.+M.+Butlerauthor=P.+Keller&title=A+twist+of+nature+-+the+significance+of+atopisomers+in+biological+systems&doi=10.1039%2FC4NP00121D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">A twist of nature - the significance of atropisomers in biological systems</span></div><div class="casAuthors">Smyth, Jamie E.; Butler, Nicholas M.; Keller, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1562-1583</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covering: up to mid-2015Recently identified natural atropisomeric compds. with potential medicinal applications are presented.  The ability of natural receptors to possess differential binding between atropisomers is an important factor when considering active and inactive atropisomeric drugs, and has required the development of new techniques for atropselective synthesis of desired targets.  Advances in this field therefore have significant relevance to modern pharmaceutical and medicinal chem.  The atropisomeric natural products discussed include hibarimicinone, flavomannins, talaromannins, viriditoxin, rugulotrosin A, abyssomicin C, marinopyrroles, dixiamycins, streptorubin B, ustiloxins A-F, haouamine A, bisnicalaterines, and tedarene B, all of which show significant potential as leads in antibiotic, antiviral and anticancer studies.  The importance for the development of common practices regarding atropisomer recognition and classification is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0hzR1osyzPLVg90H21EOLACvtfcHk0lggB-cKEhAgmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsLfF&md5=449bdc252cc2b0206fa71c1b0a1ce418</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1039%2FC4NP00121D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00121D%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DJ.%2BE.%26aulast%3DButler%26aufirst%3DN.%2BM.%26aulast%3DKeller%26aufirst%3DP.%26atitle%3DA%2520twist%2520of%2520nature%2520-%2520the%2520significance%2520of%2520atopisomers%2520in%2520biological%2520systems%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2015%26volume%3D32%26spage%3D1562%26epage%3D1583%26doi%3D10.1039%2FC4NP00121D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bringmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortimer, A. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gresser, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuning, M.</span></span> <span> </span><span class="NLM_article-title">Atroposelective synthesis of axially chiral biaryl compounds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">5384</span>– <span class="NLM_lpage">5427</span>, <span class="refDoi"> DOI: 10.1002/anie.200462661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.200462661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2ks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5384-5427&author=G.+Bringmannauthor=A.+J.+P.+Mortimerauthor=P.+A.+Kellerauthor=M.+J.+Gresserauthor=J.+Garnerauthor=M.+Breuning&title=Atroposelective+synthesis+of+axially+chiral+biaryl+compounds&doi=10.1002%2Fanie.200462661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Atroposelective synthesis of axially chiral biaryl compounds</span></div><div class="casAuthors">Bringmann, Gerhard; Mortimer, Anne J. Price; Keller, Paul A.; Gresser, Mary J.; Garner, James; Breuning, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5384-5427</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  A rotationally hindered and thus stereogenic biaryl axis is the structurally and stereochem. decisive element of a steadily growing no. of natural products, chiral auxiliaries, and catalysts.  Thus, it is not surprising that significant advances have been made in the asym. synthesis of axially chiral biaryl compds. over the past decade.  In addn. to the classic approach (direct stereoselective aryl-aryl coupling), innovative concepts have been developed in which the asym. information is introduced into a preformed, but achiral-i.e., sym. or configurationally labile-biaryl compd., or in which an aryl-C single bond is stereoselectively transformed into an axis.  This review classifies these strategies according to their underlying concepts and critically evaluates their scope and limitations with ref. to selected model reactions and applications.  Furthermore, the preconditions required for the existence of axial chirality in biaryl compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL_2TLwAMAebVg90H21EOLACvtfcHk0lggB-cKEhAgmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2ks7c%253D&md5=707d980d89cf63000577df2be2e2881d</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462661%26sid%3Dliteratum%253Aachs%26aulast%3DBringmann%26aufirst%3DG.%26aulast%3DMortimer%26aufirst%3DA.%2BJ.%2BP.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26aulast%3DGresser%26aufirst%3DM.%2BJ.%26aulast%3DGarner%26aufirst%3DJ.%26aulast%3DBreuning%26aufirst%3DM.%26atitle%3DAtroposelective%2520synthesis%2520of%2520axially%2520chiral%2520biaryl%2520compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5384%26epage%3D5427%26doi%3D10.1002%2Fanie.200462661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Oki, M.</span></span> <span> </span><span class="NLM_article-title">Recent advances in atropisomerism</span>. In  <i>Topics in Stereochemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allinger, N. L.</span>, <span class="NLM_string-name">Eliel, E. L.</span>, <span class="NLM_string-name">Wilen, S. H.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1983</span>; Vol.  <span class="NLM_volume">14</span>, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">81</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=1-81&author=M.+Okiauthor=N.+L.+Allinger&author=E.+L.+Eliel&author=S.+H.+Wilen&title=Topics+in+Stereochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOki%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520atropisomerism%26btitle%3DTopics%2520in%2520Stereochemistry%26aulast%3DAllinger%26aufirst%3DN.%2BL.%26pub%3DWiley%26date%3D1983%26volume%3D14%26spage%3D1%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eichelbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, A. S.</span></span> <span> </span><span class="NLM_article-title">Stereochemical aspects of drug action and disposition</span>. <i>Adv. Drug Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/S0065-2490(96)80003-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1016%2FS0065-2490%2896%2980003-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADyaK28XmvFSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1996&pages=1-64&author=M.+Eichelbaumauthor=A.+S.+Gross&title=Stereochemical+aspects+of+drug+action+and+disposition&doi=10.1016%2FS0065-2490%2896%2980003-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemical aspects of drug action and disposition</span></div><div class="casAuthors">Eichelbaum, Michel; Gross, Annette S.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Drug Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-64</span>CODEN:
                <span class="NLM_cas:coden">ADRRAN</span>;
        ISSN:<span class="NLM_cas:issn">0065-2490</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review with many refs.  In view of the widespread clin. use of racemates, it is the purpose of this article to provide background information on the implications of stereochem. for drug action and disposition.  It is not intended to cover all of the literature published on this topic but will rather focus on the principles involved, with use of illustrative examples to demonstrate the implications for the therapeutic use of chiral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqe_t6ME4XWbVg90H21EOLACvtfcHk0lg3vKmvd4jFqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvFSrsrw%253D&md5=48fe084d7fb40143d2f6fc1329e4ce54</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2FS0065-2490%2896%2980003-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-2490%252896%252980003-7%26sid%3Dliteratum%253Aachs%26aulast%3DEichelbaum%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DA.%2BS.%26atitle%3DStereochemical%2520aspects%2520of%2520drug%2520action%2520and%2520disposition%26jtitle%3DAdv.%2520Drug%2520Res.%26date%3D1996%26volume%3D28%26spage%3D1%26epage%3D64%26doi%3D10.1016%2FS0065-2490%2896%2980003-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Crossley, R. J.</span></span> <i>Chirality and the Biological Activity of Drugs</i>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=R.+J.+Crossley&title=Chirality+and+the+Biological+Activity+of+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrossley%26aufirst%3DR.%2BJ.%26btitle%3DChirality%2520and%2520the%2520Biological%2520Activity%2520of%2520Drugs%26pub%3DCRC%2520Press%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branch, S. K.</span></span> <span> </span><span class="NLM_article-title">Stereochemical origin of some clinically significant drug safety concerns: lessons for future drug development</span>. <i>Adverse Drug React. Toxicol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=9838970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFartr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=145-190&author=R.+R.+Shahauthor=J.+M.+Midgleyauthor=S.+K.+Branch&title=Stereochemical+origin+of+some+clinically+significant+drug+safety+concerns%3A+lessons+for+future+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemical origin of some clinically significant drug safety concerns: lessons for future drug development</span></div><div class="casAuthors">Shah, R. R.; Midgley, J. M.; Branch, Sarah K.</div><div class="citationInfo"><span class="NLM_cas:title">Adverse Drug Reactions and Toxicological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">145-190</span>CODEN:
                <span class="NLM_cas:coden">ADRRER</span>;
        ISSN:<span class="NLM_cas:issn">0964-198X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 147 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqztFwy82FUm7Vg90H21EOLACvtfcHk0lg3vKmvd4jFqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFartr4%253D&md5=408144ec1368248c9eedf31f0deb71ed</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%2BR.%26aulast%3DMidgley%26aufirst%3DJ.%2BM.%26aulast%3DBranch%26aufirst%3DS.%2BK.%26atitle%3DStereochemical%2520origin%2520of%2520some%2520clinically%2520significant%2520drug%2520safety%2520concerns%253A%2520lessons%2520for%2520future%2520drug%2520development%26jtitle%3DAdverse%2520Drug%2520React.%2520Toxicol.%2520Rev.%26date%3D1998%26volume%3D17%26spage%3D145%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Toenjes, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism in medicinal chemistry: challenges and opportunities</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.4155%2Ffmc-2017-0152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=29380622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=409-422&author=S.+T.+Toenjesauthor=J.+L.+Gustafson&title=Atropisomerism+in+medicinal+chemistry%3A+challenges+and+opportunities&doi=10.4155%2Ffmc-2017-0152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerism in medicinal chemistry: challenges and opportunities</span></div><div class="casAuthors">Toenjes, Sean T.; Gustafson, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-422</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Atropisomerism is a dynamic type of axial chirality that is ubiquitous in medicinal chem.  There are several examples of stable atropisomeric US FDA-approved drugs and exptl. compds., and in each case the atropisomers of these compds. possess drastically different biol. activities.  Rapidly interconverting atropisomerism is even more prevalent, and while such compds. are typically considered achiral, they bind their protein targets in an atroposelective fashion, with the nonrelevant atropisomer contributing little to the desired activities.  It has been recently demonstrated that various properties of an interconverting atropisomer can be modulated through the synthesis of atropisomer stable and pure analogs.  Herein we discuss examples of atropisomerism in drug discovery as well as challenges and opportunities moving forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaSgfKDqoiYbVg90H21EOLACvtfcHk0lg3vKmvd4jFqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCntLc%253D&md5=ceb5cc2626d980aa3e3903fd126a3f3a</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0152%26sid%3Dliteratum%253Aachs%26aulast%3DToenjes%26aufirst%3DS.%2BT.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26atitle%3DAtropisomerism%2520in%2520medicinal%2520chemistry%253A%2520challenges%2520and%2520opportunities%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D409%26epage%3D422%26doi%3D10.4155%2Ffmc-2017-0152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Glunz, P. W.</span></span> <span> </span><span class="NLM_article-title">Recent encounters with atropisomerism in drug discovery</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1016%2Fj.bmcl.2017.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=29223590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFejurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=53-60&author=P.+W.+Glunz&title=Recent+encounters+with+atropisomerism+in+drug+discovery&doi=10.1016%2Fj.bmcl.2017.11.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent encounters with atropisomerism in drug discovery</span></div><div class="casAuthors">Glunz, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Atropisomerism is stereochem. arising from restricted bond rotation that creates a chiral axis.  Atropisomers are subject to time-dependent inversion of chirality via bond rotation, a property which in drug mols. introduces complexity and challenges for drug discovery and development processes.  Greater recognition of the occurrence of atropisomerism and improved characterization techniques have helped medicinal chemists successfully advance atropisomeric drug mols.  This review provides recent examples of atropisomerism encountered in medicinal chem. efforts and the strategies used to address the accompanying challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraiY1w4I4F5bVg90H21EOLACvtfcHk0ljpA8X6nhZ3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFejurzL&md5=6a2552071f43374a3626a9e52a987fa6</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26atitle%3DRecent%2520encounters%2520with%2520atropisomerism%2520in%2520drug%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D53%26epage%3D60%26doi%3D10.1016%2Fj.bmcl.2017.11.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span> <span> </span><span class="NLM_article-title">Revealing atropisomer axial chirality in drug discovery</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fcmdc.201000485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=21360821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFCjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=505-513&author=S.+R.+Laplanteauthor=P.+J.+Edwardsauthor=L.+D.+Faderauthor=A.+Jakalianauthor=O.+Hucke&title=Revealing+atropisomer+axial+chirality+in+drug+discovery&doi=10.1002%2Fcmdc.201000485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing Atropisomer Axial Chirality in Drug Discovery</span></div><div class="casAuthors">LaPlante, Steven R.; Edwards, Paul J.; Fader, Lee D.; Jakalian, Araz; Hucke, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">505-513</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An often overlooked source of chirality is atropisomerism, which results from slow rotation along a bond axis due to steric hindrance and/or electronic factors.  If undetected or not managed properly, this time-dependent chirality has the potential to lead to serious consequences, because atropisomers can be present as distinct enantiomers or diastereoisomers with their attendant different properties.  Herein we introduce a strategy to reveal and classify compds. that have atropisomeric chirality.  Energy barriers to axial rotation were calcd. using quantum mechanics, from which predicted high barriers could be exptl. validated.  A calcd. rotational energy barrier of 20 kcal mol-1 was established as a suitable threshold to distinguish between atropisomers and non-atropisomers with a prediction accuracy of 86 %.  This methodol. was applied to subsets of drug databases in the course of which atropisomeric drugs were identified.  In addn., some drugs were exposed that were not yet known to have this chiral attribute.  The most valuable utility of this tool will be to predict atropisomerism along the drug discovery pathway.  When used in concert with our compd. classification scheme, decisions can be made during early discovery stages such as "hit-to-lead" and "lead optimization," to foresee and validate the presence of atropisomers and to exercise options of removing, further stabilizing, or rendering the chiral axis of interest more freely rotatable via SAR design, thereby decreasing this potential liability within a compd. series.  The strategy can also improve drug development plans, such as detg. whether a drug or series should be developed as a racemic mixt. or as an isolated single compd.  Moreover, the work described herein can be extended to other chem. fields that require the assessment of potential chiral axes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbveHPmngfyLVg90H21EOLACvtfcHk0ljpA8X6nhZ3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFCjs7w%253D&md5=d3616133d0e2f01f59ceca435cb2df69</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000485%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DHucke%26aufirst%3DO.%26atitle%3DRevealing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D505%26epage%3D513%26doi%3D10.1002%2Fcmdc.201000485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 Inhibitors: optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&issue=14&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+Dimauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.-H.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+Inhibitors%3A+optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0ljpA8X6nhZ3bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520Inhibitors%253A%2520optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D14%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forseth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppenol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious phosphoinositide 3-kinase δ inhibitors with improved metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9228</span>– <span class="NLM_lpage">9242</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01169</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01169" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9228-9242&author=L.+Patelauthor=J.+Chandrasekharauthor=J.+Evartsauthor=K.+Forsethauthor=A.+C.+Haranauthor=C.+Ipauthor=A.+Kashishianauthor=M.+Kimauthor=D.+Koditekauthor=S.+Koppenolauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=S.+Perreaultauthor=K.+D.+Puriauthor=A.%0AG.+Villase%C3%B1orauthor=J.+R.+Somozaauthor=B.+H.+Steinerauthor=J.+Therrienauthor=J.+Treibergauthor=G.+Phillips&title=Discovery+of+orally+efficacious+phosphoinositide+3-kinase+%CE%B4+inhibitors+with+improved+metabolic+stability&doi=10.1021%2Facs.jmedchem.6b01169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability</span></div><div class="casAuthors">Patel, Leena; Chandrasekhar, Jayaraman; Evarts, Jerry; Forseth, Kristen; Haran, Aaron C.; Ip, Carmen; Kashishian, Adam; Kim, Musong; Koditek, David; Koppenol, Sandy; Lad, Latesh; Lepist, Eve-Irene; McGrath, Mary E.; Perreault, Stephane; Puri, Kamal D.; Villasenor, Armando G.; Somoza, John R.; Steiner, Bart H.; Therrien, Joseph; Treiberg, Jennifer; Phillips, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9228-9242</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant signaling of phosphoinositide-3-kinase delta (PI3K-delta) has been implicated in numerous pathologies including hematol. malignancies and rheumatoid arthritis.  Described in this manuscript is the discovery, optimization and in vivo evaluation of a novel series of pyridine-contg. PI3K-delta inhibitors.  This work led to the discovery of I, a highly selective inhibitor of PI3K-delta which displays an excellent pharmacokinetic profile and is efficacious in a rodent model of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1LgrP9YV8frVg90H21EOLACvtfcHk0liKHKEylEzBIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGrs7rF&md5=6d9dff0ec5270aab250fcb4800d8635a</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01169%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DForseth%26aufirst%3DK.%26aulast%3DHaran%26aufirst%3DA.%2BC.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DKoppenol%26aufirst%3DS.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSteiner%26aufirst%3DB.%2BH.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520inhibitors%2520with%2520improved%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9228%26epage%3D9242%26doi%3D10.1021%2Facs.jmedchem.6b01169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Watterson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucca, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langevine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traeger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattoli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermeier, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discenza, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulicicchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcintyre, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1<i>H</i>-carbazole-8-carboxamide (BMS-986142): a reversible inhibitor of Bruton’s Tyrosine Kinase (BTK) conformationally constrained by two locked atropisomers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">9173</span>– <span class="NLM_lpage">9200</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9173-9200&issue=19&author=S.+H.+Wattersonauthor=G.+V.+De+Luccaauthor=Q.+Shiauthor=C.+M.+Langevineauthor=Q.+Liuauthor=D.+G.+Battauthor=M.+B.+Bertrandauthor=H.+Gongauthor=J.+Daiauthor=S.+Yipauthor=P.+Liauthor=D.+Sunauthor=D.-R.+Wuauthor=C.+Wangauthor=Y.+Zhangauthor=S.+C.+Traegerauthor=M.+A.+Pattoliauthor=S.+Skalaauthor=L.+Chengauthor=M.+T.+Obermeierauthor=R.+Vickeryauthor=L.+N.+Discenzaauthor=C.+J.+D%E2%80%99Arienzoauthor=Y.+Zhangauthor=E.+Heimrichauthor=K.+M.+Gilloolyauthor=T.+L.+Taylorauthor=C.+Pulicicchioauthor=K.+W.+Mcintyreauthor=M.+A.+Galellaauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=C.+Changauthor=R.+Rampullaauthor=A.+Mathurauthor=L.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=A.+Furaauthor=J.+R.+Burkeauthor=J.+A.+Tino&title=Discovery+of+6-fluoro-5-%28R%29-%283-%28S%29-%288-fluoro-1-methyl-2%2C4-dioxo-1%2C2-dihydroquinazolin-3%284H%29-yl%29-2-methylphenyl%29-2-%28S%29-%282-hydroxypropan-2-yl%29-2%2C3%2C4%2C9-tetrahydro-1H-carbazole-8-carboxamide+%28BMS-986142%29%3A+a+reversible+inhibitor+of+Bruton%E2%80%99s+Tyrosine+Kinase+%28BTK%29+conformationally+constrained+by+two+locked+atropisomers&doi=10.1021%2Facs.jmedchem.6b01088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01088%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DDe%2BLucca%26aufirst%3DG.%2BV.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DBertrand%26aufirst%3DM.%2BB.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DYip%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DVickery%26aufirst%3DR.%26aulast%3DDiscenza%26aufirst%3DL.%2BN.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHeimrich%26aufirst%3DE.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DMcintyre%26aufirst%3DK.%2BW.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25206-fluoro-5-%2528R%2529-%25283-%2528S%2529-%25288-fluoro-1-methyl-2%252C4-dioxo-1%252C2-dihydroquinazolin-3%25284H%2529-yl%2529-2-methylphenyl%2529-2-%2528S%2529-%25282-hydroxypropan-2-yl%2529-2%252C3%252C4%252C9-tetrahydro-1H-carbazole-8-carboxamide%2520%2528BMS-986142%2529%253A%2520a%2520reversible%2520inhibitor%2520of%2520Bruton%25E2%2580%2599s%2520Tyrosine%2520Kinase%2520%2528BTK%2529%2520conformationally%2520constrained%2520by%2520two%2520locked%2520atropisomers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D9173%26epage%3D9200%26doi%3D10.1021%2Facs.jmedchem.6b01088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokensgard, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span> <span> </span><span class="NLM_article-title">Exploring atropisomerism to increase target selectivity of kinase inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">11754</span>– <span class="NLM_lpage">11759</span>, <span class="refDoi"> DOI: 10.1002/anie.201506085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.201506085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=11754-11759&author=D.+E.+Smithauthor=I.+Marquezauthor=M.+E.+Lokensgardauthor=A.+L.+Rheingoldauthor=D.+A.+Hechtauthor=J.+L.+Gustafson&title=Exploring+atropisomerism+to+increase+target+selectivity+of+kinase+inhibitors&doi=10.1002%2Fanie.201506085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1002%2Fanie.201506085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201506085%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DMarquez%26aufirst%3DI.%26aulast%3DLokensgard%26aufirst%3DM.%2BE.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DHecht%26aufirst%3DD.%2BA.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26atitle%3DExploring%2520atropisomerism%2520to%2520increase%2520target%2520selectivity%2520of%2520kinase%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D11754%26epage%3D11759%26doi%3D10.1002%2Fanie.201506085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devadas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidate</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fcmdc.201100439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=273-280&author=L.+Xingauthor=B.+Devadasauthor=R.+V.+Devrajauthor=S.+R.+Selnessauthor=H.+Shiehauthor=J.+K.+Walkerauthor=M.+Maoauthor=D.+Messingauthor=B.+Samasauthor=J.+Z.+Yangauthor=G.+D.+Andersonauthor=E.+G.+Webbauthor=J.+B.+Monahan&title=Discovery+and+characterization+of+atropisomer+PH-797804%2C+a+p38+MAP+kinase+inhibitor%2C+as+a+clinical+drug+candidate&doi=10.1002%2Fcmdc.201100439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100439%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%2BZ.%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DWebb%26aufirst%3DE.%2BG.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520atropisomer%2520PH-797804%252C%2520a%2520p38%2520MAP%2520kinase%2520inhibitor%252C%2520as%2520a%2520clinical%2520drug%2520candidate%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D273%26epage%3D280%26doi%3D10.1002%2Fcmdc.201100439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing atropisomer axial chirality in drug discovery and development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+Laplanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+F.+Millerauthor=P.+J.+Edwards&title=Assessing+atropisomer+axial+chirality+in+drug+discovery+and+development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0lhGbZB2bYLHdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%2BF.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span> <span> </span><span class="NLM_article-title">The challenge of atropisomerism in drug discovery</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6398</span>– <span class="NLM_lpage">6401</span>, <span class="refDoi"> DOI: 10.1002/anie.200901719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.200901719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=19637174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6398-6401&author=J.+Claydenauthor=W.+J.+Moranauthor=P.+J.+Edwardsauthor=S.+R.+Laplante&title=The+challenge+of+atropisomerism+in+drug+discovery&doi=10.1002%2Fanie.200901719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">The Challenge of Atropisomerism in Drug Discovery</span></div><div class="casAuthors">Clayden, Jonathan; Moran, Wesley J.; Edwards, Paul J.; LaPlante, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">6398-6401</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Herein, we address the pharmaceutical implications of a hitherto largely overlooked alternative source of drug chirality: atropisomerism.  Atropisomers are conformers which, owing to steric or electronic constraints, interconvert slowly enough (by definition, with a half life of > 1000 s) that they can be isolated.'781 The stereochem. consequences of hindered rotation about a single bond can be such that an apparent single compd. can actually be a mixt. of two, or an apparently achiral compd. can actually be racemic.  If such pairs of stereoisomers are separable, then the implications for drug discovery may be similar to those of compds. with classical chiral centers.  In the context of a lack of std. procedures for dealing with atropisomerism, and the absence of specific regulatory policies governing conformationally based stereochem., we explore some recent examples of atropisomeric compds. that have been or are in drug development.  We also draw conclusions relating to potential strategies for design and development where atropisomerism is an issue.  We expose and propose options for the management of atropisomerism, which, many view as a lurking menace with the potential to significantly increase the cost of pharmaceutical research and development if ignored.  Atropisomerism may give rise to geometrical isomers, diastereoisomers, or enantiomers, all with the distinctive feature that they can in principle be equilibrated thermally.  In the absence of specific regulatory policies, atropisomeric stereoisomers are best dealt with in the same way as stereoisomers with classical chiral centers, but with isomerization rates and where necessary, differential conformer populations taken into account.  For racemic drug candidates, the FDA policy statement from 1992 emphasizes the importance of understanding the main therapeutic activities of the isomers through in vitro or in vivo studies.  Studies of the pharmacokinetic behavior of the individual enantiomers carried out early in the development of drug candidates are also valuable.  Knowledge gained from these studies can help guide the choice of development of a single enantiomer vs. a racemic mixt.  Development of a drug as a racemic mixt. may be appropriate if the mixt. is not reasonably separable (by synthetic methods, HPLC anal., etc.) or if racemization is rapid in vitro and/or in vivo (as in ibuprofen or thalidomide), thus making it futile to administer only the eutomer (more active isomer).  However, it is nonetheless highly recommended that crit. pharmacol. attributes related to the safety and efficacy of both isomers is investigated: overall, there must be an acceptable toxicol. profile and a suitable therapeutic window (in vitro, in animal models, and in humans).  FDA website provides some useful guidance to their expectations for drug development in this context.  Options for dealing with the phenomenon of atropisomerism can be implemented at the early stage of drug design.  For example, it may be possible to make related analogs that have the following features: (1) symmetry about a hindered bond, thus eliminating a chiral axis; (2) faster rotation about a hindered bond, thus pushing the half-life for conformational interconversion down to the order of seconds; (3) further encumbrance about a hindered bond to produce separable atropisomers whose interconversion is negligibly slow (for example, half-lives of the order of millennia); or (4) introduction of a stable stereogenic center to perturb the population of interconverting atropisomers such that only one desirable conformation predominates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsMjlS3iQPEbVg90H21EOLACvtfcHk0lhGbZB2bYLHdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurfN&md5=70ff6fe476e7db4653130fe74af9325e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1002%2Fanie.200901719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200901719%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DW.%2BJ.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26atitle%3DThe%2520challenge%2520of%2520atropisomerism%2520in%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D6398%26epage%3D6401%26doi%3D10.1002%2Fanie.200901719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of a phosphoinositide 3-kinase (PI3K) β/δ Inhibitor for the treatment of phosphatase and tensin homolog (PTEN) deficient tumors: building PI3Kβ potency in a PI3Kδ-selective template by targeting non-conserved Asp856</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1567</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01821</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01821" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1555-1567&author=S.+Perreaultauthor=J.+Chandrasekharauthor=Z.-H.+Cuiauthor=J.+Evartsauthor=J.+Haoauthor=J.+A.+Kaplanauthor=A.+Kashishianauthor=K.+S.+Keeganauthor=T.+Kenneyauthor=D.+Koditekauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=L.+Patelauthor=B.+Phillipsauthor=J.+Therrienauthor=J.+Treibergauthor=A.+Yahiaouiauthor=G.+Phillips&title=Discovery+of+a+phosphoinositide+3-kinase+%28PI3K%29+%CE%B2%2F%CE%B4+Inhibitor+for+the+treatment+of+phosphatase+and+tensin+homolog+%28PTEN%29+deficient+tumors%3A+building+PI3K%CE%B2+potency+in+a+PI3K%CE%B4-selective+template+by+targeting+non-conserved+Asp856&doi=10.1021%2Facs.jmedchem.6b01821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01821%26sid%3Dliteratum%253Aachs%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DZ.-H.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DJ.%2BA.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKeegan%26aufirst%3DK.%2BS.%26aulast%3DKenney%26aufirst%3DT.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DYahiaoui%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520phosphoinositide%25203-kinase%2520%2528PI3K%2529%2520%25CE%25B2%252F%25CE%25B4%2520Inhibitor%2520for%2520the%2520treatment%2520of%2520phosphatase%2520and%2520tensin%2520homolog%2520%2528PTEN%2529%2520deficient%2520tumors%253A%2520building%2520PI3K%25CE%25B2%2520potency%2520in%2520a%2520PI3K%25CE%25B4-selective%2520template%2520by%2520targeting%2520non-conserved%2520Asp856%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1555%26epage%3D1567%26doi%3D10.1021%2Facs.jmedchem.6b01821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosulich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert-van der Brempt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmann, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maudet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgentin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquet, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Péru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vautier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warin, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R)-8-(1-(3,5-difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4Hchromene-6-carboxamide (AZD8186): a potent and selective inhibitor of PI3Kβ and PI3Kδ for the treatment of PTEN-deficient cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1021/jm501629p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501629p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=943-962&author=B.+Barlaamauthor=S.+Cosulichauthor=S.+Degorceauthor=M.+Fitzekauthor=S.+Greenauthor=U.+Hancoxauthor=C.+Lambert-van+der+Bremptauthor=J.-J.+Lohmannauthor=M.+Maudetauthor=R.+Morgentinauthor=M.-J.+Pasquetauthor=A.+P%C3%A9ruauthor=P.+Pl%C3%A9author=T.+Salehauthor=M.+Vautierauthor=M.+Walkerauthor=L.+Wardauthor=N.+Warin&title=Discovery+of+%28R%29-8-%281-%283%2C5-difluorophenylamino%29ethyl%29-N%2CN-dimethyl-2-morpholino-4-oxo-4Hchromene-6-carboxamide+%28AZD8186%29%3A+a+potent+and+selective+inhibitor+of+PI3K%CE%B2+and+PI3K%CE%B4+for+the+treatment+of+PTEN-deficient+cancers&doi=10.1021%2Fjm501629p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm501629p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501629p%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DDegorce%26aufirst%3DS.%26aulast%3DFitzek%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHancox%26aufirst%3DU.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DLohmann%26aufirst%3DJ.-J.%26aulast%3DMaudet%26aufirst%3DM.%26aulast%3DMorgentin%26aufirst%3DR.%26aulast%3DPasquet%26aufirst%3DM.-J.%26aulast%3DP%25C3%25A9ru%26aufirst%3DA.%26aulast%3DPl%25C3%25A9%26aufirst%3DP.%26aulast%3DSaleh%26aufirst%3DT.%26aulast%3DVautier%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DWarin%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520%2528R%2529-8-%25281-%25283%252C5-difluorophenylamino%2529ethyl%2529-N%252CN-dimethyl-2-morpholino-4-oxo-4Hchromene-6-carboxamide%2520%2528AZD8186%2529%253A%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520PI3K%25CE%25B2%2520and%2520PI3K%25CE%25B4%2520for%2520the%2520treatment%2520of%2520PTEN-deficient%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D943%26epage%3D962%26doi%3D10.1021%2Fjm501629p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Certal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halley, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virone-Oddos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filoche-Rommé, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Ahmad, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carry, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnevaux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquette, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Below, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vade, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebourg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilorge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angouillant-Boniface, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louboutin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1021/jm401642q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401642q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=903-920&issue=3&author=V.+Certalauthor=F.+Halleyauthor=A.+Virone-Oddosauthor=C.+Delormeauthor=A.+Karlssonauthor=A.+Rakauthor=F.+Thompsonauthor=B.+Filoche-Romm%C3%A9author=Y.+El-Ahmadauthor=J.-C.+Carryauthor=P.-Y.+Abecassisauthor=P.+Lejeuneauthor=L.+Vincentauthor=H.+Bonnevauxauthor=J.-P.+Nicolasauthor=T.+Bertrandauthor=J.-P.+Marquetteauthor=N.+Michotauthor=T.+Benardauthor=P.+Belowauthor=I.+Vadeauthor=F.+Chatreauxauthor=G.+Lebourgauthor=F.+Pilorgeauthor=O.+Angouillant-Bonifaceauthor=A.+Louboutinauthor=C.+Lengauerauthor=L.+Schio&title=Discovery+and+optimization+of+pyrimidone+indoline+amide+PI3K%CE%B2+inhibitors+for+the+treatment+of+phosphatase+and+tensin+homologue+%28PTEN%29-deficient+cancers&doi=10.1021%2Fjm401642q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Pyrimidone Indoline Amide PI3Kβ Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)-Deficient Cancers</span></div><div class="casAuthors">Certal, Victor; Carry, Jean-Christophe; Halley, Frank; Virone-Oddos, Angela; Thompson, Fabienne; Filoche-Romme, Bruno; El-Ahmad, Youssef; Karlsson, Andreas; Charrier, Veronique; Delorme, Cecile; Rak, Alexey; Abecassis, Pierre-Yves; Amara, Celine; Vincent, Loic; Bonnevaux, Helene; Nicolas, Jean-Paul; Mathieu, Magali; Bertrand, Thomas; Marquette, Jean-Pierre; Michot, Nadine; Benard, Tsiala; Perrin, Marc-Antoine; Lemaitre, Olivier; Guerif, Stephane; Perron, Sebastien; Monget, Sylvie; Gruss-Leleu, Florence; Doerflinger, Gilles; Guizani, Houlfa; Brollo, Maurice; Delbarre, Laurence; Bertin, Luc; Richepin, Patrick; Loyau, Veronique; Garcia-Echeverria, Carlos; Lengauer, Christoph; Schio, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">903-920</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compelling mol. biol. publications have reported the implication of phosphoinositide kinase PI3Kβ in PTEN-deficient cell line growth and proliferation.  These findings supported a scientific rationale for the development of PI3Kβ-specific inhibitors for the treatment of PTEN-deficient cancers.  This paper describes the discovery of 2-[2-(2,3-dihydro-indol-1-yl)-2-oxo-ethyl]-6-morpholin-4-yl-3H-pyrimidin-4-one and the optimization of this new series of active and selective pyrimidone indoline amide PI3Kβ inhibitors. 2-[2-(2-Methyl-2,3-dihydro-indol-1-yl)-2-oxo-ethyl]-6-morpholin-4-yl-3H-pyrimidin-4-one (I), identified following a carefully designed Me scan, displayed improved physicochem. and in vitro pharmacokinetic properties.  Structural biol. efforts enabled the acquisition of the first x-ray cocrystal structure of p110β with the selective inhibitor compd. I bound to the ATP site.  The nonplanar binding mode described herein is consistent with obsd. structure-activity relationship for the series.  Compd. I demonstrated significant in vivo activity in a UACC-62 xenograft model in mice, warranting further preclin. investigation.  Following successful development, compd. 28 entered phase I/Ib clin. trial in patients with advanced cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5QsHhXYO6d7Vg90H21EOLACvtfcHk0lg_74Hk8jhXZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOjsw%253D%253D&md5=8141ae91a81b06ad129afd2263e2a007</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fjm401642q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401642q%26sid%3Dliteratum%253Aachs%26aulast%3DCertal%26aufirst%3DV.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DVirone-Oddos%26aufirst%3DA.%26aulast%3DDelorme%26aufirst%3DC.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DF.%26aulast%3DFiloche-Romm%25C3%25A9%26aufirst%3DB.%26aulast%3DEl-Ahmad%26aufirst%3DY.%26aulast%3DCarry%26aufirst%3DJ.-C.%26aulast%3DAbecassis%26aufirst%3DP.-Y.%26aulast%3DLejeune%26aufirst%3DP.%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DBonnevaux%26aufirst%3DH.%26aulast%3DNicolas%26aufirst%3DJ.-P.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DMarquette%26aufirst%3DJ.-P.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DBenard%26aufirst%3DT.%26aulast%3DBelow%26aufirst%3DP.%26aulast%3DVade%26aufirst%3DI.%26aulast%3DChatreaux%26aufirst%3DF.%26aulast%3DLebourg%26aufirst%3DG.%26aulast%3DPilorge%26aufirst%3DF.%26aulast%3DAngouillant-Boniface%26aufirst%3DO.%26aulast%3DLouboutin%26aufirst%3DA.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DSchio%26aufirst%3DL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520pyrimidone%2520indoline%2520amide%2520PI3K%25CE%25B2%2520inhibitors%2520for%2520the%2520treatment%2520of%2520phosphatase%2520and%2520tensin%2520homologue%2520%2528PTEN%2529-deficient%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D3%26spage%3D903%26epage%3D920%26doi%3D10.1021%2Fjm401642q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lopez de Turiso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaropong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seganish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simard, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7667</span>– <span class="NLM_lpage">7685</span>, <span class="refDoi"> DOI: 10.1021/jm300679u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300679u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKnsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7667-7685&author=F.+Gonzalez-Lopez+de+Turisoauthor=Y.+Shinauthor=M.+Brownauthor=M.+Cardozoauthor=Y.+Chenauthor=D.+Fongauthor=X.+Haoauthor=X.+Heauthor=K.+Henneauthor=Y.-L.+Huauthor=M.+G.+Johnsonauthor=T.+Kohnauthor=J.+Lohmanauthor=H.+J.+McBrideauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=K.+Minerauthor=D.+Mohnauthor=V.+Pattaropongauthor=J.+Seganishauthor=J.+L.+Simardauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=G.+Yuauthor=T.+D.+Cushing&title=Discovery+and+in+vivo+evaluation+of+dual+PI3K%CE%B2%2F%CE%B4+inhibitors&doi=10.1021%2Fjm300679u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors</span></div><div class="casAuthors">Gonzalez-Lopez de Turiso, Felix; Shin, Youngsook; Brown, Matthew; Cardozo, Mario; Chen, Yi; Fong, David; Hao, Xiaolin; He, Xiao; Henne, Kirk; Hu, Yi-Ling; Johnson, Michael G.; Kohn, Todd; Lohman, Julia; McBride, Helen J.; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; Miner, Kent; Mohn, Deanna; Pattaropong, Vatee; Seganish, Jennifer; Simard, Jillian L.; Wannberg, Sharon; Whittington, Douglas A.; Yu, Gang; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7667-7685</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based rational design led to the synthesis of a novel series of potent PI3K inhibitors.  The optimized pyrrolopyridine analog I was a potent and selective PI3Kβ/δ dual inhibitor that displayed suitable physicochem. properties and pharmacokinetic profile for animal studies.  Analog I was found to be efficacious in animal models of inflammation including a keyhole limpet hemocyanin (KLH) study and a collagen-induced arthritis (CIA) disease model of rheumatoid arthritis.  These studies highlight the potential therapeutic value of inhibiting both the PI3Kβ and δ isoforms in the treatment of a no. of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpslq3QL1Tg7LVg90H21EOLACvtfcHk0lgi3dA_s4p7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKnsr3J&md5=fbf690a0e702faf17e16ef68db076635</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm300679u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300679u%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DKohn%26aufirst%3DT.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DMcBride%26aufirst%3DH.%2BJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMiner%26aufirst%3DK.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DSeganish%26aufirst%3DJ.%26aulast%3DSimard%26aufirst%3DJ.%2BL.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%2520and%2520in%2520vivo%2520evaluation%2520of%2520dual%2520PI3K%25CE%25B2%252F%25CE%25B4%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7667%26epage%3D7685%26doi%3D10.1021%2Fjm300679u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span> <span> </span><span class="NLM_article-title">The PI3K pathway as drug target in human cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1200/JCO.2009.25.3641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1200%2FJCO.2009.25.3641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=20085938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1075-1083&author=K.+D.+Courtneyauthor=R.+B.+Corcoranauthor=J.+A.+Engelman&title=The+PI3K+pathway+as+drug+target+in+human+cancer&doi=10.1200%2FJCO.2009.25.3641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The PI3K pathway as drug target in human cancer</span></div><div class="casAuthors">Courtney, Kevin D.; Corcoran, Ryan B.; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1083</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth, survival, motility, and metab.  This pathway is activated by several different mechanisms in cancers, including somatic mutation and amplification of genes encoding key components.  In addn., PI3K signaling may serve integral functions for noncancerous cells in the tumor microenvironment.  Consequently, therapeutics targeting the PI3K pathway are being developed at a rapid pace, and preclin. and early clin. studies are beginning to suggest specific strategies to effectively use them.  However, the central role of PI3K signaling in a large array of diverse biol. processes raises concerns about its use in therapeutics and increases the need to develop sophisticated strategies for its use.  In this review, we will discuss how PI3K signaling affects the growth and survival of tumor cells.  From this vantage, we will consider how inhibitors of the PI3K signaling cascade, either alone or in combination with other therapeutics, can most effectively be used for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPqtk2bVl0rVg90H21EOLACvtfcHk0liqaopXxmx7ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D&md5=b88b394919647e2eb47e7735355fde2a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.3641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.3641%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520PI3K%2520pathway%2520as%2520drug%2520target%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1075%26epage%3D1083%26doi%3D10.1200%2FJCO.2009.25.3641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Haas-Kogan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yount, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G.</span></span> <span> </span><span class="NLM_article-title">Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1016/S0960-9822(07)00493-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1016%2FS0960-9822%2807%2900493-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=9799739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADyaK1cXntFWgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1195-1198&author=D.+Haas-Koganauthor=N.+Shalevauthor=M.+Wongauthor=G.+Yountauthor=D.+Stokoeauthor=G.+Mills&title=Protein+kinase+B+%28PKB%2FAkt%29+activity+is+elevated+in+glioblastoma+cells+due+to+mutation+of+the+tumor+suppressor+PTEN%2FMMAC&doi=10.1016%2FS0960-9822%2807%2900493-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC</span></div><div class="casAuthors">Haas-Kogan, Daphne; Shalev, Noga; Wong, Michelle; Mills, Gordon; Yount, Garret; Stokoe, David</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1195-1198</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Glioblastomas are highly malignant tumors of the central nervous system that are resistant to radiation and chemotherapy.  The authors explored the role of the phosphatidylinositol (PI) 3-kinase signal transduction pathway in glioblastomas, as this pathway has been shown to inhibit apoptosis induced by cytokine withdrawal and the detachment of cells from the extracellular matrix.  Components of this pathway have been implicated in tumor development.  The authors show that glioblastoma cells, in contrast to primary human astrocytes, contain high endogenous protein kinase B (PKB/Akt) activity and high levels of PI 3,4,5-triphosphate (PI(3,4,5)P3) and PI(3,4)P2, the lipid products of PI 3-kinase.  These glioblastoma cells express mutant forms of the putative 3' phospholipid phosphatase PTEN, also known as MMAC.  Expression of wild-type PTEN derived from primary astrocytes, but not of mutant forms of PTEN, reduced the levels of 3' phosphoinositides and inhibited PKB/Akt activity.  PTEN antagonized the activation of PKB/Akt by growth factors, by activated PI 3-kinase, and by PI-dependent protein kinase-1 (PDK1), but did not antagonize the phospholipid-independent activation of PKB/Akt lacking the pleckstrin homol. (PH) domain.  These results suggest a role for PTEN in regulating the activity of the PI 3-kinase pathway in malignant human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4DJ3A1shJorVg90H21EOLACvtfcHk0liqaopXxmx7ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFWgsbg%253D&md5=1f85263b620aa6e104aa8080274aa2d3</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2807%2900493-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252807%252900493-9%26sid%3Dliteratum%253Aachs%26aulast%3DHaas-Kogan%26aufirst%3DD.%26aulast%3DShalev%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DYount%26aufirst%3DG.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DG.%26atitle%3DProtein%2520kinase%2520B%2520%2528PKB%252FAkt%2529%2520activity%2520is%2520elevated%2520in%2520glioblastoma%2520cells%2520due%2520to%2520mutation%2520of%2520the%2520tumor%2520suppressor%2520PTEN%252FMMAC%26jtitle%3DCurr.%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D1195%26epage%3D1198%26doi%3D10.1016%2FS0960-9822%2807%2900493-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batty, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der
Kaay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolarov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigler, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">The lipid phosphatase activity of PTEN is critical for its tumor suppressor function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">13513</span>– <span class="NLM_lpage">13518</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.23.13513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1073%2Fpnas.95.23.13513" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13513-13518&author=M.+P.+Myersauthor=I.+Passauthor=I.+H.+Battyauthor=J.+Van+der%0AKaayauthor=J.+P.+Stolarovauthor=B.+A.+Hemmingsauthor=M.+H.+Wiglerauthor=C.+P.+Downesauthor=N.+K.+Tonks&title=The+lipid+phosphatase+activity+of+PTEN+is+critical+for+its+tumor+suppressor+function&doi=10.1073%2Fpnas.95.23.13513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.23.13513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.23.13513%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DM.%2BP.%26aulast%3DPass%26aufirst%3DI.%26aulast%3DBatty%26aufirst%3DI.%2BH.%26aulast%3DVan%2Bder%2BKaay%26aufirst%3DJ.%26aulast%3DStolarov%26aufirst%3DJ.%2BP.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DDownes%26aufirst%3DC.%2BP.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DThe%2520lipid%2520phosphatase%2520activity%2520of%2520PTEN%2520is%2520critical%2520for%2520its%2520tumor%2520suppressor%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D13513%26epage%3D13518%26doi%3D10.1073%2Fpnas.95.23.13513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deBeaumont, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span> <span> </span><span class="NLM_article-title">PTEN-deficient cancers depend on PIK3CB</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13057</span>– <span class="NLM_lpage">13062</span>, <span class="refDoi"> DOI: 10.1073/pnas.0802655105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1073%2Fpnas.0802655105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=18755892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSitbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13057-13062&author=S.+Weeauthor=D.+Wiederschainauthor=S.-M.+Mairaauthor=A.+Looauthor=C.+Millerauthor=R.+deBeaumontauthor=F.+Stegmeierauthor=Y.-M.+Yaoauthor=C.+Lengauer&title=PTEN-deficient+cancers+depend+on+PIK3CB&doi=10.1073%2Fpnas.0802655105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN-deficient cancers depend on PIK3CB</span></div><div class="casAuthors">Wee, Susan; Wiederschain, Dmitri; Maira, Sauveur-Michel; Loo, Alice; Miller, Christine; de Beaumont, Rosalie; Stegmeier, Frank; Yao, Yung-Mae; Lengauer, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">13057-13062</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Deregulation of the PI3K signaling pathway is obsd. in many human cancers and occurs most frequently through loss of PTEN phosphatase tumor suppressor function or through somatic activating mutations in the Class IA PI3K, PIK3CA.  Tumors harboring activated p110α, the protein product of PIK3CA, require p110α activity for growth and survival and hence are expected to be responsive to inhibitors of its lipid kinase activity.  Whether PTEN-deficient cancers similarly depend on p110α activity to sustain activation of the PI3K pathway has been unclear.  In this study, we used a single-vector lentiviral inducible shRNA system to selectively inactivate the three Class IA PI3Ks, PIK3CA, PIK3CB, and PIK3CD, to det. which PI3K isoforms are responsible for driving the abnormal proliferation of PTEN-deficient cancers.  Down-regulation of PIK3CA in colorectal cancer cells harboring mutations in PIK3CA inhibited downstream PI3K signaling and cell growth.  Surprisingly, PIK3CA depletion affected neither PI3K signaling nor cell growth in 3 PTEN-deficient cancer cell lines.  In contrast, down-regulation of the PIK3CB isoform, which encodes p110β, resulted in pathway inactivation and subsequent inhibition of growth in both cell-based and in vivo settings.  This essential function of PIK3CB in PTEN-deficient cancer cells required its lipid kinase activity.  Our findings demonstrate that although p110α activation is required to sustain the proliferation of established PIK3CA-mutant tumors, PTEN-deficient tumors are dependent instead on p110β signaling.  This unexpected finding demonstrates the need to tailor therapeutic approaches to the genetic basis of PI3K pathway activation to achieve optimal treatment response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ybGsv3DVCrVg90H21EOLACvtfcHk0lj4IPE3vK4-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSitbrO&md5=b7c690d3631ac6cbee9d7d7414dae1da</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802655105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802655105%26sid%3Dliteratum%253Aachs%26aulast%3DWee%26aufirst%3DS.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DdeBeaumont%26aufirst%3DR.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DYao%26aufirst%3DY.-M.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DPTEN-deficient%2520cancers%2520depend%2520on%2520PIK3CB%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13057%26epage%3D13062%26doi%3D10.1073%2Fpnas.0802655105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span> <span> </span><span class="NLM_article-title">Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>454</i></span>,  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1038/nature07091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1038%2Fnature07091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=18594509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Snu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=776-779&author=S.+Jiaauthor=Z.+Liuauthor=S.+Zhangauthor=P.+Liuauthor=L.+Zhangauthor=S.+H.+Leeauthor=L.+J.+Zhangauthor=S.+Signorettiauthor=M.+Lodaauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Essential+roles+of+PI%283%29K-p110%CE%B2+in+cell+growth%2C+metabolism+and+tumorigenesis&doi=10.1038%2Fnature07091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis</span></div><div class="casAuthors">Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Signoretti, Sabina; Loda, Massimo; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">454</span>
        (<span class="NLM_cas:issue">7205</span>),
    <span class="NLM_cas:pages">776-779</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">On activation by receptors, the ubiquitously expressed class IA isoforms (p110α and p110β) of phosphatidylinositol-3-kinase (PI(3)K) generate lipid second messengers, which initiate multiple signal transduction cascades.  Recent studies have demonstrated specific functions for p110α in growth factor and insulin signaling.  To probe for distinct functions of p110β, we constructed conditional knockout mice.  Here we show that ablation of p110β in the livers of the resulting mice leads to impaired insulin sensitivity and glucose homeostasis, while having little effect on phosphorylation of Akt, suggesting the involvement of a kinase-independent role of p110β in insulin metabolic action.  Using established mouse embryonic fibroblasts, we found that removal of p110β also had little effect on Akt phosphorylation in response to stimulation by insulin and epidermal growth factor, but resulted in retarded cell proliferation.  Reconstitution of p110β-null cells with a wild-type or kinase-dead allele of p110β demonstrated that p110β possesses kinase-independent functions in regulating cell proliferation and trafficking.  However, the kinase activity of p110β was required for G-protein-coupled receptor signaling triggered by lysophosphatidic acid and had a function in oncogenic transformation.  Most strikingly, in an animal model of prostate tumor formation induced by Pten loss, ablation of p110β (also known as Pik3cb), but not that of p110α (also known as Pik3ca), impeded tumorigenesis with a concomitant diminution of Akt phosphorylation.  Taken together, our findings demonstrate both kinase-dependent and kinase-independent functions for p110β, and strongly indicate the kinase-dependent functions of p110β as a promising target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm6EUnzNHwHrVg90H21EOLACvtfcHk0lj4IPE3vK4-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Snu7w%253D&md5=b32d9fcd1e8a0090da3ee8ae918a49db</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fnature07091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07091%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DL.%2BJ.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DEssential%2520roles%2520of%2520PI%25283%2529K-p110%25CE%25B2%2520in%2520cell%2520growth%252C%2520metabolism%2520and%2520tumorigenesis%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D776%26epage%3D779%26doi%3D10.1038%2Fnature07091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span>Force
field minimizations and conformational scans were carried out using
Macromodel, and ab initio calculations were performed using Jaguar,
as implemented in the Maestro suite of programs: Maestro V11.1; Schrödinger,
Inc. Portland, OR, 2017. <a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Force%0Afield+minimizations+and+conformational+scans+were+carried+out+using%0AMacromodel%2C+and+ab+initio+calculations+were+performed+using+Jaguar%2C%0Aas+implemented+in+the+Maestro+suite+of+programs%3A+Maestro+V11.1%3B+Schr%C3%B6dinger%2C%0AInc.+Portland%2C+OR%2C+2017.+http%3A%2F%2Fwww.schrodinger.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">Atoms that are not constrained during the torsional scan tend to distort significantly out of plane to avoid steric clashes near the transition states. The calculated energy barriers vary with the choice of the specific atoms used to define the torsional scan.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Closely related analogs lacking the 5- or 8-fluoro on the quinoline ((<i>rac</i>)-3-fluoro-4-(1-(8-fluoroquinolin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1H-benzo[<i>d</i>]imidazol-6-yl)pyridin-2-amine and (<i>rac</i>)-3-fluoro-4-(1-(5-fluoroquinolin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)pyridin-2-amine) result in approximatively 3-fold loss in potency against PI3Kβ.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">Analytical methods indicate that both purified atropisomers are free of the other by the limit of detection of our technology (>99% ee). (<i>M</i>)-<b>28</b> may be completely devoid of activity, but a 0.1% impurity of (<i>P</i>)-<b>28</b> would result in single digit micromolar activity (<10 μM).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span> The crystallization
and structure determination of PI3Kδ bound with (<i>P</i>)-<b>28</b> was determined using methods described previously:<span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villasenor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novikov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagpacan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papalia, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span> <span> </span><span class="NLM_article-title">Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase δ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">8439</span>– <span class="NLM_lpage">8446</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.634683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1074%2Fjbc.M114.634683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=25631052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=8439-8446&author=J.+R.+Somozaauthor=D.+Koditekauthor=A.+G.+Villasenorauthor=N.+Novikovauthor=M.+H.+Wongauthor=A.+Liclicanauthor=W.+Xingauthor=L.+Lagpacanauthor=R.+Wangauthor=B.+E.+Schultzauthor=G.+A.+Papaliaauthor=D.+Samuelauthor=L.+Ladauthor=M.+E.+McGrath&title=Structural%2C+biochemical%2C+and+biophysical+characterization+of+idelalisib+binding+to+phosphoinositide+3-kinase+%CE%B4&doi=10.1074%2Fjbc.M114.634683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ</span></div><div class="casAuthors">Somoza, John R.; Koditek, David; Villasenor, Armando G.; Novikov, Nikolai; Wong, Melanie H.; Liclican, Albert; Xing, Weimei; Lagpacan, Leanna; Wang, Ruth; Schultz, Brian E.; Papalia, Giuseppe A.; Samuel, Dharmaraj; Lad, Latesh; McGrath, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">8439-8446</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Idelalisib (also known as GS-1101, CAL-101, IC489666, and Zydelig) is a PI3Kδ inhibitor that has recently been approved for the treatment of several hematol. malignancies.  Given its use in human diseases, we needed a clear picture of how idelalisib binds to and inhibits PI3Kδ.  Our data show that idelalisib is a potent and selective inhibitor of the kinase activity of PI3Kδ.  A kinetic characterization clearly demonstrated ATP-competitive inhibition, and several addnl. biochem. and biophys. assays showed that the compd. binds reversibly and noncovalently to the kinase.  A crystal structure of idelalisib bound to the p110δ subunit of PI3Kδ furthers our understanding of the binding interactions that confer the potency and selectivity of idelalisib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXZo8_qK79rVg90H21EOLACvtfcHk0lj4IPE3vK4-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVSqtrs%253D&md5=2969b7407f4edc367249215bbbf22a0e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.634683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.634683%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DW.%26aulast%3DLagpacan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26atitle%3DStructural%252C%2520biochemical%252C%2520and%2520biophysical%2520characterization%2520of%2520idelalisib%2520binding%2520to%2520phosphoinositide%25203-kinase%2520%25CE%25B4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D8439%26epage%3D8446%26doi%3D10.1074%2Fjbc.M114.634683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prelog, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmchen, G.</span></span> <span> </span><span class="NLM_article-title">Basic principles of the CIP-system and proposals for a revision</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1002/anie.198205671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.198205671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1982&pages=567-583&author=V.+Prelogauthor=G.+Helmchen&title=Basic+principles+of+the+CIP-system+and+proposals+for+a+revision&doi=10.1002%2Fanie.198205671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fanie.198205671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.198205671%26sid%3Dliteratum%253Aachs%26aulast%3DPrelog%26aufirst%3DV.%26aulast%3DHelmchen%26aufirst%3DG.%26atitle%3DBasic%2520principles%2520of%2520the%2520CIP-system%2520and%2520proposals%2520for%2520a%2520revision%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1982%26volume%3D21%26spage%3D567%26epage%3D583%26doi%3D10.1002%2Fanie.198205671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span> <span> </span><span class="NLM_article-title">The p110δ crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williamsauthor=P.+Ren&title=The+p110%CE%B4+crystal+structure+uncovers+mechanisms+for+selectivity+and+potency+of+novel+PI3K+inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0li4SYk7npdNLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DRen%26aufirst%3DP.%26atitle%3DThe%2520p110%25CE%25B4%2520crystal%2520structure%2520uncovers%2520mechanisms%2520for%2520selectivity%2520and%2520potency%2520of%2520novel%2520PI3K%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">The DiscoveRx KINOMEscan platform employs an active site-directed competition binding assay to quantitatively measure interactions between test compounds against more than 400 human kinases. KINOME scan assays do not require ATP and thereby report true thermodynamic interaction affinities, as opposed to IC<sub>50</sub> values, which can depend on the ATP concentration.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-D.</span></span> <span> </span><span class="NLM_article-title">Aldehyde oxidase: an enzyme of emerging importance in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8441</span>– <span class="NLM_lpage">8460</span>, <span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+an+enzyme+of+emerging+importance+in+drug+discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0li71eBpyR9ezQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520an%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1124%2Fdmd.110.033555" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1322-1327&author=M.+Zientekauthor=Y.+Jiangauthor=K.+Youdimauthor=R.+S.+Obach&title=In+vitro-in+vivo+correlation+for+intrinsic+clearance+for+drugs+metabolized+by+human+aldehyde+oxidase&doi=10.1124%2Fdmd.110.033555"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033555%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520for%2520intrinsic%2520clearance%2520for%2520drugs%2520metabolized%2520by%2520human%2520aldehyde%2520oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1322%26epage%3D1327%26doi%3D10.1124%2Fdmd.110.033555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4642</span>– <span class="NLM_lpage">4647</span>, <span class="refDoi"> DOI: 10.1021/jm0703690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&issue=19&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+density+functional+calculations+to+predict+the+regioselectivity+of+drugs+and+molecules+metabolized+by+aldehyde+oxidase&doi=10.1021%2Fjm0703690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Torres, Rhonda A.; Korzekwa, Kenneth R.; McMasters, Daniel R.; Fandozzi, Christine M.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4642-4647</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidn. of aldehydes and nitrogen-contg. heterocycles.  The enzyme plays a dual role in the metab. of physiol. important endogenous compds. and the biotransformation of xenobiotics.  Using d. functional theory methods, geometry optimization of tetrahedral intermediates of drugs and druglike compds. was examd. to predict the likely metabolites of aldehyde oxidase.  The calcns. suggest that the lowest energy tetrahedral intermediate resulting from the initial substrate corresponds to the obsd. metabolite ≥90% of the time.  Addnl. calcns. were performed on a series of heterocyclic compds. where the products resulting from metab. by xanthine oxidase and aldehyde oxidase differ in many instances.  Again, the lowest energy tetrahedral intermediate corresponded to the obsd. product of aldehyde oxidase metab. ≥90% for the compds. examd., while the obsd. products of xanthine oxidase were not well predicted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmnIR2Ha4_oLVg90H21EOLACvtfcHk0li71eBpyR9ezQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D&md5=514ee5703f306287a3b7315fc5cea434</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520density%2520functional%2520calculations%2520to%2520predict%2520the%2520regioselectivity%2520of%2520drugs%2520and%2520molecules%2520metabolized%2520by%2520aldehyde%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4642%26epage%3D4647%26doi%3D10.1021%2Fjm0703690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. A.</span></span> <span> </span><span class="NLM_article-title">Refinement of in vitro methods for identification of aldehyde oxidase substrate reveals metabolites of kinases inhibitors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.080960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1124%2Fdmd.118.080960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=846-859&author=R.+A.+Dick&title=Refinement+of+in+vitro+methods+for+identification+of+aldehyde+oxidase+substrate+reveals+metabolites+of+kinases+inhibitors&doi=10.1124%2Fdmd.118.080960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.080960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.080960%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DR.%2BA.%26atitle%3DRefinement%2520of%2520in%2520vitro%2520methods%2520for%2520identification%2520of%2520aldehyde%2520oxidase%2520substrate%2520reveals%2520metabolites%2520of%2520kinases%2520inhibitors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26spage%3D846%26epage%3D859%26doi%3D10.1124%2Fdmd.118.080960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1124%2Fdmd.112.045195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=22522748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1441-1448&author=T.+J.+Strelevitzauthor=C.+C.+Orozcoauthor=R.+S.+Obach&title=Hydralazine+as+a+selective+probe+inactivator+of+aldehyde+oxidase+in+human+hepatocytes%3A+estimation+of+the+contribution+of+aldehyde+oxidase+to+metabolic+clearance&doi=10.1124%2Fdmd.112.045195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance</span></div><div class="casAuthors">Strelevitz, Timothy J.; Orozco, Christine C.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1441-1448</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) metab. could lead to significant underestimation of clearance in prediction of human pharmacokinetics as well as unanticipated exposure to AO-generated metabolites, if not accounted for early in drug research.  We report a method using cryopreserved human hepatocytes and the time-dependent AO inhibitor hydralazine (KI = 83 ± 27 μM, kintact = 0.063 ± 0.007 min-1), which ests. the contribution of AO metab. relative to total hepatic clearance.  Using zaleplon as a probe substrate and simultaneously monitoring the AO-catalyzed formation of oxozaleplon and the CYP3A-catalyzed formation of desethyzaleplon in the presence of a range of hydralazine concns., it was detd. that >90% inhibition of the AO activity with minimal effect on the CYP3A activity could be achieved with 25 to 50 μM hydralazine.  This method was used to est. the fraction metabolized due to AO [fm(AO)] for six compds. with clearance attributed to AO along with four other drugs not metabolized by AO.  The fm(AO) values for the AO substrates ranged between 0.49 and 0.83.  Differences in estd. fm(AO) between two batches of pooled human hepatocytes suggest that sensitivity to hydralazine varies slightly with hepatocyte prepns.  Substrates with a CYP2D6 contribution to clearance were affected by hydralazine to a minor extent, because of weak inhibition of this enzyme.  Overall, these findings demonstrate that hydralazine, at a concn. of 25 to 50 μM, can be used in human hepatocyte incubations to est. the contribution of AO to the hepatic clearance of drugs and other compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBKznnCiG-LVg90H21EOLACvtfcHk0lioDw36E6hSxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ&md5=6237313df0fe4ded2d2f37e55c3d4b03</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045195%26sid%3Dliteratum%253Aachs%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DHydralazine%2520as%2520a%2520selective%2520probe%2520inactivator%2520of%2520aldehyde%2520oxidase%2520in%2520human%2520hepatocytes%253A%2520estimation%2520of%2520the%2520contribution%2520of%2520aldehyde%2520oxidase%2520to%2520metabolic%2520clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1441%26epage%3D1448%26doi%3D10.1124%2Fdmd.112.045195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anslyn, E. V.</span>; <span class="NLM_string-name">Dougherty, D. A.</span></span> <i>Modern Physical Organic Chemistry</i>; <span class="NLM_publisher-name">University Science Books</span>: <span class="NLM_publisher-loc">Sausalito, CA</span>, <span class="NLM_year">2006</span>, pp  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">389</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=388-389&author=E.+V.+Anslyn&author=D.+A.+Dougherty&title=Modern+Physical+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAnslyn%26aufirst%3DE.%2BV.%26btitle%3DModern%2520Physical%2520Organic%2520Chemistry%26pub%3DUniversity%2520Science%2520Books%26date%3D2006%26spage%3D388%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eyring, H.</span></span> <span> </span><span class="NLM_article-title">The activated complex and the absolute rate of chemial reaction</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1935</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1021/cr60056a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr60056a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1935&pages=65-77&author=H.+Eyring&title=The+activated+complex+and+the+absolute+rate+of+chemial+reaction&doi=10.1021%2Fcr60056a006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fcr60056a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60056a006%26sid%3Dliteratum%253Aachs%26aulast%3DEyring%26aufirst%3DH.%26atitle%3DThe%2520activated%2520complex%2520and%2520the%2520absolute%2520rate%2520of%2520chemial%2520reaction%26jtitle%3DChem.%2520Rev.%26date%3D1935%26volume%3D17%26spage%3D65%26epage%3D77%26doi%3D10.1021%2Fcr60056a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eyring, H.</span></span> <span> </span><span class="NLM_article-title">The activated complex in chemical reaction</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1935</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1063/1.1749604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1063%2F1.1749604" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1935&pages=107-115&author=H.+Eyring&title=The+activated+complex+in+chemical+reaction&doi=10.1063%2F1.1749604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1063%2F1.1749604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.1749604%26sid%3Dliteratum%253Aachs%26aulast%3DEyring%26aufirst%3DH.%26atitle%3DThe%2520activated%2520complex%2520in%2520chemical%2520reaction%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1935%26volume%3D3%26spage%3D107%26epage%3D115%26doi%3D10.1063%2F1.1749604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':[],'ref13':[],'ref14':[],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':[],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22a','cit22b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jiamiao Jin, Xuan Huang, Jun Xu, Tingting Li, Xiaolin Peng, Xun Zhu, Junmin Zhang, Zhichao Jin, <span class="NLM_string-name hlFld-ContribAuthor">Yonggui Robin Chi</span>. </span><span class="cited-content_cbyCitation_article-title">Carbene-Catalyzed Atroposelective Annulation and Desymmetrization of Urazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (10)
                                     , 3991-3996. <a href="https://doi.org/10.1021/acs.orglett.1c01191" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01191%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCarbene-Catalyzed%252BAtroposelective%252BAnnulation%252Band%252BDesymmetrization%252Bof%252BUrazoles%26aulast%3DJin%26aufirst%3DJiamiao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07042021%26date%3D12052021%26volume%3D23%26issue%3D10%26spage%3D3991%26epage%3D3996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stephane Perreault, Fatima Arjmand, Jayaraman Chandrasekhar, Jia Hao, Kathleen S. Keegan, David Koditek, Eve-Irene Lepist, Clinton K. Matson, Mary E. McGrath, Leena Patel, Kassandra Sedillo, Joseph Therrien, Nicholas A. Till, Adrian Tomkinson, Jennifer Treiberg, Yelena Zherebina, <span class="NLM_string-name hlFld-ContribAuthor">Gary Phillips</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an Atropisomeric PI3Kβ Selective Inhibitor through Optimization of the Hinge Binding Motif. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1236-1243. <a href="https://doi.org/10.1021/acsmedchemlett.0c00095" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00095%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ban%252BAtropisomeric%252BPI3K%2525CE%2525B2%252BSelective%252BInhibitor%252Bthrough%252BOptimization%252Bof%252Bthe%252BHinge%252BBinding%252BMotif%26aulast%3DPerreault%26aufirst%3DStephane%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22022020%26date%3D13042020%26date%3D15042020%26date%3D13042020%26volume%3D11%26issue%3D6%26spage%3D1236%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nenad Manevski, Lloyd King, William R. Pitt, Fabien Lecomte, <span class="NLM_string-name hlFld-ContribAuthor">Francesca Toselli</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 10955-10994. <a href="https://doi.org/10.1021/acs.jmedchem.9b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetabolism%252Bby%252BAldehyde%252BOxidase%25253A%252BDrug%252BDesign%252Band%252BComplementary%252BApproaches%252Bto%252BChallenges%252Bin%252BDrug%252BDiscovery%26aulast%3DManevski%26aufirst%3DNenad%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30052019%26date%3D20082019%26date%3D06082019%26volume%3D62%26issue%3D24%26spage%3D10955%26epage%3D10994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Danielle
R. Hirsch, Anthony J. Metrano, Elizabeth A. Stone, Golo Storch, Scott J. Miller, <span class="NLM_string-name hlFld-ContribAuthor">Ryan P. Murelli</span>. </span><span class="cited-content_cbyCitation_article-title">Troponoid Atropisomerism: Studies on the Configurational Stability of Tropone-Amide Chiral Axes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (7)
                                     , 2412-2415. <a href="https://doi.org/10.1021/acs.orglett.9b00707" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00707%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTroponoid%252BAtropisomerism%25253A%252BStudies%252Bon%252Bthe%252BConfigurational%252BStability%252Bof%252BTropone-Amide%252BChiral%252BAxes%26aulast%3DHirsch%26aufirst%3DDanielle%2BR.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25022019%26date%3D14032019%26volume%3D21%26issue%3D7%26spage%3D2412%26epage%3D2415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart  Vanhaesebroeck</span>, <span class="hlFld-ContribAuthor ">Matthew W. D.  Perry</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Brown</span>, <span class="hlFld-ContribAuthor ">Fabrice  André</span>, <span class="hlFld-ContribAuthor ">Klaus  Okkenhaug</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K inhibitors are finally coming of age. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>170 </em><a href="https://doi.org/10.1038/s41573-021-00209-1" title="DOI URL">https://doi.org/10.1038/s41573-021-00209-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-021-00209-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-021-00209-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DPI3K%252Binhibitors%252Bare%252Bfinally%252Bcoming%252Bof%252Bage%26aulast%3DVanhaesebroeck%26aufirst%3DBart%26date%3D2021%26date%3D2021%26volume%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberta  Franzini</span>, <span class="hlFld-ContribAuthor ">Alessia  Rosetti</span>, <span class="hlFld-ContribAuthor ">Claudio  Villani</span>. </span><span class="cited-content_cbyCitation_article-title">Low Temperature Dynamic Chromatography for the Separation of the Interconverting Conformational Enantiomers of the Benzodiazepines Clonazolam, Flubromazolam, Diclazepam and Flurazepam. </span><span class="cited-content_cbyCitation_journal-name">Symmetry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (6)
                                     , 1012. <a href="https://doi.org/10.3390/sym13061012" title="DOI URL">https://doi.org/10.3390/sym13061012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/sym13061012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fsym13061012%26sid%3Dliteratum%253Aachs%26jtitle%3DSymmetry%26atitle%3DLow%252BTemperature%252BDynamic%252BChromatography%252Bfor%252Bthe%252BSeparation%252Bof%252Bthe%252BInterconverting%252BConformational%252BEnantiomers%252Bof%252Bthe%252BBenzodiazepines%252BClonazolam%25252C%252BFlubromazolam%25252C%252BDiclazepam%252Band%252BFlurazepam%26aulast%3DFranzini%26aufirst%3DRoberta%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D6%26spage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean T  Toenjes</span>, <span class="hlFld-ContribAuthor ">Mariam  Basilaia</span>, <span class="hlFld-ContribAuthor ">Jeffrey L  Gustafson</span>. </span><span class="cited-content_cbyCitation_article-title">Leveraging conformational control about a potential atropisomeric axis as a strategy in medical chemistry. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 443-446. <a href="https://doi.org/10.4155/fmc-2020-0348" title="DOI URL">https://doi.org/10.4155/fmc-2020-0348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0348%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DLeveraging%252Bconformational%252Bcontrol%252Babout%252Ba%252Bpotential%252Batropisomeric%252Baxis%252Bas%252Ba%252Bstrategy%252Bin%252Bmedical%252Bchemistry%26aulast%3DToenjes%26aufirst%3DSean%2BT%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D443%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tyler  Peryea</span>, <span class="hlFld-ContribAuthor ">Noel  Southall</span>, <span class="hlFld-ContribAuthor ">Mitch  Miller</span>, <span class="hlFld-ContribAuthor ">Daniel  Katzel</span>, <span class="hlFld-ContribAuthor ">Niko  Anderson</span>, <span class="hlFld-ContribAuthor ">Jorge  Neyra</span>, <span class="hlFld-ContribAuthor ">Sarah  Stemann</span>, <span class="hlFld-ContribAuthor ">Ðắc-Trung  Nguyễn</span>, <span class="hlFld-ContribAuthor ">Dammika  Amugoda</span>, <span class="hlFld-ContribAuthor ">Archana  Newatia</span>, <span class="hlFld-ContribAuthor ">Ramez  Ghazzaoui</span>, <span class="hlFld-ContribAuthor ">Elaine  Johanson</span>, <span class="hlFld-ContribAuthor ">Herman  Diederik</span>, <span class="hlFld-ContribAuthor ">Larry  Callahan</span>, <span class="hlFld-ContribAuthor ">Frank  Switzer</span>. </span><span class="cited-content_cbyCitation_article-title">Global Substance Registration System: consistent scientific descriptions for substances related to health. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2021,</strong> <em>49 </em>
                                    (D1)
                                     , D1179-D1185. <a href="https://doi.org/10.1093/nar/gkaa962" title="DOI URL">https://doi.org/10.1093/nar/gkaa962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa962%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DGlobal%252BSubstance%252BRegistration%252BSystem%25253A%252Bconsistent%252Bscientific%252Bdescriptions%252Bfor%252Bsubstances%252Brelated%252Bto%252Bhealth%26aulast%3DPeryea%26aufirst%3DTyler%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3DD1%26spage%3DD1179%26epage%3DD1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao-Yue  Xiang</span>, <span class="hlFld-ContribAuthor ">Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Xi  Zhang</span>, <span class="hlFld-ContribAuthor ">Cun  Tan</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Su</span>, <span class="hlFld-ContribAuthor ">Zhi-Wei  Gao</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>, <span class="hlFld-ContribAuthor ">Zhao-Bing  Gao</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Ling-Hua  Meng</span>, <span class="hlFld-ContribAuthor ">Chun-Hao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) as an orally bioavailable, highly potent, PI3K alpha inhibitor for the treatment of advanced solid tumors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112913. <a href="https://doi.org/10.1016/j.ejmech.2020.112913" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112913%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bmethyl%252B%2525285-%2525286-%252528%2525284-%252528methylsulfonyl%252529piperazin-1-yl%252529methyl%252529-4-morpholinopyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-2-yl%252529-4-%252528trifluoromethyl%252529pyridin-2-yl%252529carbamate%252B%252528CYH33%252529%252Bas%252Ban%252Borally%252Bbioavailable%25252C%252Bhighly%252Bpotent%25252C%252BPI3K%252Balpha%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Badvanced%252Bsolid%252Btumors%26aulast%3DXiang%26aufirst%3DHao-Yue%26date%3D2021%26volume%3D209%26spage%3D112913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Mancinelli</span>, <span class="hlFld-ContribAuthor ">Giorgio  Bencivenni</span>, <span class="hlFld-ContribAuthor ">Daniel  Pecorari</span>, <span class="hlFld-ContribAuthor ">Andrea  Mazzanti</span>. </span><span class="cited-content_cbyCitation_article-title">Stereochemistry and Recent Applications of Axially Chiral Organic Molecules. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (27)
                                     , 4070-4086. <a href="https://doi.org/10.1002/ejoc.201901918" title="DOI URL">https://doi.org/10.1002/ejoc.201901918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901918%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereochemistry%252Band%252BRecent%252BApplications%252Bof%252BAxially%252BChiral%252BOrganic%252BMolecules%26aulast%3DMancinelli%26aufirst%3DMichele%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D27%26spage%3D4070%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian  Scharinger</span>, <span class="hlFld-ContribAuthor ">Ádám  Márk Pálvölgyi</span>, <span class="hlFld-ContribAuthor ">Veronika  Zeindlhofer</span>, <span class="hlFld-ContribAuthor ">Michael  Schnürch</span>, <span class="hlFld-ContribAuthor ">Christian  Schröder</span>, <span class="hlFld-ContribAuthor ">Katharina  Bica‐Schröder</span>. </span><span class="cited-content_cbyCitation_article-title">Counterion Enhanced Organocatalysis: A Novel Approach for the Asymmetric Transfer Hydrogenation of Enones. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2020,</strong> <em>12 </em>
                                    (14)
                                     , 3776-3782. <a href="https://doi.org/10.1002/cctc.202000414" title="DOI URL">https://doi.org/10.1002/cctc.202000414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.202000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.202000414%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DCounterion%252BEnhanced%252BOrganocatalysis%25253A%252BA%252BNovel%252BApproach%252Bfor%252Bthe%252BAsymmetric%252BTransfer%252BHydrogenation%252Bof%252BEnones%26aulast%3DScharinger%26aufirst%3DFabian%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D14%26spage%3D3776%26epage%3D3782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johanna  Frey</span>, <span class="hlFld-ContribAuthor ">Alaleh  Malekafzali</span>, <span class="hlFld-ContribAuthor ">Isabel  Delso</span>, <span class="hlFld-ContribAuthor ">Sabine  Choppin</span>, <span class="hlFld-ContribAuthor ">Françoise  Colobert</span>, <span class="hlFld-ContribAuthor ">Joanna  Wencel‐Delord</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of N–C Axially Chiral Compounds by Cu‐Catalyzed Atroposelective Aryl Amination. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (23)
                                     , 8929-8933. <a href="https://doi.org/10.1002/ange.201914876" title="DOI URL">https://doi.org/10.1002/ange.201914876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201914876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201914876%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEnantioselective%252BSynthesis%252Bof%252BN%2525E2%252580%252593C%252BAxially%252BChiral%252BCompounds%252Bby%252BCu%2525E2%252580%252590Catalyzed%252BAtroposelective%252BAryl%252BAmination%26aulast%3DFrey%26aufirst%3DJohanna%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D23%26spage%3D8929%26epage%3D8933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johanna  Frey</span>, <span class="hlFld-ContribAuthor ">Alaleh  Malekafzali</span>, <span class="hlFld-ContribAuthor ">Isabel  Delso</span>, <span class="hlFld-ContribAuthor ">Sabine  Choppin</span>, <span class="hlFld-ContribAuthor ">Françoise  Colobert</span>, <span class="hlFld-ContribAuthor ">Joanna  Wencel‐Delord</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of N–C Axially Chiral Compounds by Cu‐Catalyzed Atroposelective Aryl Amination. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (23)
                                     , 8844-8848. <a href="https://doi.org/10.1002/anie.201914876" title="DOI URL">https://doi.org/10.1002/anie.201914876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201914876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201914876%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEnantioselective%252BSynthesis%252Bof%252BN%2525E2%252580%252593C%252BAxially%252BChiral%252BCompounds%252Bby%252BCu%2525E2%252580%252590Catalyzed%252BAtroposelective%252BAryl%252BAmination%26aulast%3DFrey%26aufirst%3DJohanna%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D23%26spage%3D8844%26epage%3D8848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Ballard</span>, <span class="hlFld-ContribAuthor ">Stefania  Narduolo</span>, <span class="hlFld-ContribAuthor ">Hiwa O.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Nathaniel I.  Keymer</span>, <span class="hlFld-ContribAuthor ">Nabil  Asaad</span>, <span class="hlFld-ContribAuthor ">David A.  Cosgrove</span>, <span class="hlFld-ContribAuthor ">Niklaas J.  Buurma</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Racemisation in Chemistry and Biology. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (17)
                                     , 3661-3687. <a href="https://doi.org/10.1002/chem.201903917" title="DOI URL">https://doi.org/10.1002/chem.201903917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201903917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201903917%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DRacemisation%252Bin%252BChemistry%252Band%252BBiology%26aulast%3DBallard%26aufirst%3DAndrew%26date%3D2020%26volume%3D26%26issue%3D17%26spage%3D3661%26epage%3D3687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bibliography. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 137-248. <a href="https://doi.org/10.1016/B978-0-12-812212-9.16001-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-812212-9.16001-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-812212-9.16001-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-812212-9.16001-4%26sid%3Dliteratum%253Aachs%26atitle%3DBibliography%26date%3D2020%26spage%3D137%26epage%3D248%26pub%3DElsevier%26atitle%3DBiological%252BChirality%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lotfi  Derdour</span>, <span class="hlFld-ContribAuthor ">Eric J.  Chan</span>, <span class="hlFld-ContribAuthor ">Dimitri  Skliar</span>. </span><span class="cited-content_cbyCitation_article-title">Review and Modeling of Crystal Growth of Atropisomers from Solutions. </span><span class="cited-content_cbyCitation_journal-name">Processes</span><span> <strong>2019,</strong> <em>7 </em>
                                    (9)
                                     , 611. <a href="https://doi.org/10.3390/pr7090611" title="DOI URL">https://doi.org/10.3390/pr7090611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pr7090611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpr7090611%26sid%3Dliteratum%253Aachs%26jtitle%3DProcesses%26atitle%3DReview%252Band%252BModeling%252Bof%252BCrystal%252BGrowth%252Bof%252BAtropisomers%252Bfrom%252BSolutions%26aulast%3DDerdour%26aufirst%3DLotfi%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D9%26spage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne R  Bresnick</span>, <span class="hlFld-ContribAuthor ">Jonathan M  Backer</span>. </span><span class="cited-content_cbyCitation_article-title">PI3Kβ—A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling. </span><span class="cited-content_cbyCitation_journal-name">Endocrinology</span><span> <strong>2019,</strong> <em>160 </em>
                                    (3)
                                     , 536-555. <a href="https://doi.org/10.1210/en.2018-00843" title="DOI URL">https://doi.org/10.1210/en.2018-00843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/en.2018-00843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fen.2018-00843%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrinology%26atitle%3DPI3K%2525CE%2525B2%2525E2%252580%252594A%252BVersatile%252BTransducer%252Bfor%252BGPCR%25252C%252BRTK%25252C%252Band%252BSmall%252BGTPase%252BSignaling%26aulast%3DBresnick%26aufirst%3DAnne%2BR%26date%3D2019%26date%3D2019%26volume%3D160%26issue%3D3%26spage%3D536%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle  Miller</span>, <span class="hlFld-ContribAuthor ">Philip  Thompson</span>, <span class="hlFld-ContribAuthor ">Sandra  Gabelli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of Isoform Selectivity in PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , 82. <a href="https://doi.org/10.3390/biom9030082" title="DOI URL">https://doi.org/10.3390/biom9030082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9030082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9030082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructural%252BDeterminants%252Bof%252BIsoform%252BSelectivity%252Bin%252BPI3K%252BInhibitors%26aulast%3DMiller%26aufirst%3DMichelle%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D3%26spage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Docked pose of <b>1</b> in the cocrystal structure of mouse p110β (catalytic subunit of PI3Kβ, residues 114–1064, pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BFR">4BFR</a>, coordinates included in the <a class="ref internalNav" href="#notes1" aria-label="SI">SI</a>). The quinoline adopts an orthogonal conformation relative to the benzimidazole. For clarity, some residues have been removed. Blue dashed lines show hydrogen bond contacts between the inhibitor and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. 2.60 Å X-ray crystal structure of (<i>P</i>)-<b>28</b> bound in the PI3Kδ ATP binding site (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DGT">6DGT</a>). For clarity, some residues have been removed. Blue dashed lines show hydrogen bond contacts between the inhibitor and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Protein and lipid kinase selectivity profiles of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a) and (<i>P</i>)-<b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b) using the DiscoveRx KINOMEscan platform at a compound concentration of 10 μM (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for data report). PI3Kβ highlighted with a blue circle. Image generated using TREEspot Software Tool and reprinted with permission from KINOMEscan, a division of DiscoveRx Corporation, DiscoveRx Corp., 2010.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Major metabolites of (<i>M</i>)-<b>28</b> after 4 h incubation in cryopreserved human hepatocytes. The analogous oxidation of the quinoline to <b>M1</b> for (<i>P</i>)-<b>28</b> could not be identified in the same experiment (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for complete analyses of the metabolic profiles of (<i>M</i>)-<b>28</b> and (<i>P</i>)-<b>28</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. UV chromatograms of (<i>M</i>)-<b>28</b> and (<i>P</i>)-<b>28</b> following 2 h incubation with human liver cytosol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Rotational Barriers of Compounds <b>1</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>The best estimates for the rotational barriers Δ<i>E</i><sub>rot</sub> via TS<sub>in</sub> and TS<sub>out</sub> were obtained from the lowest energy pathway in either direction (clockwise or counterclockwise).</p><p class="last"><span class="fn-label"><sup>b</sup></span>Determined using equilibrium kinetics and the Eyring–Polanyi equation (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a> for details).</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/medium/jm-2018-00797c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>1</b>, (<i>rac</i>)-<b>28</b>, (<i>P</i>)-<b>28</b>, and (<i>M</i>)-<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00797/20180802/images/large/jm-2018-00797c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00797&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C (49%); (b) Zn dust, AcOH, MeOH, rt (93%); (c) bromine, DCM, 0 °C (62%); (d) trimethyl orthoformate, reflux (61%); (e) 1 M LiOH, THF, rt; (f) NH<sub>4</sub>Cl, EDC, HOBt, DIEA, 50 °C (82% over 2 steps); (g) bis(neopentyl glycolato)diboron, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, dioxane, reflux (96%); (h) 2,3-difluoro-4-iodopyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 100 °C (54%); (i) DMF-DMA, 100 °C, then hydrazine, AcOH, 45 °C; (j) NH<sub>4</sub>OH (28–30% in water), DMSO, 85 °C (16% over 2 steps); (k) Ac<sub>2</sub>O, AcOH, reflux (62%); (l) bis(neopentyl glycolato)diboron, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, dioxane, reflux (91%); (m) 2,3-difluoro-4-iodopyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, dioxane, 90 °C (72%); (n) 1 M LiOH, THF, rt; (o) NH<sub>4</sub>Cl, EDC, HOBt, DIEA, 50 °C (80% over 2 steps); (p) DMF-DMA, 100 °C, then hydrazine, AcOH, 45) NH<sub>4</sub>OH (28–30% in water), DMSO, 85 °C (55% over 2 steps); and (r) chiral separation (CHIRALPAK OD-H SFC 5 μM 21 × 250 mm column in 30% MeOH/CO<sub>2</sub> at 60 mL/min).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Eliel, E. L.</span>; <span class="NLM_string-name">Wilen, S. H.</span></span> <i>Stereochemistry of Organic Compounds</i>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=E.+L.+Eliel&author=S.+H.+Wilen&title=Stereochemistry+of+Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEliel%26aufirst%3DE.%2BL.%26btitle%3DStereochemistry%2520of%2520Organic%2520Compounds%26pub%3DWiley%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasamy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghunathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaguru, J.</span></span> <span> </span><span class="NLM_article-title">Nonbiaryl and heterobiaryl atropisomers: molecular templates with promise for atroposelective chemical transformations</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">11239</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKru7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=11239-1130&author=E.+Kumarasamyauthor=R.+Raghunathanauthor=M.+P.+Sibiauthor=J.+Sivaguru&title=Nonbiaryl+and+heterobiaryl+atropisomers%3A+molecular+templates+with+promise+for+atroposelective+chemical+transformations&doi=10.1021%2Facs.chemrev.5b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Nonbiaryl and Heterobiaryl Atropisomers: Molecular Templates with Promise for Atropselective Chemical Transformations</span></div><div class="casAuthors">Kumarasamy, Elango; Raghunathan, Ramya; Sibi, Mukund P.; Sivaguru, J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11239-11300</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on synthesis, phys. characteristics, and applications of nonbiaryl atropisomers in synthetic transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLa9BsyBCVwrVg90H21EOLACvtfcHk0lg3uhUlyn2KMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKru7jE&md5=64f3442934834101d51dcbe7d6fd1122</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00136%26sid%3Dliteratum%253Aachs%26aulast%3DKumarasamy%26aufirst%3DE.%26aulast%3DRaghunathan%26aufirst%3DR.%26aulast%3DSibi%26aufirst%3DM.%2BP.%26aulast%3DSivaguru%26aufirst%3DJ.%26atitle%3DNonbiaryl%2520and%2520heterobiaryl%2520atropisomers%253A%2520molecular%2520templates%2520with%2520promise%2520for%2520atroposelective%2520chemical%2520transformations%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D11239%26epage%3D1130%26doi%3D10.1021%2Facs.chemrev.5b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P.</span></span> <span> </span><span class="NLM_article-title">A twist of nature - the significance of atopisomers in biological systems</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1562</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1039/C4NP00121D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1039%2FC4NP00121D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=26282828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=1562-1583&author=J.+E.+Smythauthor=N.+M.+Butlerauthor=P.+Keller&title=A+twist+of+nature+-+the+significance+of+atopisomers+in+biological+systems&doi=10.1039%2FC4NP00121D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">A twist of nature - the significance of atropisomers in biological systems</span></div><div class="casAuthors">Smyth, Jamie E.; Butler, Nicholas M.; Keller, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1562-1583</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covering: up to mid-2015Recently identified natural atropisomeric compds. with potential medicinal applications are presented.  The ability of natural receptors to possess differential binding between atropisomers is an important factor when considering active and inactive atropisomeric drugs, and has required the development of new techniques for atropselective synthesis of desired targets.  Advances in this field therefore have significant relevance to modern pharmaceutical and medicinal chem.  The atropisomeric natural products discussed include hibarimicinone, flavomannins, talaromannins, viriditoxin, rugulotrosin A, abyssomicin C, marinopyrroles, dixiamycins, streptorubin B, ustiloxins A-F, haouamine A, bisnicalaterines, and tedarene B, all of which show significant potential as leads in antibiotic, antiviral and anticancer studies.  The importance for the development of common practices regarding atropisomer recognition and classification is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0hzR1osyzPLVg90H21EOLACvtfcHk0lgrH2qTSgLTRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsLfF&md5=449bdc252cc2b0206fa71c1b0a1ce418</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1039%2FC4NP00121D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00121D%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DJ.%2BE.%26aulast%3DButler%26aufirst%3DN.%2BM.%26aulast%3DKeller%26aufirst%3DP.%26atitle%3DA%2520twist%2520of%2520nature%2520-%2520the%2520significance%2520of%2520atopisomers%2520in%2520biological%2520systems%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2015%26volume%3D32%26spage%3D1562%26epage%3D1583%26doi%3D10.1039%2FC4NP00121D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bringmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortimer, A. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gresser, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuning, M.</span></span> <span> </span><span class="NLM_article-title">Atroposelective synthesis of axially chiral biaryl compounds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">5384</span>– <span class="NLM_lpage">5427</span>, <span class="refDoi"> DOI: 10.1002/anie.200462661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.200462661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2ks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5384-5427&author=G.+Bringmannauthor=A.+J.+P.+Mortimerauthor=P.+A.+Kellerauthor=M.+J.+Gresserauthor=J.+Garnerauthor=M.+Breuning&title=Atroposelective+synthesis+of+axially+chiral+biaryl+compounds&doi=10.1002%2Fanie.200462661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Atroposelective synthesis of axially chiral biaryl compounds</span></div><div class="casAuthors">Bringmann, Gerhard; Mortimer, Anne J. Price; Keller, Paul A.; Gresser, Mary J.; Garner, James; Breuning, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5384-5427</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  A rotationally hindered and thus stereogenic biaryl axis is the structurally and stereochem. decisive element of a steadily growing no. of natural products, chiral auxiliaries, and catalysts.  Thus, it is not surprising that significant advances have been made in the asym. synthesis of axially chiral biaryl compds. over the past decade.  In addn. to the classic approach (direct stereoselective aryl-aryl coupling), innovative concepts have been developed in which the asym. information is introduced into a preformed, but achiral-i.e., sym. or configurationally labile-biaryl compd., or in which an aryl-C single bond is stereoselectively transformed into an axis.  This review classifies these strategies according to their underlying concepts and critically evaluates their scope and limitations with ref. to selected model reactions and applications.  Furthermore, the preconditions required for the existence of axial chirality in biaryl compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL_2TLwAMAebVg90H21EOLACvtfcHk0lgrH2qTSgLTRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2ks7c%253D&md5=707d980d89cf63000577df2be2e2881d</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462661%26sid%3Dliteratum%253Aachs%26aulast%3DBringmann%26aufirst%3DG.%26aulast%3DMortimer%26aufirst%3DA.%2BJ.%2BP.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26aulast%3DGresser%26aufirst%3DM.%2BJ.%26aulast%3DGarner%26aufirst%3DJ.%26aulast%3DBreuning%26aufirst%3DM.%26atitle%3DAtroposelective%2520synthesis%2520of%2520axially%2520chiral%2520biaryl%2520compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5384%26epage%3D5427%26doi%3D10.1002%2Fanie.200462661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Oki, M.</span></span> <span> </span><span class="NLM_article-title">Recent advances in atropisomerism</span>. In  <i>Topics in Stereochemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allinger, N. L.</span>, <span class="NLM_string-name">Eliel, E. L.</span>, <span class="NLM_string-name">Wilen, S. H.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1983</span>; Vol.  <span class="NLM_volume">14</span>, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">81</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=1-81&author=M.+Okiauthor=N.+L.+Allinger&author=E.+L.+Eliel&author=S.+H.+Wilen&title=Topics+in+Stereochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOki%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520atropisomerism%26btitle%3DTopics%2520in%2520Stereochemistry%26aulast%3DAllinger%26aufirst%3DN.%2BL.%26pub%3DWiley%26date%3D1983%26volume%3D14%26spage%3D1%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eichelbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, A. S.</span></span> <span> </span><span class="NLM_article-title">Stereochemical aspects of drug action and disposition</span>. <i>Adv. Drug Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/S0065-2490(96)80003-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1016%2FS0065-2490%2896%2980003-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADyaK28XmvFSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1996&pages=1-64&author=M.+Eichelbaumauthor=A.+S.+Gross&title=Stereochemical+aspects+of+drug+action+and+disposition&doi=10.1016%2FS0065-2490%2896%2980003-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemical aspects of drug action and disposition</span></div><div class="casAuthors">Eichelbaum, Michel; Gross, Annette S.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Drug Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-64</span>CODEN:
                <span class="NLM_cas:coden">ADRRAN</span>;
        ISSN:<span class="NLM_cas:issn">0065-2490</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review with many refs.  In view of the widespread clin. use of racemates, it is the purpose of this article to provide background information on the implications of stereochem. for drug action and disposition.  It is not intended to cover all of the literature published on this topic but will rather focus on the principles involved, with use of illustrative examples to demonstrate the implications for the therapeutic use of chiral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqe_t6ME4XWbVg90H21EOLACvtfcHk0lgiJQe854CJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvFSrsrw%253D&md5=48fe084d7fb40143d2f6fc1329e4ce54</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2FS0065-2490%2896%2980003-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-2490%252896%252980003-7%26sid%3Dliteratum%253Aachs%26aulast%3DEichelbaum%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DA.%2BS.%26atitle%3DStereochemical%2520aspects%2520of%2520drug%2520action%2520and%2520disposition%26jtitle%3DAdv.%2520Drug%2520Res.%26date%3D1996%26volume%3D28%26spage%3D1%26epage%3D64%26doi%3D10.1016%2FS0065-2490%2896%2980003-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Crossley, R. J.</span></span> <i>Chirality and the Biological Activity of Drugs</i>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=R.+J.+Crossley&title=Chirality+and+the+Biological+Activity+of+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrossley%26aufirst%3DR.%2BJ.%26btitle%3DChirality%2520and%2520the%2520Biological%2520Activity%2520of%2520Drugs%26pub%3DCRC%2520Press%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branch, S. K.</span></span> <span> </span><span class="NLM_article-title">Stereochemical origin of some clinically significant drug safety concerns: lessons for future drug development</span>. <i>Adverse Drug React. Toxicol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=9838970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFartr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=145-190&author=R.+R.+Shahauthor=J.+M.+Midgleyauthor=S.+K.+Branch&title=Stereochemical+origin+of+some+clinically+significant+drug+safety+concerns%3A+lessons+for+future+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemical origin of some clinically significant drug safety concerns: lessons for future drug development</span></div><div class="casAuthors">Shah, R. R.; Midgley, J. M.; Branch, Sarah K.</div><div class="citationInfo"><span class="NLM_cas:title">Adverse Drug Reactions and Toxicological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">145-190</span>CODEN:
                <span class="NLM_cas:coden">ADRRER</span>;
        ISSN:<span class="NLM_cas:issn">0964-198X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 147 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqztFwy82FUm7Vg90H21EOLACvtfcHk0lgiJQe854CJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFartr4%253D&md5=408144ec1368248c9eedf31f0deb71ed</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%2BR.%26aulast%3DMidgley%26aufirst%3DJ.%2BM.%26aulast%3DBranch%26aufirst%3DS.%2BK.%26atitle%3DStereochemical%2520origin%2520of%2520some%2520clinically%2520significant%2520drug%2520safety%2520concerns%253A%2520lessons%2520for%2520future%2520drug%2520development%26jtitle%3DAdverse%2520Drug%2520React.%2520Toxicol.%2520Rev.%26date%3D1998%26volume%3D17%26spage%3D145%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Toenjes, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism in medicinal chemistry: challenges and opportunities</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.4155%2Ffmc-2017-0152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=29380622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=409-422&author=S.+T.+Toenjesauthor=J.+L.+Gustafson&title=Atropisomerism+in+medicinal+chemistry%3A+challenges+and+opportunities&doi=10.4155%2Ffmc-2017-0152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerism in medicinal chemistry: challenges and opportunities</span></div><div class="casAuthors">Toenjes, Sean T.; Gustafson, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-422</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Atropisomerism is a dynamic type of axial chirality that is ubiquitous in medicinal chem.  There are several examples of stable atropisomeric US FDA-approved drugs and exptl. compds., and in each case the atropisomers of these compds. possess drastically different biol. activities.  Rapidly interconverting atropisomerism is even more prevalent, and while such compds. are typically considered achiral, they bind their protein targets in an atroposelective fashion, with the nonrelevant atropisomer contributing little to the desired activities.  It has been recently demonstrated that various properties of an interconverting atropisomer can be modulated through the synthesis of atropisomer stable and pure analogs.  Herein we discuss examples of atropisomerism in drug discovery as well as challenges and opportunities moving forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaSgfKDqoiYbVg90H21EOLACvtfcHk0liIDrMrtiG9Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCntLc%253D&md5=ceb5cc2626d980aa3e3903fd126a3f3a</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0152%26sid%3Dliteratum%253Aachs%26aulast%3DToenjes%26aufirst%3DS.%2BT.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26atitle%3DAtropisomerism%2520in%2520medicinal%2520chemistry%253A%2520challenges%2520and%2520opportunities%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D409%26epage%3D422%26doi%3D10.4155%2Ffmc-2017-0152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Glunz, P. W.</span></span> <span> </span><span class="NLM_article-title">Recent encounters with atropisomerism in drug discovery</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1016%2Fj.bmcl.2017.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=29223590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFejurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=53-60&author=P.+W.+Glunz&title=Recent+encounters+with+atropisomerism+in+drug+discovery&doi=10.1016%2Fj.bmcl.2017.11.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent encounters with atropisomerism in drug discovery</span></div><div class="casAuthors">Glunz, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Atropisomerism is stereochem. arising from restricted bond rotation that creates a chiral axis.  Atropisomers are subject to time-dependent inversion of chirality via bond rotation, a property which in drug mols. introduces complexity and challenges for drug discovery and development processes.  Greater recognition of the occurrence of atropisomerism and improved characterization techniques have helped medicinal chemists successfully advance atropisomeric drug mols.  This review provides recent examples of atropisomerism encountered in medicinal chem. efforts and the strategies used to address the accompanying challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraiY1w4I4F5bVg90H21EOLACvtfcHk0liIDrMrtiG9Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFejurzL&md5=6a2552071f43374a3626a9e52a987fa6</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26atitle%3DRecent%2520encounters%2520with%2520atropisomerism%2520in%2520drug%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D53%26epage%3D60%26doi%3D10.1016%2Fj.bmcl.2017.11.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span> <span> </span><span class="NLM_article-title">Revealing atropisomer axial chirality in drug discovery</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fcmdc.201000485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=21360821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFCjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=505-513&author=S.+R.+Laplanteauthor=P.+J.+Edwardsauthor=L.+D.+Faderauthor=A.+Jakalianauthor=O.+Hucke&title=Revealing+atropisomer+axial+chirality+in+drug+discovery&doi=10.1002%2Fcmdc.201000485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing Atropisomer Axial Chirality in Drug Discovery</span></div><div class="casAuthors">LaPlante, Steven R.; Edwards, Paul J.; Fader, Lee D.; Jakalian, Araz; Hucke, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">505-513</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An often overlooked source of chirality is atropisomerism, which results from slow rotation along a bond axis due to steric hindrance and/or electronic factors.  If undetected or not managed properly, this time-dependent chirality has the potential to lead to serious consequences, because atropisomers can be present as distinct enantiomers or diastereoisomers with their attendant different properties.  Herein we introduce a strategy to reveal and classify compds. that have atropisomeric chirality.  Energy barriers to axial rotation were calcd. using quantum mechanics, from which predicted high barriers could be exptl. validated.  A calcd. rotational energy barrier of 20 kcal mol-1 was established as a suitable threshold to distinguish between atropisomers and non-atropisomers with a prediction accuracy of 86 %.  This methodol. was applied to subsets of drug databases in the course of which atropisomeric drugs were identified.  In addn., some drugs were exposed that were not yet known to have this chiral attribute.  The most valuable utility of this tool will be to predict atropisomerism along the drug discovery pathway.  When used in concert with our compd. classification scheme, decisions can be made during early discovery stages such as "hit-to-lead" and "lead optimization," to foresee and validate the presence of atropisomers and to exercise options of removing, further stabilizing, or rendering the chiral axis of interest more freely rotatable via SAR design, thereby decreasing this potential liability within a compd. series.  The strategy can also improve drug development plans, such as detg. whether a drug or series should be developed as a racemic mixt. or as an isolated single compd.  Moreover, the work described herein can be extended to other chem. fields that require the assessment of potential chiral axes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbveHPmngfyLVg90H21EOLACvtfcHk0liIDrMrtiG9Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFCjs7w%253D&md5=d3616133d0e2f01f59ceca435cb2df69</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000485%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DHucke%26aufirst%3DO.%26atitle%3DRevealing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D505%26epage%3D513%26doi%3D10.1002%2Fcmdc.201000485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 Inhibitors: optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&issue=14&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+Dimauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.-H.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+Inhibitors%3A+optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0lgWViL1DOofhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520Inhibitors%253A%2520optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D14%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forseth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppenol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious phosphoinositide 3-kinase δ inhibitors with improved metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9228</span>– <span class="NLM_lpage">9242</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01169</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01169" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9228-9242&author=L.+Patelauthor=J.+Chandrasekharauthor=J.+Evartsauthor=K.+Forsethauthor=A.+C.+Haranauthor=C.+Ipauthor=A.+Kashishianauthor=M.+Kimauthor=D.+Koditekauthor=S.+Koppenolauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=S.+Perreaultauthor=K.+D.+Puriauthor=A.%0AG.+Villase%C3%B1orauthor=J.+R.+Somozaauthor=B.+H.+Steinerauthor=J.+Therrienauthor=J.+Treibergauthor=G.+Phillips&title=Discovery+of+orally+efficacious+phosphoinositide+3-kinase+%CE%B4+inhibitors+with+improved+metabolic+stability&doi=10.1021%2Facs.jmedchem.6b01169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability</span></div><div class="casAuthors">Patel, Leena; Chandrasekhar, Jayaraman; Evarts, Jerry; Forseth, Kristen; Haran, Aaron C.; Ip, Carmen; Kashishian, Adam; Kim, Musong; Koditek, David; Koppenol, Sandy; Lad, Latesh; Lepist, Eve-Irene; McGrath, Mary E.; Perreault, Stephane; Puri, Kamal D.; Villasenor, Armando G.; Somoza, John R.; Steiner, Bart H.; Therrien, Joseph; Treiberg, Jennifer; Phillips, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9228-9242</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant signaling of phosphoinositide-3-kinase delta (PI3K-delta) has been implicated in numerous pathologies including hematol. malignancies and rheumatoid arthritis.  Described in this manuscript is the discovery, optimization and in vivo evaluation of a novel series of pyridine-contg. PI3K-delta inhibitors.  This work led to the discovery of I, a highly selective inhibitor of PI3K-delta which displays an excellent pharmacokinetic profile and is efficacious in a rodent model of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1LgrP9YV8frVg90H21EOLACvtfcHk0liL8g6HwYACzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGrs7rF&md5=6d9dff0ec5270aab250fcb4800d8635a</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01169%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DForseth%26aufirst%3DK.%26aulast%3DHaran%26aufirst%3DA.%2BC.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DKoppenol%26aufirst%3DS.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSteiner%26aufirst%3DB.%2BH.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520inhibitors%2520with%2520improved%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9228%26epage%3D9242%26doi%3D10.1021%2Facs.jmedchem.6b01169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Watterson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucca, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langevine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traeger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattoli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermeier, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discenza, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulicicchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcintyre, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1<i>H</i>-carbazole-8-carboxamide (BMS-986142): a reversible inhibitor of Bruton’s Tyrosine Kinase (BTK) conformationally constrained by two locked atropisomers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">9173</span>– <span class="NLM_lpage">9200</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9173-9200&issue=19&author=S.+H.+Wattersonauthor=G.+V.+De+Luccaauthor=Q.+Shiauthor=C.+M.+Langevineauthor=Q.+Liuauthor=D.+G.+Battauthor=M.+B.+Bertrandauthor=H.+Gongauthor=J.+Daiauthor=S.+Yipauthor=P.+Liauthor=D.+Sunauthor=D.-R.+Wuauthor=C.+Wangauthor=Y.+Zhangauthor=S.+C.+Traegerauthor=M.+A.+Pattoliauthor=S.+Skalaauthor=L.+Chengauthor=M.+T.+Obermeierauthor=R.+Vickeryauthor=L.+N.+Discenzaauthor=C.+J.+D%E2%80%99Arienzoauthor=Y.+Zhangauthor=E.+Heimrichauthor=K.+M.+Gilloolyauthor=T.+L.+Taylorauthor=C.+Pulicicchioauthor=K.+W.+Mcintyreauthor=M.+A.+Galellaauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=C.+Changauthor=R.+Rampullaauthor=A.+Mathurauthor=L.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=A.+Furaauthor=J.+R.+Burkeauthor=J.+A.+Tino&title=Discovery+of+6-fluoro-5-%28R%29-%283-%28S%29-%288-fluoro-1-methyl-2%2C4-dioxo-1%2C2-dihydroquinazolin-3%284H%29-yl%29-2-methylphenyl%29-2-%28S%29-%282-hydroxypropan-2-yl%29-2%2C3%2C4%2C9-tetrahydro-1H-carbazole-8-carboxamide+%28BMS-986142%29%3A+a+reversible+inhibitor+of+Bruton%E2%80%99s+Tyrosine+Kinase+%28BTK%29+conformationally+constrained+by+two+locked+atropisomers&doi=10.1021%2Facs.jmedchem.6b01088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01088%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DDe%2BLucca%26aufirst%3DG.%2BV.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DBertrand%26aufirst%3DM.%2BB.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DYip%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DVickery%26aufirst%3DR.%26aulast%3DDiscenza%26aufirst%3DL.%2BN.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHeimrich%26aufirst%3DE.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DMcintyre%26aufirst%3DK.%2BW.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25206-fluoro-5-%2528R%2529-%25283-%2528S%2529-%25288-fluoro-1-methyl-2%252C4-dioxo-1%252C2-dihydroquinazolin-3%25284H%2529-yl%2529-2-methylphenyl%2529-2-%2528S%2529-%25282-hydroxypropan-2-yl%2529-2%252C3%252C4%252C9-tetrahydro-1H-carbazole-8-carboxamide%2520%2528BMS-986142%2529%253A%2520a%2520reversible%2520inhibitor%2520of%2520Bruton%25E2%2580%2599s%2520Tyrosine%2520Kinase%2520%2528BTK%2529%2520conformationally%2520constrained%2520by%2520two%2520locked%2520atropisomers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D9173%26epage%3D9200%26doi%3D10.1021%2Facs.jmedchem.6b01088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokensgard, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span> <span> </span><span class="NLM_article-title">Exploring atropisomerism to increase target selectivity of kinase inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">11754</span>– <span class="NLM_lpage">11759</span>, <span class="refDoi"> DOI: 10.1002/anie.201506085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.201506085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=11754-11759&author=D.+E.+Smithauthor=I.+Marquezauthor=M.+E.+Lokensgardauthor=A.+L.+Rheingoldauthor=D.+A.+Hechtauthor=J.+L.+Gustafson&title=Exploring+atropisomerism+to+increase+target+selectivity+of+kinase+inhibitors&doi=10.1002%2Fanie.201506085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1002%2Fanie.201506085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201506085%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DMarquez%26aufirst%3DI.%26aulast%3DLokensgard%26aufirst%3DM.%2BE.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DHecht%26aufirst%3DD.%2BA.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26atitle%3DExploring%2520atropisomerism%2520to%2520increase%2520target%2520selectivity%2520of%2520kinase%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D11754%26epage%3D11759%26doi%3D10.1002%2Fanie.201506085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devadas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selness, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of atropisomer PH-797804, a p38 MAP kinase inhibitor, as a clinical drug candidate</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fcmdc.201100439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=273-280&author=L.+Xingauthor=B.+Devadasauthor=R.+V.+Devrajauthor=S.+R.+Selnessauthor=H.+Shiehauthor=J.+K.+Walkerauthor=M.+Maoauthor=D.+Messingauthor=B.+Samasauthor=J.+Z.+Yangauthor=G.+D.+Andersonauthor=E.+G.+Webbauthor=J.+B.+Monahan&title=Discovery+and+characterization+of+atropisomer+PH-797804%2C+a+p38+MAP+kinase+inhibitor%2C+as+a+clinical+drug+candidate&doi=10.1002%2Fcmdc.201100439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100439%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%2BZ.%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DWebb%26aufirst%3DE.%2BG.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520atropisomer%2520PH-797804%252C%2520a%2520p38%2520MAP%2520kinase%2520inhibitor%252C%2520as%2520a%2520clinical%2520drug%2520candidate%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D273%26epage%3D280%26doi%3D10.1002%2Fcmdc.201100439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing atropisomer axial chirality in drug discovery and development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+Laplanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+F.+Millerauthor=P.+J.+Edwards&title=Assessing+atropisomer+axial+chirality+in+drug+discovery+and+development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0lgCEYmCY7wo7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%2BF.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Clayden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span> <span> </span><span class="NLM_article-title">The challenge of atropisomerism in drug discovery</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6398</span>– <span class="NLM_lpage">6401</span>, <span class="refDoi"> DOI: 10.1002/anie.200901719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.200901719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=19637174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6398-6401&author=J.+Claydenauthor=W.+J.+Moranauthor=P.+J.+Edwardsauthor=S.+R.+Laplante&title=The+challenge+of+atropisomerism+in+drug+discovery&doi=10.1002%2Fanie.200901719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">The Challenge of Atropisomerism in Drug Discovery</span></div><div class="casAuthors">Clayden, Jonathan; Moran, Wesley J.; Edwards, Paul J.; LaPlante, Steven R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">6398-6401</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Herein, we address the pharmaceutical implications of a hitherto largely overlooked alternative source of drug chirality: atropisomerism.  Atropisomers are conformers which, owing to steric or electronic constraints, interconvert slowly enough (by definition, with a half life of > 1000 s) that they can be isolated.'781 The stereochem. consequences of hindered rotation about a single bond can be such that an apparent single compd. can actually be a mixt. of two, or an apparently achiral compd. can actually be racemic.  If such pairs of stereoisomers are separable, then the implications for drug discovery may be similar to those of compds. with classical chiral centers.  In the context of a lack of std. procedures for dealing with atropisomerism, and the absence of specific regulatory policies governing conformationally based stereochem., we explore some recent examples of atropisomeric compds. that have been or are in drug development.  We also draw conclusions relating to potential strategies for design and development where atropisomerism is an issue.  We expose and propose options for the management of atropisomerism, which, many view as a lurking menace with the potential to significantly increase the cost of pharmaceutical research and development if ignored.  Atropisomerism may give rise to geometrical isomers, diastereoisomers, or enantiomers, all with the distinctive feature that they can in principle be equilibrated thermally.  In the absence of specific regulatory policies, atropisomeric stereoisomers are best dealt with in the same way as stereoisomers with classical chiral centers, but with isomerization rates and where necessary, differential conformer populations taken into account.  For racemic drug candidates, the FDA policy statement from 1992 emphasizes the importance of understanding the main therapeutic activities of the isomers through in vitro or in vivo studies.  Studies of the pharmacokinetic behavior of the individual enantiomers carried out early in the development of drug candidates are also valuable.  Knowledge gained from these studies can help guide the choice of development of a single enantiomer vs. a racemic mixt.  Development of a drug as a racemic mixt. may be appropriate if the mixt. is not reasonably separable (by synthetic methods, HPLC anal., etc.) or if racemization is rapid in vitro and/or in vivo (as in ibuprofen or thalidomide), thus making it futile to administer only the eutomer (more active isomer).  However, it is nonetheless highly recommended that crit. pharmacol. attributes related to the safety and efficacy of both isomers is investigated: overall, there must be an acceptable toxicol. profile and a suitable therapeutic window (in vitro, in animal models, and in humans).  FDA website provides some useful guidance to their expectations for drug development in this context.  Options for dealing with the phenomenon of atropisomerism can be implemented at the early stage of drug design.  For example, it may be possible to make related analogs that have the following features: (1) symmetry about a hindered bond, thus eliminating a chiral axis; (2) faster rotation about a hindered bond, thus pushing the half-life for conformational interconversion down to the order of seconds; (3) further encumbrance about a hindered bond to produce separable atropisomers whose interconversion is negligibly slow (for example, half-lives of the order of millennia); or (4) introduction of a stable stereogenic center to perturb the population of interconverting atropisomers such that only one desirable conformation predominates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsMjlS3iQPEbVg90H21EOLACvtfcHk0lgCEYmCY7wo7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurfN&md5=70ff6fe476e7db4653130fe74af9325e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1002%2Fanie.200901719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200901719%26sid%3Dliteratum%253Aachs%26aulast%3DClayden%26aufirst%3DJ.%26aulast%3DMoran%26aufirst%3DW.%2BJ.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26atitle%3DThe%2520challenge%2520of%2520atropisomerism%2520in%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D6398%26epage%3D6401%26doi%3D10.1002%2Fanie.200901719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of a phosphoinositide 3-kinase (PI3K) β/δ Inhibitor for the treatment of phosphatase and tensin homolog (PTEN) deficient tumors: building PI3Kβ potency in a PI3Kδ-selective template by targeting non-conserved Asp856</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1567</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01821</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01821" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1555-1567&author=S.+Perreaultauthor=J.+Chandrasekharauthor=Z.-H.+Cuiauthor=J.+Evartsauthor=J.+Haoauthor=J.+A.+Kaplanauthor=A.+Kashishianauthor=K.+S.+Keeganauthor=T.+Kenneyauthor=D.+Koditekauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=L.+Patelauthor=B.+Phillipsauthor=J.+Therrienauthor=J.+Treibergauthor=A.+Yahiaouiauthor=G.+Phillips&title=Discovery+of+a+phosphoinositide+3-kinase+%28PI3K%29+%CE%B2%2F%CE%B4+Inhibitor+for+the+treatment+of+phosphatase+and+tensin+homolog+%28PTEN%29+deficient+tumors%3A+building+PI3K%CE%B2+potency+in+a+PI3K%CE%B4-selective+template+by+targeting+non-conserved+Asp856&doi=10.1021%2Facs.jmedchem.6b01821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01821%26sid%3Dliteratum%253Aachs%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DZ.-H.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DJ.%2BA.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKeegan%26aufirst%3DK.%2BS.%26aulast%3DKenney%26aufirst%3DT.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DYahiaoui%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520phosphoinositide%25203-kinase%2520%2528PI3K%2529%2520%25CE%25B2%252F%25CE%25B4%2520Inhibitor%2520for%2520the%2520treatment%2520of%2520phosphatase%2520and%2520tensin%2520homolog%2520%2528PTEN%2529%2520deficient%2520tumors%253A%2520building%2520PI3K%25CE%25B2%2520potency%2520in%2520a%2520PI3K%25CE%25B4-selective%2520template%2520by%2520targeting%2520non-conserved%2520Asp856%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1555%26epage%3D1567%26doi%3D10.1021%2Facs.jmedchem.6b01821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosulich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert-van der Brempt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmann, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maudet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgentin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquet, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Péru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vautier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warin, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of (R)-8-(1-(3,5-difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4Hchromene-6-carboxamide (AZD8186): a potent and selective inhibitor of PI3Kβ and PI3Kδ for the treatment of PTEN-deficient cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1021/jm501629p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501629p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=943-962&author=B.+Barlaamauthor=S.+Cosulichauthor=S.+Degorceauthor=M.+Fitzekauthor=S.+Greenauthor=U.+Hancoxauthor=C.+Lambert-van+der+Bremptauthor=J.-J.+Lohmannauthor=M.+Maudetauthor=R.+Morgentinauthor=M.-J.+Pasquetauthor=A.+P%C3%A9ruauthor=P.+Pl%C3%A9author=T.+Salehauthor=M.+Vautierauthor=M.+Walkerauthor=L.+Wardauthor=N.+Warin&title=Discovery+of+%28R%29-8-%281-%283%2C5-difluorophenylamino%29ethyl%29-N%2CN-dimethyl-2-morpholino-4-oxo-4Hchromene-6-carboxamide+%28AZD8186%29%3A+a+potent+and+selective+inhibitor+of+PI3K%CE%B2+and+PI3K%CE%B4+for+the+treatment+of+PTEN-deficient+cancers&doi=10.1021%2Fjm501629p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm501629p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501629p%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DDegorce%26aufirst%3DS.%26aulast%3DFitzek%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHancox%26aufirst%3DU.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DLohmann%26aufirst%3DJ.-J.%26aulast%3DMaudet%26aufirst%3DM.%26aulast%3DMorgentin%26aufirst%3DR.%26aulast%3DPasquet%26aufirst%3DM.-J.%26aulast%3DP%25C3%25A9ru%26aufirst%3DA.%26aulast%3DPl%25C3%25A9%26aufirst%3DP.%26aulast%3DSaleh%26aufirst%3DT.%26aulast%3DVautier%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DWarin%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520%2528R%2529-8-%25281-%25283%252C5-difluorophenylamino%2529ethyl%2529-N%252CN-dimethyl-2-morpholino-4-oxo-4Hchromene-6-carboxamide%2520%2528AZD8186%2529%253A%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520PI3K%25CE%25B2%2520and%2520PI3K%25CE%25B4%2520for%2520the%2520treatment%2520of%2520PTEN-deficient%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D943%26epage%3D962%26doi%3D10.1021%2Fjm501629p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Certal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halley, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virone-Oddos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filoche-Rommé, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Ahmad, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carry, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnevaux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquette, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Below, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vade, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebourg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilorge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angouillant-Boniface, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louboutin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1021/jm401642q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401642q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=903-920&issue=3&author=V.+Certalauthor=F.+Halleyauthor=A.+Virone-Oddosauthor=C.+Delormeauthor=A.+Karlssonauthor=A.+Rakauthor=F.+Thompsonauthor=B.+Filoche-Romm%C3%A9author=Y.+El-Ahmadauthor=J.-C.+Carryauthor=P.-Y.+Abecassisauthor=P.+Lejeuneauthor=L.+Vincentauthor=H.+Bonnevauxauthor=J.-P.+Nicolasauthor=T.+Bertrandauthor=J.-P.+Marquetteauthor=N.+Michotauthor=T.+Benardauthor=P.+Belowauthor=I.+Vadeauthor=F.+Chatreauxauthor=G.+Lebourgauthor=F.+Pilorgeauthor=O.+Angouillant-Bonifaceauthor=A.+Louboutinauthor=C.+Lengauerauthor=L.+Schio&title=Discovery+and+optimization+of+pyrimidone+indoline+amide+PI3K%CE%B2+inhibitors+for+the+treatment+of+phosphatase+and+tensin+homologue+%28PTEN%29-deficient+cancers&doi=10.1021%2Fjm401642q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Pyrimidone Indoline Amide PI3Kβ Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)-Deficient Cancers</span></div><div class="casAuthors">Certal, Victor; Carry, Jean-Christophe; Halley, Frank; Virone-Oddos, Angela; Thompson, Fabienne; Filoche-Romme, Bruno; El-Ahmad, Youssef; Karlsson, Andreas; Charrier, Veronique; Delorme, Cecile; Rak, Alexey; Abecassis, Pierre-Yves; Amara, Celine; Vincent, Loic; Bonnevaux, Helene; Nicolas, Jean-Paul; Mathieu, Magali; Bertrand, Thomas; Marquette, Jean-Pierre; Michot, Nadine; Benard, Tsiala; Perrin, Marc-Antoine; Lemaitre, Olivier; Guerif, Stephane; Perron, Sebastien; Monget, Sylvie; Gruss-Leleu, Florence; Doerflinger, Gilles; Guizani, Houlfa; Brollo, Maurice; Delbarre, Laurence; Bertin, Luc; Richepin, Patrick; Loyau, Veronique; Garcia-Echeverria, Carlos; Lengauer, Christoph; Schio, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">903-920</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compelling mol. biol. publications have reported the implication of phosphoinositide kinase PI3Kβ in PTEN-deficient cell line growth and proliferation.  These findings supported a scientific rationale for the development of PI3Kβ-specific inhibitors for the treatment of PTEN-deficient cancers.  This paper describes the discovery of 2-[2-(2,3-dihydro-indol-1-yl)-2-oxo-ethyl]-6-morpholin-4-yl-3H-pyrimidin-4-one and the optimization of this new series of active and selective pyrimidone indoline amide PI3Kβ inhibitors. 2-[2-(2-Methyl-2,3-dihydro-indol-1-yl)-2-oxo-ethyl]-6-morpholin-4-yl-3H-pyrimidin-4-one (I), identified following a carefully designed Me scan, displayed improved physicochem. and in vitro pharmacokinetic properties.  Structural biol. efforts enabled the acquisition of the first x-ray cocrystal structure of p110β with the selective inhibitor compd. I bound to the ATP site.  The nonplanar binding mode described herein is consistent with obsd. structure-activity relationship for the series.  Compd. I demonstrated significant in vivo activity in a UACC-62 xenograft model in mice, warranting further preclin. investigation.  Following successful development, compd. 28 entered phase I/Ib clin. trial in patients with advanced cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5QsHhXYO6d7Vg90H21EOLACvtfcHk0lgKxF-qVsr8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOjsw%253D%253D&md5=8141ae91a81b06ad129afd2263e2a007</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fjm401642q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401642q%26sid%3Dliteratum%253Aachs%26aulast%3DCertal%26aufirst%3DV.%26aulast%3DHalley%26aufirst%3DF.%26aulast%3DVirone-Oddos%26aufirst%3DA.%26aulast%3DDelorme%26aufirst%3DC.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DF.%26aulast%3DFiloche-Romm%25C3%25A9%26aufirst%3DB.%26aulast%3DEl-Ahmad%26aufirst%3DY.%26aulast%3DCarry%26aufirst%3DJ.-C.%26aulast%3DAbecassis%26aufirst%3DP.-Y.%26aulast%3DLejeune%26aufirst%3DP.%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DBonnevaux%26aufirst%3DH.%26aulast%3DNicolas%26aufirst%3DJ.-P.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DMarquette%26aufirst%3DJ.-P.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DBenard%26aufirst%3DT.%26aulast%3DBelow%26aufirst%3DP.%26aulast%3DVade%26aufirst%3DI.%26aulast%3DChatreaux%26aufirst%3DF.%26aulast%3DLebourg%26aufirst%3DG.%26aulast%3DPilorge%26aufirst%3DF.%26aulast%3DAngouillant-Boniface%26aufirst%3DO.%26aulast%3DLouboutin%26aufirst%3DA.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DSchio%26aufirst%3DL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520pyrimidone%2520indoline%2520amide%2520PI3K%25CE%25B2%2520inhibitors%2520for%2520the%2520treatment%2520of%2520phosphatase%2520and%2520tensin%2520homologue%2520%2528PTEN%2529-deficient%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D3%26spage%3D903%26epage%3D920%26doi%3D10.1021%2Fjm401642q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lopez de Turiso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaropong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seganish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simard, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7667</span>– <span class="NLM_lpage">7685</span>, <span class="refDoi"> DOI: 10.1021/jm300679u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300679u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKnsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7667-7685&author=F.+Gonzalez-Lopez+de+Turisoauthor=Y.+Shinauthor=M.+Brownauthor=M.+Cardozoauthor=Y.+Chenauthor=D.+Fongauthor=X.+Haoauthor=X.+Heauthor=K.+Henneauthor=Y.-L.+Huauthor=M.+G.+Johnsonauthor=T.+Kohnauthor=J.+Lohmanauthor=H.+J.+McBrideauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=K.+Minerauthor=D.+Mohnauthor=V.+Pattaropongauthor=J.+Seganishauthor=J.+L.+Simardauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=G.+Yuauthor=T.+D.+Cushing&title=Discovery+and+in+vivo+evaluation+of+dual+PI3K%CE%B2%2F%CE%B4+inhibitors&doi=10.1021%2Fjm300679u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors</span></div><div class="casAuthors">Gonzalez-Lopez de Turiso, Felix; Shin, Youngsook; Brown, Matthew; Cardozo, Mario; Chen, Yi; Fong, David; Hao, Xiaolin; He, Xiao; Henne, Kirk; Hu, Yi-Ling; Johnson, Michael G.; Kohn, Todd; Lohman, Julia; McBride, Helen J.; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; Miner, Kent; Mohn, Deanna; Pattaropong, Vatee; Seganish, Jennifer; Simard, Jillian L.; Wannberg, Sharon; Whittington, Douglas A.; Yu, Gang; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7667-7685</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based rational design led to the synthesis of a novel series of potent PI3K inhibitors.  The optimized pyrrolopyridine analog I was a potent and selective PI3Kβ/δ dual inhibitor that displayed suitable physicochem. properties and pharmacokinetic profile for animal studies.  Analog I was found to be efficacious in animal models of inflammation including a keyhole limpet hemocyanin (KLH) study and a collagen-induced arthritis (CIA) disease model of rheumatoid arthritis.  These studies highlight the potential therapeutic value of inhibiting both the PI3Kβ and δ isoforms in the treatment of a no. of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpslq3QL1Tg7LVg90H21EOLACvtfcHk0lgKxF-qVsr8ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKnsr3J&md5=fbf690a0e702faf17e16ef68db076635</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm300679u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300679u%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DKohn%26aufirst%3DT.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DMcBride%26aufirst%3DH.%2BJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMiner%26aufirst%3DK.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DSeganish%26aufirst%3DJ.%26aulast%3DSimard%26aufirst%3DJ.%2BL.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%2520and%2520in%2520vivo%2520evaluation%2520of%2520dual%2520PI3K%25CE%25B2%252F%25CE%25B4%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7667%26epage%3D7685%26doi%3D10.1021%2Fjm300679u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span> <span> </span><span class="NLM_article-title">The PI3K pathway as drug target in human cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1200/JCO.2009.25.3641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1200%2FJCO.2009.25.3641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=20085938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1075-1083&author=K.+D.+Courtneyauthor=R.+B.+Corcoranauthor=J.+A.+Engelman&title=The+PI3K+pathway+as+drug+target+in+human+cancer&doi=10.1200%2FJCO.2009.25.3641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The PI3K pathway as drug target in human cancer</span></div><div class="casAuthors">Courtney, Kevin D.; Corcoran, Ryan B.; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1083</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth, survival, motility, and metab.  This pathway is activated by several different mechanisms in cancers, including somatic mutation and amplification of genes encoding key components.  In addn., PI3K signaling may serve integral functions for noncancerous cells in the tumor microenvironment.  Consequently, therapeutics targeting the PI3K pathway are being developed at a rapid pace, and preclin. and early clin. studies are beginning to suggest specific strategies to effectively use them.  However, the central role of PI3K signaling in a large array of diverse biol. processes raises concerns about its use in therapeutics and increases the need to develop sophisticated strategies for its use.  In this review, we will discuss how PI3K signaling affects the growth and survival of tumor cells.  From this vantage, we will consider how inhibitors of the PI3K signaling cascade, either alone or in combination with other therapeutics, can most effectively be used for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPqtk2bVl0rVg90H21EOLACvtfcHk0lgz-dDEePQOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D&md5=b88b394919647e2eb47e7735355fde2a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.3641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.3641%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520PI3K%2520pathway%2520as%2520drug%2520target%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1075%26epage%3D1083%26doi%3D10.1200%2FJCO.2009.25.3641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Haas-Kogan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yount, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G.</span></span> <span> </span><span class="NLM_article-title">Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1016/S0960-9822(07)00493-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1016%2FS0960-9822%2807%2900493-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=9799739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADyaK1cXntFWgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1195-1198&author=D.+Haas-Koganauthor=N.+Shalevauthor=M.+Wongauthor=G.+Yountauthor=D.+Stokoeauthor=G.+Mills&title=Protein+kinase+B+%28PKB%2FAkt%29+activity+is+elevated+in+glioblastoma+cells+due+to+mutation+of+the+tumor+suppressor+PTEN%2FMMAC&doi=10.1016%2FS0960-9822%2807%2900493-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC</span></div><div class="casAuthors">Haas-Kogan, Daphne; Shalev, Noga; Wong, Michelle; Mills, Gordon; Yount, Garret; Stokoe, David</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1195-1198</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Glioblastomas are highly malignant tumors of the central nervous system that are resistant to radiation and chemotherapy.  The authors explored the role of the phosphatidylinositol (PI) 3-kinase signal transduction pathway in glioblastomas, as this pathway has been shown to inhibit apoptosis induced by cytokine withdrawal and the detachment of cells from the extracellular matrix.  Components of this pathway have been implicated in tumor development.  The authors show that glioblastoma cells, in contrast to primary human astrocytes, contain high endogenous protein kinase B (PKB/Akt) activity and high levels of PI 3,4,5-triphosphate (PI(3,4,5)P3) and PI(3,4)P2, the lipid products of PI 3-kinase.  These glioblastoma cells express mutant forms of the putative 3' phospholipid phosphatase PTEN, also known as MMAC.  Expression of wild-type PTEN derived from primary astrocytes, but not of mutant forms of PTEN, reduced the levels of 3' phosphoinositides and inhibited PKB/Akt activity.  PTEN antagonized the activation of PKB/Akt by growth factors, by activated PI 3-kinase, and by PI-dependent protein kinase-1 (PDK1), but did not antagonize the phospholipid-independent activation of PKB/Akt lacking the pleckstrin homol. (PH) domain.  These results suggest a role for PTEN in regulating the activity of the PI 3-kinase pathway in malignant human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4DJ3A1shJorVg90H21EOLACvtfcHk0lgz-dDEePQOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFWgsbg%253D&md5=1f85263b620aa6e104aa8080274aa2d3</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2807%2900493-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252807%252900493-9%26sid%3Dliteratum%253Aachs%26aulast%3DHaas-Kogan%26aufirst%3DD.%26aulast%3DShalev%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DYount%26aufirst%3DG.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DG.%26atitle%3DProtein%2520kinase%2520B%2520%2528PKB%252FAkt%2529%2520activity%2520is%2520elevated%2520in%2520glioblastoma%2520cells%2520due%2520to%2520mutation%2520of%2520the%2520tumor%2520suppressor%2520PTEN%252FMMAC%26jtitle%3DCurr.%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D1195%26epage%3D1198%26doi%3D10.1016%2FS0960-9822%2807%2900493-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batty, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der
Kaay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolarov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigler, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downes, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">The lipid phosphatase activity of PTEN is critical for its tumor suppressor function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">13513</span>– <span class="NLM_lpage">13518</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.23.13513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1073%2Fpnas.95.23.13513" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13513-13518&author=M.+P.+Myersauthor=I.+Passauthor=I.+H.+Battyauthor=J.+Van+der%0AKaayauthor=J.+P.+Stolarovauthor=B.+A.+Hemmingsauthor=M.+H.+Wiglerauthor=C.+P.+Downesauthor=N.+K.+Tonks&title=The+lipid+phosphatase+activity+of+PTEN+is+critical+for+its+tumor+suppressor+function&doi=10.1073%2Fpnas.95.23.13513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.23.13513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.23.13513%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DM.%2BP.%26aulast%3DPass%26aufirst%3DI.%26aulast%3DBatty%26aufirst%3DI.%2BH.%26aulast%3DVan%2Bder%2BKaay%26aufirst%3DJ.%26aulast%3DStolarov%26aufirst%3DJ.%2BP.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DDownes%26aufirst%3DC.%2BP.%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DThe%2520lipid%2520phosphatase%2520activity%2520of%2520PTEN%2520is%2520critical%2520for%2520its%2520tumor%2520suppressor%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D13513%26epage%3D13518%26doi%3D10.1073%2Fpnas.95.23.13513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederschain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deBeaumont, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span> <span> </span><span class="NLM_article-title">PTEN-deficient cancers depend on PIK3CB</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13057</span>– <span class="NLM_lpage">13062</span>, <span class="refDoi"> DOI: 10.1073/pnas.0802655105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1073%2Fpnas.0802655105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=18755892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSitbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13057-13062&author=S.+Weeauthor=D.+Wiederschainauthor=S.-M.+Mairaauthor=A.+Looauthor=C.+Millerauthor=R.+deBeaumontauthor=F.+Stegmeierauthor=Y.-M.+Yaoauthor=C.+Lengauer&title=PTEN-deficient+cancers+depend+on+PIK3CB&doi=10.1073%2Fpnas.0802655105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN-deficient cancers depend on PIK3CB</span></div><div class="casAuthors">Wee, Susan; Wiederschain, Dmitri; Maira, Sauveur-Michel; Loo, Alice; Miller, Christine; de Beaumont, Rosalie; Stegmeier, Frank; Yao, Yung-Mae; Lengauer, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">13057-13062</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Deregulation of the PI3K signaling pathway is obsd. in many human cancers and occurs most frequently through loss of PTEN phosphatase tumor suppressor function or through somatic activating mutations in the Class IA PI3K, PIK3CA.  Tumors harboring activated p110α, the protein product of PIK3CA, require p110α activity for growth and survival and hence are expected to be responsive to inhibitors of its lipid kinase activity.  Whether PTEN-deficient cancers similarly depend on p110α activity to sustain activation of the PI3K pathway has been unclear.  In this study, we used a single-vector lentiviral inducible shRNA system to selectively inactivate the three Class IA PI3Ks, PIK3CA, PIK3CB, and PIK3CD, to det. which PI3K isoforms are responsible for driving the abnormal proliferation of PTEN-deficient cancers.  Down-regulation of PIK3CA in colorectal cancer cells harboring mutations in PIK3CA inhibited downstream PI3K signaling and cell growth.  Surprisingly, PIK3CA depletion affected neither PI3K signaling nor cell growth in 3 PTEN-deficient cancer cell lines.  In contrast, down-regulation of the PIK3CB isoform, which encodes p110β, resulted in pathway inactivation and subsequent inhibition of growth in both cell-based and in vivo settings.  This essential function of PIK3CB in PTEN-deficient cancer cells required its lipid kinase activity.  Our findings demonstrate that although p110α activation is required to sustain the proliferation of established PIK3CA-mutant tumors, PTEN-deficient tumors are dependent instead on p110β signaling.  This unexpected finding demonstrates the need to tailor therapeutic approaches to the genetic basis of PI3K pathway activation to achieve optimal treatment response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ybGsv3DVCrVg90H21EOLACvtfcHk0ljSQIxPLOuirQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSitbrO&md5=b7c690d3631ac6cbee9d7d7414dae1da</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802655105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802655105%26sid%3Dliteratum%253Aachs%26aulast%3DWee%26aufirst%3DS.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DdeBeaumont%26aufirst%3DR.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DYao%26aufirst%3DY.-M.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DPTEN-deficient%2520cancers%2520depend%2520on%2520PIK3CB%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13057%26epage%3D13062%26doi%3D10.1073%2Fpnas.0802655105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span> <span> </span><span class="NLM_article-title">Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>454</i></span>,  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1038/nature07091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1038%2Fnature07091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=18594509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Snu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=776-779&author=S.+Jiaauthor=Z.+Liuauthor=S.+Zhangauthor=P.+Liuauthor=L.+Zhangauthor=S.+H.+Leeauthor=L.+J.+Zhangauthor=S.+Signorettiauthor=M.+Lodaauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Essential+roles+of+PI%283%29K-p110%CE%B2+in+cell+growth%2C+metabolism+and+tumorigenesis&doi=10.1038%2Fnature07091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis</span></div><div class="casAuthors">Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Signoretti, Sabina; Loda, Massimo; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">454</span>
        (<span class="NLM_cas:issue">7205</span>),
    <span class="NLM_cas:pages">776-779</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">On activation by receptors, the ubiquitously expressed class IA isoforms (p110α and p110β) of phosphatidylinositol-3-kinase (PI(3)K) generate lipid second messengers, which initiate multiple signal transduction cascades.  Recent studies have demonstrated specific functions for p110α in growth factor and insulin signaling.  To probe for distinct functions of p110β, we constructed conditional knockout mice.  Here we show that ablation of p110β in the livers of the resulting mice leads to impaired insulin sensitivity and glucose homeostasis, while having little effect on phosphorylation of Akt, suggesting the involvement of a kinase-independent role of p110β in insulin metabolic action.  Using established mouse embryonic fibroblasts, we found that removal of p110β also had little effect on Akt phosphorylation in response to stimulation by insulin and epidermal growth factor, but resulted in retarded cell proliferation.  Reconstitution of p110β-null cells with a wild-type or kinase-dead allele of p110β demonstrated that p110β possesses kinase-independent functions in regulating cell proliferation and trafficking.  However, the kinase activity of p110β was required for G-protein-coupled receptor signaling triggered by lysophosphatidic acid and had a function in oncogenic transformation.  Most strikingly, in an animal model of prostate tumor formation induced by Pten loss, ablation of p110β (also known as Pik3cb), but not that of p110α (also known as Pik3ca), impeded tumorigenesis with a concomitant diminution of Akt phosphorylation.  Taken together, our findings demonstrate both kinase-dependent and kinase-independent functions for p110β, and strongly indicate the kinase-dependent functions of p110β as a promising target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm6EUnzNHwHrVg90H21EOLACvtfcHk0liQJZLxebIrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Snu7w%253D&md5=b32d9fcd1e8a0090da3ee8ae918a49db</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fnature07091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07091%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DL.%2BJ.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DEssential%2520roles%2520of%2520PI%25283%2529K-p110%25CE%25B2%2520in%2520cell%2520growth%252C%2520metabolism%2520and%2520tumorigenesis%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D776%26epage%3D779%26doi%3D10.1038%2Fnature07091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span>Force
field minimizations and conformational scans were carried out using
Macromodel, and ab initio calculations were performed using Jaguar,
as implemented in the Maestro suite of programs: Maestro V11.1; Schrödinger,
Inc. Portland, OR, 2017. <a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Force%0Afield+minimizations+and+conformational+scans+were+carried+out+using%0AMacromodel%2C+and+ab+initio+calculations+were+performed+using+Jaguar%2C%0Aas+implemented+in+the+Maestro+suite+of+programs%3A+Maestro+V11.1%3B+Schr%C3%B6dinger%2C%0AInc.+Portland%2C+OR%2C+2017.+http%3A%2F%2Fwww.schrodinger.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">Atoms that are not constrained during the torsional scan tend to distort significantly out of plane to avoid steric clashes near the transition states. The calculated energy barriers vary with the choice of the specific atoms used to define the torsional scan.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Closely related analogs lacking the 5- or 8-fluoro on the quinoline ((<i>rac</i>)-3-fluoro-4-(1-(8-fluoroquinolin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1H-benzo[<i>d</i>]imidazol-6-yl)pyridin-2-amine and (<i>rac</i>)-3-fluoro-4-(1-(5-fluoroquinolin-4-yl)-2-methyl-4-(4<i>H</i>-1,2,4-triazol-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)pyridin-2-amine) result in approximatively 3-fold loss in potency against PI3Kβ.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">Analytical methods indicate that both purified atropisomers are free of the other by the limit of detection of our technology (>99% ee). (<i>M</i>)-<b>28</b> may be completely devoid of activity, but a 0.1% impurity of (<i>P</i>)-<b>28</b> would result in single digit micromolar activity (<10 μM).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span> The crystallization
and structure determination of PI3Kδ bound with (<i>P</i>)-<b>28</b> was determined using methods described previously:<span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villasenor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novikov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagpacan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papalia, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span> <span> </span><span class="NLM_article-title">Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase δ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">8439</span>– <span class="NLM_lpage">8446</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.634683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1074%2Fjbc.M114.634683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=25631052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVSqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=8439-8446&author=J.+R.+Somozaauthor=D.+Koditekauthor=A.+G.+Villasenorauthor=N.+Novikovauthor=M.+H.+Wongauthor=A.+Liclicanauthor=W.+Xingauthor=L.+Lagpacanauthor=R.+Wangauthor=B.+E.+Schultzauthor=G.+A.+Papaliaauthor=D.+Samuelauthor=L.+Ladauthor=M.+E.+McGrath&title=Structural%2C+biochemical%2C+and+biophysical+characterization+of+idelalisib+binding+to+phosphoinositide+3-kinase+%CE%B4&doi=10.1074%2Fjbc.M114.634683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ</span></div><div class="casAuthors">Somoza, John R.; Koditek, David; Villasenor, Armando G.; Novikov, Nikolai; Wong, Melanie H.; Liclican, Albert; Xing, Weimei; Lagpacan, Leanna; Wang, Ruth; Schultz, Brian E.; Papalia, Giuseppe A.; Samuel, Dharmaraj; Lad, Latesh; McGrath, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">8439-8446</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Idelalisib (also known as GS-1101, CAL-101, IC489666, and Zydelig) is a PI3Kδ inhibitor that has recently been approved for the treatment of several hematol. malignancies.  Given its use in human diseases, we needed a clear picture of how idelalisib binds to and inhibits PI3Kδ.  Our data show that idelalisib is a potent and selective inhibitor of the kinase activity of PI3Kδ.  A kinetic characterization clearly demonstrated ATP-competitive inhibition, and several addnl. biochem. and biophys. assays showed that the compd. binds reversibly and noncovalently to the kinase.  A crystal structure of idelalisib bound to the p110δ subunit of PI3Kδ furthers our understanding of the binding interactions that confer the potency and selectivity of idelalisib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnXZo8_qK79rVg90H21EOLACvtfcHk0liQJZLxebIrEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVSqtrs%253D&md5=2969b7407f4edc367249215bbbf22a0e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.634683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.634683%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DW.%26aulast%3DLagpacan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26atitle%3DStructural%252C%2520biochemical%252C%2520and%2520biophysical%2520characterization%2520of%2520idelalisib%2520binding%2520to%2520phosphoinositide%25203-kinase%2520%25CE%25B4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D8439%26epage%3D8446%26doi%3D10.1074%2Fjbc.M114.634683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prelog, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmchen, G.</span></span> <span> </span><span class="NLM_article-title">Basic principles of the CIP-system and proposals for a revision</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1002/anie.198205671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1002%2Fanie.198205671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1982&pages=567-583&author=V.+Prelogauthor=G.+Helmchen&title=Basic+principles+of+the+CIP-system+and+proposals+for+a+revision&doi=10.1002%2Fanie.198205671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fanie.198205671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.198205671%26sid%3Dliteratum%253Aachs%26aulast%3DPrelog%26aufirst%3DV.%26aulast%3DHelmchen%26aufirst%3DG.%26atitle%3DBasic%2520principles%2520of%2520the%2520CIP-system%2520and%2520proposals%2520for%2520a%2520revision%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1982%26volume%3D21%26spage%3D567%26epage%3D583%26doi%3D10.1002%2Fanie.198205671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span> <span> </span><span class="NLM_article-title">The p110δ crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williamsauthor=P.+Ren&title=The+p110%CE%B4+crystal+structure+uncovers+mechanisms+for+selectivity+and+potency+of+novel+PI3K+inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lgED2EPJQLq4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DRen%26aufirst%3DP.%26atitle%3DThe%2520p110%25CE%25B4%2520crystal%2520structure%2520uncovers%2520mechanisms%2520for%2520selectivity%2520and%2520potency%2520of%2520novel%2520PI3K%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">The DiscoveRx KINOMEscan platform employs an active site-directed competition binding assay to quantitatively measure interactions between test compounds against more than 400 human kinases. KINOME scan assays do not require ATP and thereby report true thermodynamic interaction affinities, as opposed to IC<sub>50</sub> values, which can depend on the ATP concentration.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pryde, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-D.</span></span> <span> </span><span class="NLM_article-title">Aldehyde oxidase: an enzyme of emerging importance in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8441</span>– <span class="NLM_lpage">8460</span>, <span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+an+enzyme+of+emerging+importance+in+drug+discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0ljgo1jodYgmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520an%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1124/dmd.110.033555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1124%2Fdmd.110.033555" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1322-1327&author=M.+Zientekauthor=Y.+Jiangauthor=K.+Youdimauthor=R.+S.+Obach&title=In+vitro-in+vivo+correlation+for+intrinsic+clearance+for+drugs+metabolized+by+human+aldehyde+oxidase&doi=10.1124%2Fdmd.110.033555"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033555%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520for%2520intrinsic%2520clearance%2520for%2520drugs%2520metabolized%2520by%2520human%2520aldehyde%2520oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1322%26epage%3D1327%26doi%3D10.1124%2Fdmd.110.033555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korzekwa, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMasters, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. P.</span></span> <span> </span><span class="NLM_article-title">Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4642</span>– <span class="NLM_lpage">4647</span>, <span class="refDoi"> DOI: 10.1021/jm0703690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&issue=19&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+density+functional+calculations+to+predict+the+regioselectivity+of+drugs+and+molecules+metabolized+by+aldehyde+oxidase&doi=10.1021%2Fjm0703690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Torres, Rhonda A.; Korzekwa, Kenneth R.; McMasters, Daniel R.; Fandozzi, Christine M.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4642-4647</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidn. of aldehydes and nitrogen-contg. heterocycles.  The enzyme plays a dual role in the metab. of physiol. important endogenous compds. and the biotransformation of xenobiotics.  Using d. functional theory methods, geometry optimization of tetrahedral intermediates of drugs and druglike compds. was examd. to predict the likely metabolites of aldehyde oxidase.  The calcns. suggest that the lowest energy tetrahedral intermediate resulting from the initial substrate corresponds to the obsd. metabolite ≥90% of the time.  Addnl. calcns. were performed on a series of heterocyclic compds. where the products resulting from metab. by xanthine oxidase and aldehyde oxidase differ in many instances.  Again, the lowest energy tetrahedral intermediate corresponded to the obsd. product of aldehyde oxidase metab. ≥90% for the compds. examd., while the obsd. products of xanthine oxidase were not well predicted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmnIR2Ha4_oLVg90H21EOLACvtfcHk0ljgo1jodYgmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D&md5=514ee5703f306287a3b7315fc5cea434</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520density%2520functional%2520calculations%2520to%2520predict%2520the%2520regioselectivity%2520of%2520drugs%2520and%2520molecules%2520metabolized%2520by%2520aldehyde%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4642%26epage%3D4647%26doi%3D10.1021%2Fjm0703690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. A.</span></span> <span> </span><span class="NLM_article-title">Refinement of in vitro methods for identification of aldehyde oxidase substrate reveals metabolites of kinases inhibitors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1124/dmd.118.080960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1124%2Fdmd.118.080960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=846-859&author=R.+A.+Dick&title=Refinement+of+in+vitro+methods+for+identification+of+aldehyde+oxidase+substrate+reveals+metabolites+of+kinases+inhibitors&doi=10.1124%2Fdmd.118.080960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.118.080960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.118.080960%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DR.%2BA.%26atitle%3DRefinement%2520of%2520in%2520vitro%2520methods%2520for%2520identification%2520of%2520aldehyde%2520oxidase%2520substrate%2520reveals%2520metabolites%2520of%2520kinases%2520inhibitors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2018%26volume%3D46%26spage%3D846%26epage%3D859%26doi%3D10.1124%2Fdmd.118.080960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Strelevitz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.045195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1124%2Fdmd.112.045195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=22522748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1441-1448&author=T.+J.+Strelevitzauthor=C.+C.+Orozcoauthor=R.+S.+Obach&title=Hydralazine+as+a+selective+probe+inactivator+of+aldehyde+oxidase+in+human+hepatocytes%3A+estimation+of+the+contribution+of+aldehyde+oxidase+to+metabolic+clearance&doi=10.1124%2Fdmd.112.045195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance</span></div><div class="casAuthors">Strelevitz, Timothy J.; Orozco, Christine C.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1441-1448</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) metab. could lead to significant underestimation of clearance in prediction of human pharmacokinetics as well as unanticipated exposure to AO-generated metabolites, if not accounted for early in drug research.  We report a method using cryopreserved human hepatocytes and the time-dependent AO inhibitor hydralazine (KI = 83 ± 27 μM, kintact = 0.063 ± 0.007 min-1), which ests. the contribution of AO metab. relative to total hepatic clearance.  Using zaleplon as a probe substrate and simultaneously monitoring the AO-catalyzed formation of oxozaleplon and the CYP3A-catalyzed formation of desethyzaleplon in the presence of a range of hydralazine concns., it was detd. that >90% inhibition of the AO activity with minimal effect on the CYP3A activity could be achieved with 25 to 50 μM hydralazine.  This method was used to est. the fraction metabolized due to AO [fm(AO)] for six compds. with clearance attributed to AO along with four other drugs not metabolized by AO.  The fm(AO) values for the AO substrates ranged between 0.49 and 0.83.  Differences in estd. fm(AO) between two batches of pooled human hepatocytes suggest that sensitivity to hydralazine varies slightly with hepatocyte prepns.  Substrates with a CYP2D6 contribution to clearance were affected by hydralazine to a minor extent, because of weak inhibition of this enzyme.  Overall, these findings demonstrate that hydralazine, at a concn. of 25 to 50 μM, can be used in human hepatocyte incubations to est. the contribution of AO to the hepatic clearance of drugs and other compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBKznnCiG-LVg90H21EOLACvtfcHk0lginmXzNHehuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrs7vJ&md5=6237313df0fe4ded2d2f37e55c3d4b03</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.045195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.045195%26sid%3Dliteratum%253Aachs%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DOrozco%26aufirst%3DC.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DHydralazine%2520as%2520a%2520selective%2520probe%2520inactivator%2520of%2520aldehyde%2520oxidase%2520in%2520human%2520hepatocytes%253A%2520estimation%2520of%2520the%2520contribution%2520of%2520aldehyde%2520oxidase%2520to%2520metabolic%2520clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1441%26epage%3D1448%26doi%3D10.1124%2Fdmd.112.045195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anslyn, E. V.</span>; <span class="NLM_string-name">Dougherty, D. A.</span></span> <i>Modern Physical Organic Chemistry</i>; <span class="NLM_publisher-name">University Science Books</span>: <span class="NLM_publisher-loc">Sausalito, CA</span>, <span class="NLM_year">2006</span>, pp  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">389</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=388-389&author=E.+V.+Anslyn&author=D.+A.+Dougherty&title=Modern+Physical+Organic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAnslyn%26aufirst%3DE.%2BV.%26btitle%3DModern%2520Physical%2520Organic%2520Chemistry%26pub%3DUniversity%2520Science%2520Books%26date%3D2006%26spage%3D388%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eyring, H.</span></span> <span> </span><span class="NLM_article-title">The activated complex and the absolute rate of chemial reaction</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1935</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1021/cr60056a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr60056a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1935&pages=65-77&author=H.+Eyring&title=The+activated+complex+and+the+absolute+rate+of+chemial+reaction&doi=10.1021%2Fcr60056a006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fcr60056a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60056a006%26sid%3Dliteratum%253Aachs%26aulast%3DEyring%26aufirst%3DH.%26atitle%3DThe%2520activated%2520complex%2520and%2520the%2520absolute%2520rate%2520of%2520chemial%2520reaction%26jtitle%3DChem.%2520Rev.%26date%3D1935%26volume%3D17%26spage%3D65%26epage%3D77%26doi%3D10.1021%2Fcr60056a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eyring, H.</span></span> <span> </span><span class="NLM_article-title">The activated complex in chemical reaction</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1935</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1063/1.1749604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;key=10.1063%2F1.1749604" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1935&pages=107-115&author=H.+Eyring&title=The+activated+complex+in+chemical+reaction&doi=10.1063%2F1.1749604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1063%2F1.1749604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.1749604%26sid%3Dliteratum%253Aachs%26aulast%3DEyring%26aufirst%3DH.%26atitle%3DThe%2520activated%2520complex%2520in%2520chemical%2520reaction%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1935%26volume%3D3%26spage%3D107%26epage%3D115%26doi%3D10.1063%2F1.1749604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BFR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BFR','PDB','4BFR'); return false;">PDB: 4BFR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DGT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DGT','PDB','6DGT'); return false;">PDB: 6DGT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00797">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08440"></div></div></div></div></div><hr /></hr><p class="last">. The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00797">10.1021/acs.jmedchem.8b00797</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Details of all protocols for in vitro and in vivo experiments, chiral SFC and calculations leading to the experimental rotational barrier, NMR spectra (<sup>1</sup>H, <sup>19</sup>F, and <sup>13</sup>C), kinase selectivity, and molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf">PDF</a>)</p></li><li><p class="inline">(<i>P</i>)-<b>28</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Compounds,	smiles	 data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf">jm8b00797_si_001.pdf (972.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_002.pdb">jm8b00797_si_002.pdb (1.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_003.csv">jm8b00797_si_003.csv (0.41 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates of compound <b>1</b> docked in the cocrystal structure of mouse p110β (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BFR">4BFR</a>, ref <a onclick="showRef(event, 'cit7c'); return false;" href="javascript:void(0);" class="ref cit7c">(7c)</a>) are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00797/suppl_file/jm8b00797_si_001.pdf" class="ext-link">SI</a>. PDB code for (<i>P</i>)-<b>28</b> is 6DGT. Authors will release the atomic coordinates and experimental data upon publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00797&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00797%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-15%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00797" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996db6e95b248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
